Processing 00000000.tx.1: Differential Interactions of Id Proteins with Basic-Helix-Loop-Helix Transcription Factors* (Received for publication, March 21,1997, and in revised form, June 5,1997) Kenneth Langlands , Xiaoying Yin , Geetha Anand and Edward V. 

Phrase: "Differential Interactions of Id Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0872079:interactions protein [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "with Basic-Helix-Loop-Helix Transcription Factors"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0288972:Basic Helix-Loop-Helix Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282642:helix loop helix [Spatial Concept]
   827   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018882:Helix [Eukaryote]
   799   C0040649:Transcription [Genetic Function]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C0419518:Loop [Medical Device]
   799   C0445022:Loop [Spatial Concept]
   799   C1527178:Basic [Functional Concept]
   799   C1704821:Helix [Spatial Concept]
   799   C1705682:Helix [Anatomical Structure]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]
   727 E C0920750:basicity [Quantitative Concept]

Phrase: "*"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "March 21,"

Phrase: "1997,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "June 5,"

Phrase: "1997"

Phrase: ")"

Phrase: "Kenneth Langlands ,"

Phrase: "Xiaoying Yin ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945618:yin [Idea or Concept]

Phrase: "Geetha Anand"

Phrase: "and"

Phrase: "Edward V."
Processing 00000000.tx.2: Prochownik  From the Section of Hematology/Oncology, Children's Hospital of Pittsburgh, The Department of Molecular Genetics and Biochemistry, and The University of Pittsburgh Cancer Institute, The University of Pittsburgh Medical Center, Pittsburgh,Pennsylvania15213 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS REFERENCES ABSTRACT Dimerization of three Id proteins (Id1, Id2, and Id3) with the four class A E proteins (E12, E47, E2-2, and HEB) and two groups of class B proteins, the myogenic regulatory factors (MRFs: MyoD, myogenin, Myf-5 and MRF4/Myf-6), and the hematopoietic factors (Scl/Tal-1, Tal-2, and Lyl-1) were tested in a quantitative yeast 2-hybrid assay. 

Phrase: "Prochownik  From the Section of Hematology/Oncology,"

Phrase: "Children's Hospital of Pittsburgh,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0020017:Children's hospital [Health Care Related Organization]
   770   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   770   C1510665:Hospital [Qualitative Concept]

Phrase: "The Department of Molecular Genetics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587466:Genetics department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "The University of Pittsburgh Cancer Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1519803:University of Pittsburgh Cancer Institute [Health Care Related Organization]
   804   C0006826:Cancer [Neoplastic Process]
   804   C0021622:institute [Organization]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0998265:Cancer [Eukaryote]
   804   C1272753:Institute [Idea or Concept]
   804   C1306459:Cancer [Finding]

Phrase: "The University of Pittsburgh Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0041740:University [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Pittsburgh,"

Phrase: "Pennsylvania15213 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES ACKNOWLEDGEMENTS"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT Dimerization of three Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C2350408:Protein Dimerization [Phenomenon or Process]
   753   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "(Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: ")"

Phrase: "with the four class A E proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "E2-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420639:E2-2 [Gene or Genome]
   861   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "HEB)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420632:HEB [Gene or Genome]
  1000   C3273649:HEB [Gene or Genome]

Phrase: "and"

Phrase: "two groups of class B proteins,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "the myogenic regulatory factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "(MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "myogenin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417575:MYOGENIN [Gene or Genome]
  1000   C2986638:MYOGENIN [Gene or Genome]

Phrase: "Myf-5"

Phrase: "and"

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the hematopoietic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0312859:Haematopoietic factor [Hormone]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(Scl/Tal-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "Tal-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1447263:TAL-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1428449:TAL [Gene or Genome]

Phrase: "and"

Phrase: "Lyl-1"

Phrase: ")"

Phrase: "were"

Phrase: "tested in a quantitative yeast 2-hybrid assay."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0020205:Hybrid [Organism]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0243073:assay [Qualitative Concept]
   744   C0392366:tested [Intellectual Product]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C1510438:Assay [Laboratory Procedure]
   711 E C0022885:Test [Laboratory Procedure]
   711 E C0039593:Test [Functional Concept]
Processing 00000000.tx.3: All three Ids bound with high affinity to E proteins, but a much broader range of interactions was observed between Ids and the class B factors. 

Phrase: "All three Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "bound with high affinity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0205250:High [Qualitative Concept]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "to E proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "a much broader range of interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "observed between Ids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441672:Observed [Functional Concept]
   706   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the class B factors."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0033453:b factor [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   867   C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.4: Id1 and Id2 interacted strongly with MyoD and Myf-5 and weakly with myogenin and MRF4/Myf-6, whereas Id3 interacted weakly with all four MRFs. 

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "interacted"

Phrase: "strongly with MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1417574:MYOD [Gene or Genome]
   790   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5"

Phrase: "and"

Phrase: "weakly with myogenin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1417575:MYOGENIN [Gene or Genome]
   790   C2986638:MYOGENIN [Gene or Genome]

Phrase: "and"

Phrase: "MRF4/Myf-6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: "whereas"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "interacted"

Phrase: "weakly with all four MRFs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205450:Four [Quantitative Concept]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.5: Similar specificities were observed in co-immunoprecipitation and mammalian 2-hybrid analyses. 

Phrase: "Similar specificities"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0037791:Specificity [Quantitative Concept]
   827   C1511884:Specificity [Quantitative Concept]
   777 E C0205369:Specific [Qualitative Concept]
   777 E C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "observed in co-immunoprecipitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "mammalian 2-hybrid analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020205:Hybrid [Organism]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]
Processing 00000000.tx.6: No interactions were found between the Ids and any of the hematopoietic factors. 

Phrase: "No interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "found between the Ids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "any of the hematopoietic factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0312859:Haematopoietic factor [Hormone]
   760   C0018957:Haematopoietic [Body System]
   760   C0229601:Hematopoietic [Functional Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.7: Each Id was able to disrupt the ability of E protein-MyoD complexes to transactivate from a muscle creatine kinase reporter construct in vivo. 

Phrase: "Each Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the ability of E protein-MyoD complexes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "transactivate from a muscle creatine kinase reporter"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0010291:Muscle Creatine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1413435:creatine kinase, muscle [Gene or Genome]
   778   C0010287:Creatine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0010286:Creatine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0026845:Muscle [Tissue]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.8: Finally, mutagenesis experiments showed that the differences between Id1 and Id3 binding map to three amino acids in the first helix and to a small cluster of upstream residues. 

Phrase: "Finally,"

Phrase: "mutagenesis experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the differences between Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "Id3 binding map to three amino acids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0024779:Map [Manufactured Object]
   748   C1706473:Map [Conceptual Entity]

Phrase: "in the first helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "and to a small cluster of upstream residues."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0522505:Upstream [Spatial Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1555715:Cluster [Idea or Concept]
   744   C1704332:Cluster [Quantitative Concept]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.9: The Id proteins thus display a signature range of interactions with all of their potential dimerization partners and may play a role in myogenesis which is distinct from that in hematopoiesis. 

Phrase: "The Id proteins thus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a signature range of interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "with all"

Phrase: "of their potential dimerization partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0682323:partners [Family Group]

Phrase: "and"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in myogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "distinct from that"

Phrase: "in hematopoiesis."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.10: INTRODUCTION An increasingly important role is ascribed to protein-protein interactions in the regulation of cellular growth and differentiation pathways. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "An increasingly important role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "ascribed to protein-protein interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   828   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C1704675:Interaction [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of cellular growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cellular Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "differentiation pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.11: Dimerization serves to convert inactive monomeric molecules into transcriptionally active dimeric complexes at specific times during cellular development. 

Phrase: "Dimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "serves"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "convert"

Phrase: "inactive monomeric molecules into transcriptionally active dimeric complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0567416:molecules [Substance]

Phrase: "at specific times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "during cellular development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.12: Deletional analysis has identified a number of evolutionarily conserved regions that mediate these interactions. 

Phrase: "Deletional analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "has"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a number of evolutionarily conserved regions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "these interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.13: One such region, commonly associated with transcription factors involved in a range of proliferative and differentiation pathways, is the basic-helix-loop-helix (bHLH)1 (1). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "commonly"

Phrase: "associated with transcription factors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0040649:Transcription [Genetic Function]
   737 E C0750490:Associate [Idea or Concept]
   737   C1521761:Factor [Functional Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "involved in a range of proliferative"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0334094:Proliferative [Pathologic Function]
   753   C1314939:Involved [Functional Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "differentiation pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "is"

Phrase: "the basic-helix-loop-helix (bHLH)1"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0282642:helix loop helix [Spatial Concept]
   804   C0018882:Helix [Eukaryote]
   804   C0229304:Helix [Body Part, Organ, or Organ Component]
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]
   804   C1527178:Basic [Functional Concept]
   804   C1704821:Helix [Spatial Concept]
   804   C1705682:Helix [Anatomical Structure]
   733 E C0920750:basicity [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.14: This domain is conserved from yeast to mammals and is composed of a positively charged basic region followed by two amphipathic -helices separated by a spacer loop. 

Phrase: "This domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1880389:Domain [Functional Concept]
  1000   C1883221:Domain [Conceptual Entity]
  1000   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "conserved from yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "to mammals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "and"

Phrase: "is"

Phrase: "composed of a positively"

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "basic region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "followed by two amphipathic -helices"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0018882:Helix [Eukaryote]
   760   C0205448:Two [Quantitative Concept]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1017315:helices [Eukaryote]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "separated by a spacer loop."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0086972:Separated [Finding]
   760   C0221874:Spacer [Medical Device]
   760   C0419518:Loop [Medical Device]
   760   C0443299:separated [Spatial Concept]
   760   C0445022:Loop [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1704737:Spacer [Medical Device]
Processing 00000000.tx.15: Dimers are stabilized by a series of hydrophobic and electrostatic interactions between the helices of compatible molecules (2-5). 

Phrase: "Dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "are"

Phrase: "stabilized by a series of hydrophobic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0184512:Stabilized [Qualitative Concept]
   753   C0205549:Series [Quantitative Concept]
   753   C0598629:Hydrophobic [Qualitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "electrostatic interactions between the helices of compatible molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1704675:Interaction [Functional Concept]
   709   C1167622:Molecular Interaction [Molecular Function]

Phrase: "(2-5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: The juxtaposition of two basic regions resulting from dimerization forms a DNA binding interface able to insert into the major groove in a sequence-specific manner (2, 6). 

Phrase: "The juxtaposition of two basic regions"

Phrase: "resulting from dimerization"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0376525:Dimerization [Natural Phenomenon or Process]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0000702:A-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708533:Interface [Manufactured Object]
  1000   C2698172:Interface [Intellectual Product]

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "insert into the major groove"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1518157:Major Groove [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205164:Major [Qualitative Concept]
   760   C0441587:Insert [Health Care Activity]
   760   C1184482:Groove [Body Space or Junction]
   760   C1743766:Insert [Medical Device]
   760   C1883719:Insert [Functional Concept]

Phrase: "in a sequence-specific manner"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.17: Although bHLH proteins have no discernible DNA binding activity as monomers, dimers recognize a consensus DNA sequence (CANNTG), termed the E box (4, 7-9). 

Phrase: "Although"

Phrase: "bHLH proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   993   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "have"

Phrase: "no discernible DNA binding activity as monomers,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2266866:Binding Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "recognize"

Phrase: "a consensus DNA sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   913   C0079160:Consensus Sequence [Nucleotide Sequence]
   901   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(CANNTG"

Phrase: ")"

Phrase: ","

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "the E box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "(4,"

Phrase: "7-9"

Phrase: ")."
Processing 00000000.tx.18: bHLH transcription factors can be broadly placed into two categories (reviewed in Ref. 10). 

Phrase: "bHLH transcription factors"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0288972:Basic Helix-Loop-Helix Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282642:helix loop helix [Spatial Concept]
   827   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018882:Helix [Eukaryote]
   799   C0040649:Transcription [Genetic Function]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C0419518:Loop [Medical Device]
   799   C0445022:Loop [Spatial Concept]
   799   C1527178:Basic [Functional Concept]
   799   C1704821:Helix [Spatial Concept]
   799   C1705682:Helix [Anatomical Structure]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]
   727 E C0920750:basicity [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "broadly"

Phrase: "placed into two categories"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205448:Two [Quantitative Concept]
   770   C0683312:Categories [Intellectual Product]
   737   C0442504:Place [Spatial Concept]
   737 E C1555713:category [Idea or Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "("

Phrase: "reviewed in Ref. 10"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.19: The class A factors, or E proteins, (E2-2, HEB, and the E2A gene products E12 and E47) are expressed in a virtually ubiquitous pattern and are able to dimerize efficiently with tissue-restricted class B factors to activate gene expression (1, 11-13). 

Phrase: "The class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "E proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(E2-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420639:E2-2 [Gene or Genome]
   861   C3539520:E2 [Gene or Genome]

Phrase: "HEB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420632:HEB [Gene or Genome]
  1000   C3273649:HEB [Gene or Genome]

Phrase: "and"

Phrase: "the E2A gene products E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: ")"

Phrase: "are"

Phrase: "expressed in a virtually ubiquitous pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "dimerize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerize [Natural Phenomenon or Process]

Phrase: "efficiently with tissue-restricted class B factors to"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   767   C0040048:factors tissue [Amino Acid, Peptide, or Protein,Immunologic Factor]
   750   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   750 E C1333522:TISSUE FACTOR [Gene or Genome]
   750   C1824728:FACTOR B [Gene or Genome]
   744   C0040300:Tissue [Tissue]
   744   C0443288:Restricted [Functional Concept]
   744   C0456387:Class [Intellectual Product]
   744   C1547928:Tissue [Intellectual Product]
   744   C1705943:Class [Classification]
   737 E C0046774:B-factor [Nucleic Acid, Nucleoside, or Nucleotide]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "11-13"

Phrase: ")."
Processing 00000000.tx.20: Because each factor contributes a specific DNA recognition half-site, class A and class B heterodimeric complexes and class A hetero- or homodimers theoretically provide distinct combinatorial E box binding specificities (7). 

Phrase: "Because"

Phrase: "each factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "a specific DNA recognition half-site,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0449604:Specific site [Spatial Concept]
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]

Phrase: "class A"

Phrase: "and"

Phrase: "class B heterodimeric complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A hetero-"

Phrase: "or"

Phrase: "homodimers theoretically"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "distinct combinatorial E box binding specificities"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   766   C0037791:Specificity [Quantitative Concept]
   766   C1511884:Specificity [Quantitative Concept]
   716 E C0205369:Specific [Qualitative Concept]
   716 E C1552740:specific [Intellectual Product]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.21: Class B members thus far characterized include the myogenic regulatory factors (MRFs) involved in skeletal muscle development (MyoD, myogenin, Myf-5, and MRF4/Myf-6) and the hematopoietic factors (Scl/Tal-1, Tal-2, and Lyl-1) (14-21). 

Phrase: "Class B members thus far"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0205108:far [Spatial Concept]
   804   C0456387:Class [Intellectual Product]
   804   C0680022:members [Population Group]
   804   C1705943:Class [Classification]
   771 E C2698041:Member [Professional or Occupational Group]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the myogenic regulatory factors (MRFs)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "involved in skeletal muscle development"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0242692:Muscle, Skeletal [Tissue]
   806   C0949649:Muscle Development [Organ or Tissue Function]
   806   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   797   C0449621:Muscle involved [Functional Concept]
   797   C1160401:Skeletal Development [Organism Function]
   760   C0026845:Muscle [Tissue]
   760   C0037253:skeletal [Body System]
   760   C0243107:development [Physiologic Function]
   760   C0521324:Skeletal [Spatial Concept]
   760   C0678723:Development [Organism Function]
   760   C1314939:Involved [Functional Concept]
   760   C1527148:Development [Functional Concept]

Phrase: "(MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "myogenin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417575:MYOGENIN [Gene or Genome]
  1000   C2986638:MYOGENIN [Gene or Genome]

Phrase: "Myf-5,"

Phrase: "and"

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the hematopoietic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0312859:Haematopoietic factor [Hormone]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(Scl/Tal-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "Tal-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1447263:TAL-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1428449:TAL [Gene or Genome]

Phrase: "and"

Phrase: "Lyl-1"

Phrase: ")"

Phrase: "(14-21"

Phrase: ")."
Processing 00000000.tx.22: Mammalian homologues of the Drosophila bHLH achaete scute genes (mash1 and -2) have been implicated in neuronal development as has neurod (beta2) which also has a role in insulin regulation (22-24). 

Phrase: "Mammalian homologues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1334043:Homologue [Gene or Genome]

Phrase: "of the Drosophila bHLH achaete scute genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0017337:Genes [Gene or Genome]

Phrase: "(mash1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083344:MASH1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332009:MASH1 [Gene or Genome]
  1000   C1705844:MASH1 [Gene or Genome]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "implicated in neuronal development"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1657987:neuron development [Cell Function]
   770   C0243107:development [Physiologic Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "as"

Phrase: "has"

Phrase: "neurod"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0297513:NeuroD [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417683:NEUROD [Gene or Genome]
  1000   C3273872:NEUROD [Gene or Genome]

Phrase: "(beta2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1417683:BETA2 [Gene or Genome]
  1000   C1823554:Beta2 [Gene or Genome]
  1000   C3273872:BETA2 [Gene or Genome]

Phrase: ")"

Phrase: "which also"

Phrase: "has"

Phrase: "a role in insulin regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(22-24"

Phrase: ")."
Processing 00000000.tx.23: A range of other class B bHLH proteins have been associated with early mesoderm formation and later muscle development (Twist), adipocyte development (Add1), and skeleton formation (Scl-1) (25-27). 

Phrase: "A range of other class B bHLH proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1514721:Range [Quantitative Concept]
   738   C2348147:Range [Quantitative Concept]
   738   C3542016:Range [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "associated with early mesoderm formation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1160070:mesoderm formation [Organ or Tissue Function]
   760   C0025485:Mesoderm [Embryonic Structure]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1522492:Formation [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "later muscle development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0949649:Muscle Development [Organ or Tissue Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Twist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040480:twist [Physiologic Function]

Phrase: ")"

Phrase: ","

Phrase: "adipocyte development (Add1),"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "skeleton formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Scl-1"

Phrase: ")"

Phrase: "(25-27"

Phrase: ")."
Processing 00000000.tx.24: E box motifs have been identified in the enhancer elements of a number of bHLH factor-regulated genes such as myosin heavy chain, immunoglobulins, and chymotrypsin (10). 

Phrase: "E box motifs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0949655:E-Box Motifs [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C1514562:Motif [Amino Acid Sequence]

Phrase: "have"

Phrase: "been"

Phrase: "identified in the enhancer elements of a number"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0014290:Enhancer Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013879:Elements [Element, Ion, or Isotope]
   744   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205396:Identified [Qualitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "of bHLH factor-regulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017337:Genes [Gene or Genome]

Phrase: "such as myosin heavy chain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420192:heavy chain [Gene or Genome]
   827   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0337112:Chain [Manufactured Object]
   827   C0439539:Heavy [Qualitative Concept]
   827   C1524075:Chain [Idea or Concept]

Phrase: "immunoglobulins,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   966 E C1621846:immunoglobulin [Molecular Function]

Phrase: "and"

Phrase: "chymotrypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.25: The formation of active class A-class B complexes is modulated by the Id (inhibitor of DNA binding) family members. 

Phrase: "The formation of active class A-class B complexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "modulated by the Id (inhibitor of DNA binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C1148673:DNA Binding [Genetic Function]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C0443264:Modulated [Spatial Concept]
   744   C0600091:ID [Intellectual Product]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "family members."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.26: The four Id proteins identified thus far have an HLH domain that lacks the amino-terminal associated basic region necessary for DNA binding (28-33). 

Phrase: "The four Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "thus far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "have"

Phrase: "an HLH domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206678:HLH Domain [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the amino-terminal associated basic region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0017446:Region [Geographic Area]
   804   C0205147:Region [Spatial Concept]
   733 E C0205276:Regional [Spatial Concept]
   733 E C1947913:Regional [Spatial Concept]

Phrase: "necessary for DNA binding"

Phrase: "(28-33"

Phrase: ")."
Processing 00000000.tx.27: Id proteins act to sequester class A factors, inhibiting the formation of active class A-class B heterodimers and are therefore considered to act as dominant negative regulators of differentiation pathways (28, 34, 35). 

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sequester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:sequester [Functional Concept]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the formation of active class A-class B heterodimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "are"

Phrase: "therefore"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as dominant negative regulators of differentiation pathways"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   770   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   744   C0007589:Differentiation [Cell Function]
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0182953:regulators [Medical Device]
   744   C0205160:Negative [Qualitative Concept]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1513916:Negative [Finding]
   744   C1527180:Dominant [Functional Concept]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C2825415:Negative [Conceptual Entity]
   744   C2825491:Negative [Qualitative Concept]
   744   C2945687:Differentiation [Functional Concept]
   711 E C1704734:Regulator [Medical Device]
   711 E C1704735:Regulator [Conceptual Entity]

Phrase: "(28,"

Phrase: "34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.28: Ids are expressed in a largely overlapping but distinct fashion during development, with the highest levels generally being achieved during embryogenesis (33). 

Phrase: "Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "expressed in a largely"

Phrase: "overlapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "but"

Phrase: "distinct fashion during development,"

Phrase: "with the highest levels generally"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "being"

Phrase: "achieved during embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.29: Significant Id levels persist in a range of actively proliferating tissues and in some tumor cell lines (28, 33). 

Phrase: "Significant Id levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0814896:Significance Level [Research Activity]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "persist in a range of actively proliferating tissues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0040300:Tissues [Tissue]
   744   C1514485:Proliferating [Functional Concept]
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]
   711 E C1547928:Tissue [Intellectual Product]

Phrase: "and in some tumor cell lines"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0085983:Tumor Cell Lines [Cell]
   790   C0007600:Cell lines [Cell]
   790   C0431085:Tumor cell [Cell]
   790   C0597032:Tumor Cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1515981:And [Idea or Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3273930:Tumor [Finding]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]

Phrase: "(28,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.30: Rapid Id down-regulation has been reported in myoblasts and hematopoietic cells during terminal differentiation, consistent with their negative regulatory role (28, 34). 

Phrase: "Rapid Id down-regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0013081:Down-Regulation [Cell Function,Molecular Function]
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]
   756   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   756   C2626739:Lanugo [Eukaryote]

Phrase: "has"

Phrase: "been"

Phrase: "reported in myoblasts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0596995:Myoblasts [Cell]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "hematopoietic cells during terminal differentiation,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0007589:cells differentiation [Cell Function]
   790   C2323499:Hematopoietic cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "consistent with their negative regulatory role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(28,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.31: Indeed, forced Id expression has been shown to inhibit the differentiation of each of these cell types (36-40). 

Phrase: "Indeed,"

Phrase: "forced Id expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the differentiation of each of these cell types"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "(36-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.32: Because considerable overlap exists in the expression patterns of Id proteins, redundancy in their function has been inferred (30, 33). 

Phrase: "Because"

Phrase: "considerable overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0185027:overlap [Therapeutic or Preventive Procedure]
   861   C1948020:Overlap [Conceptual Entity]

Phrase: "exists in the expression patterns of Id proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1171362:expression protein [Genetic Function]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0449774:Patterns [Spatial Concept]
   744   C0600091:ID [Intellectual Product]
   744   C2987476:Exist [Conceptual Entity]
   734   C1317658:Protein pattern [Clinical Attribute]

Phrase: "redundancy in their function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1313915:Redundancy [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "inferred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679201:Inferred [Mental Process]
  1000   C3245504:inferred [Idea or Concept]

Phrase: "(30,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.33: Ids are known to bind avidly to class A factors such as E47, weakly to the myogenic factors, and poorly, if at all, to the hematopoietic factors (28, 34, 41). 

Phrase: "Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "avidly to class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456387:Class [Intellectual Product]
   790   C1705943:Class [Classification]

Phrase: "A factors such as E47,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   781 E C0960756:factor A [Organic Chemical]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "weakly to the myogenic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "poorly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "if at all,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750557:If [Qualitative Concept]

Phrase: "to the hematopoietic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0312859:Haematopoietic factor [Hormone]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(28,"

Phrase: "34,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.34: This has led to the assumption that transcriptional control is exerted primarily at the level of Id-class A interactions. 

Phrase: "This"

Phrase: "has"

Phrase: "led to the assumption"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that transcriptional control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1158770:Transcriptional Control [Genetic Function]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "is"

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "primarily at the level of Id-class"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0456387:Class [Intellectual Product]
   748   C0600091:ID [Intellectual Product]
   748   C1547707:Level [Geographic Area]
   748   C1705943:Class [Classification]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "A interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.35: However, these studies were performed with select members of the class A and class B families. 

Phrase: "However,"

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed with"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "members of the class A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "class B families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.36: Thus far, no exhaustive studies exist to compare the relative strengths of interactions among a broader range of family members. 

Phrase: "Thus far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "no exhaustive studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the relative strengths of interactions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0808080:strengths [Idea or Concept]
   726 E C0237897:Strength [Quantitative Concept]
   726 E C1705922:Strength [Qualitative Concept]

Phrase: "among a broader range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "of family members."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0086282:Family Members [Family Group]
   966 E C1611821:Family Member [Intellectual Product]
   861   C0015576:Family [Family Group]
   861   C0680022:members [Population Group]
   861   C1704727:Family [Conceptual Entity]
   827 E C2698041:Member [Professional or Occupational Group]
   789 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.37: The yeast 2-hybrid system has become an increasingly popular method for assessing protein-protein interactions and has been employed previously to study a subset of bHLH interactions (35, 42-44). 

Phrase: "The yeast 2-hybrid system"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "has"

Phrase: "become"

Phrase: "an increasingly popular method for assessing protein-protein interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "previously to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a subset of bHLH interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1515021:Subset [Classification]

Phrase: "(35,"

Phrase: "42-44"

Phrase: ")."
Processing 00000000.tx.38: We sought to develop a quantitative yeast 2-hybrid assay to investigate interactions of three Id proteins with a range of class A and class B factor targets. 

Phrase: "We"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "a quantitative yeast 2-hybrid assay to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   799   C0005507:Assay [Laboratory Procedure]
   799   C0020205:Hybrid [Organism]
   799   C0036025:yeast [Fungus]
   799   C0043392:Yeast [Food]
   799   C0043393:Yeast [Fungus]
   799   C0243073:assay [Qualitative Concept]
   799   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   799   C1510438:Assay [Laboratory Procedure]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "interactions of three Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0872079:interactions protein [Molecular Function]
   726   C1704675:Interaction [Functional Concept]

Phrase: "with a range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of class A"

Phrase: "and"

Phrase: "class B factor targets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521840:Target [Functional Concept]
   779   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.39: Our observations, confirmed and extended by co-immunoprecipitation (IP) of in vitro translated proteins and mammalian 2-hybrid analyses, indicate that discrete and reproducible differences exist in relative binding preferences among the Id proteins. 

Phrase: "Our observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extended by co-immunoprecipitation (IP) of in vitro translated proteins"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0021069:Immunoprecipitation [Laboratory Procedure]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0040710:translated [Occupational Activity]
   742   C0231448:Extended [Functional Concept]
   742   C0231449:Extended [Spatial Concept]
   742   C0439792:extended [Spatial Concept]

Phrase: "and"

Phrase: "mammalian 2-hybrid analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0020205:Hybrid [Organism]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "indicate"

Phrase: "that discrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699782:Discrete [Qualitative Concept]

Phrase: "and"

Phrase: "reproducible differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "exist in relative binding preferences"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0558295:Preferences [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1547039:*Relative [Quantitative Concept]
   760   C2987476:Exist [Conceptual Entity]
   726 E C1549513:Preference [Idea or Concept]

Phrase: "among the Id proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.40: As expected, Id proteins bound avidly to all the class A factors tested, although a range of affinities were apparent. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "avidly to all"

Phrase: "the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "although"

Phrase: "a range of affinities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]

Phrase: "were"

Phrase: "apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.41: A broader range of affinities for myogenic factors was observed, and no interactions with the hematopoietic factors were seen despite their expression in functional form. 

Phrase: "A broader range of affinities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "for myogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "no interactions with the hematopoietic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "seen despite their expression"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "in functional form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.42: Transient transfection studies in C3H myoblasts employing a muscle-specific creatinine kinase- chloramphenicol acetyltransferase (CAT) reporter vector provided independent confirmation of the hierarchical interactions of Id proteins with class A factors. 

Phrase: "Transient transfection studies in C3H myoblasts"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   753   C0040704:Transient [Population Group]
   753   C0205374:Transient [Temporal Concept]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "employing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:employing [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "a muscle-specific creatinine kinase- chloramphenicol acetyltransferase (CAT) reporter vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0442335:Vector [Spatial Concept]
   793   C1705099:Vector [Idea or Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "independent confirmation of the hierarchical interactions of Id proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   742   C0750484:Confirmation [Idea or Concept]

Phrase: "with class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.43: Site-directed mutagenesis enabled us to map the regions responsible for establishing Id dimerization preferences to the first helix of the HLH domain and to residues immediately adjacent to this. 

Phrase: "Site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "the regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "responsible for establishing Id dimerization preferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "to the first helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "of the HLH domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206678:HLH Domain [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "and to residues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1515981:And [Idea or Concept]
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "immediately adjacent to this."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent
Processing 00000000.tx.44: Our findings have implications for the mechanism by which Id proteins influence class A and class B interactions and for the roles played by different Id proteins in tissue-specific gene regulation. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "implications for the mechanism"

Phrase: "by which Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "influence"

Phrase: "class A"

Phrase: "and"

Phrase: "class B interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "and for the roles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0035820:Roles [Social Behavior]
   770   C1515981:And [Idea or Concept]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "played by different Id proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600091:ID [Intellectual Product]
   760   C0600138:played [Finding]
   760   C1705242:Different [Qualitative Concept]
   726 E C0032214:Play [Daily or Recreational Activity]

Phrase: "in tissue-specific gene regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017263:Gene Regulation [Genetic Function]
   812   C0851285:Regulation [Governmental or Regulatory Activity]
   812   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.45: EXPERIMENTAL PROCEDURES Plasmid Construction Parental yeast vectors pGBT9 and pGAD were kindly supplied by Dr. 

Phrase: "EXPERIMENTAL PROCEDURES Plasmid Construction Parental yeast vectors pGBT9"

Phrase: "and"

Phrase: "pGAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3274756:PGAD [Gene or Genome]

Phrase: "were"

Phrase: "kindly"

Phrase: "supplied by Dr."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Supplied [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.46: S.

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.47: Elledge (Baylor College of Medicine). 

Phrase: "Elledge"

Phrase: "(Baylor College of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.48: Parental expression vectors for mammalian 2-hybrid analysis, pSG424 and pNLVP16, were obtained from Drs. 

Phrase: "Parental expression vectors for mammalian 2-hybrid analysis,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0442335:Vectors [Spatial Concept]
   711 E C1705099:Vector [Idea or Concept]

Phrase: "pSG424"

Phrase: "and"

Phrase: "pNLVP16,"

Phrase: "were"

Phrase: "obtained from Drs."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.49: C.Dang (Johns Hopkins University School of Medicine) and M.

Phrase: "C.Dang"

Phrase: "(Johns Hopkins University School of Medicine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.50: Green (University of Massachusetts) (45, 46). 

Phrase: "Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "(University of Massachusetts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024874:Massachusetts [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.51: Murine Id1 was obtained from Dr. 

Phrase: "Murine Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415855:ID1 [Gene or Genome]

Phrase: "was"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.52: H.

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.53: Weintraub (Fred Hutchinson Cancer Research Center), and murine Id2 and Id3 cDNAs were obtained from Dr. 

Phrase: "Weintraub"

Phrase: "(Fred Hutchinson Cancer Research Center"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517309:Fred Hutchinson Cancer Research Center [Health Care Related Organization]
   853   C1513817:Cancer Center [Health Care Related Organization]
   840   C0683939:research center [Manufactured Object,Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "murine Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.54: D.

Phrase: "D."
Processing 00000000.tx.55: Nathans (Johns Hopkins University) (28, 30, 34). 

Phrase: "Nathans"

Phrase: "(Johns Hopkins University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "(28,"

Phrase: "30,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.56: Fragments encoding the HLH regions plus 15-20 flanking amino acid residues were generated by PCR primers incorporating EcoRI (forward primer) and BamHI (reverse primer) sites and cloned directionally and in-frame into pGAD, pGBT9, and pSG424. 

Phrase: "Fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the HLH regions plus 15-20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "were"

Phrase: "generated by PCR primers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C3146294:Generated [Activity]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "incorporating"

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(forward primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953382:Forward primer [Cell]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and"

Phrase: "BamHI"

Phrase: "(reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "directionally"

Phrase: "and"

Phrase: "in-frame into pGAD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080089:Frame [Nucleotide Sequence]
   770   C0180979:Frame [Medical Device]
   770   C1705858:Frame [Manufactured Object]

Phrase: "pGBT9,"

Phrase: "and"

Phrase: "pSG424."
Processing 00000000.tx.57: The fragments amplified encoded amino acids 73-138 of Id1, 72-140 of Id2, and 28-91 of Id3. 

Phrase: "The fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "amplified"

Phrase: "encoded amino acids 73-138 of Id1,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0001128:Acids [Chemical]
   748   C0679058:encoded [Mental Process]
   748   C1415855:ID1 [Gene or Genome]
   748   C2700640:Encoded [Activity]
   745 E C2917660:Amino Acid [Pharmacologic Substance]
   714 E C0202406:Acid [Laboratory Procedure]

Phrase: "72-140 of Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "28-91 of Id3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1415856:ID3 [Gene or Genome]
Processing 00000000.tx.58: All products were sequenced to confirm the fidelity of the PCR amplification reaction. 

Phrase: "All products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the fidelity of the PCR amplification reaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680011:fidelity [Social Behavior]
Processing 00000000.tx.59: Full-length cDNAs were cloned into pRcCMV (Invitrogen, San Diego, CA) for use in in vitro transcription/translation reactions and transient transfection assays. 

Phrase: "Full-length cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "cloned into pRcCMV"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]

Phrase: "(Invitrogen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA) for use"

Phrase: "in in vitro transcription/translation reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0443286:Reaction [Functional Concept]
   771   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "transient transfection assays."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.60: Murine MyoD, murine myogenin, and human Myf-5 were supplied by Dr. 

Phrase: "Murine MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417574:MYOD [Gene or Genome]
   861   C2985443:MYOD [Gene or Genome]

Phrase: "murine myogenin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1417575:MYOGENIN [Gene or Genome]
   861   C2986638:MYOGENIN [Gene or Genome]

Phrase: "and"

Phrase: "human Myf-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086418:Human [Human]

Phrase: "were"

Phrase: "supplied by Dr."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Supplied [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.61: D.

Phrase: "D."
Processing 00000000.tx.62: Shapiro (St. Jude Children's Research Hospital) and rat MRF4/Myf-6 by Dr. 

Phrase: "Shapiro"

Phrase: "(St. Jude Children's Research Hospital"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1519168:St. Jude Children's Research Hospital [Health Care Related Organization]
   853   C0020017:Children's hospital [Health Care Related Organization]
   804   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   804   C1510665:Hospital [Qualitative Concept]
   721 E C1609061:Hospitals [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "rat MRF4/Myf-6 by Dr."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   753   C0031831:DR [Professional or Occupational Group]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1417533:MRF4 [Gene or Genome]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]
Processing 00000000.tx.63: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.64: Konieczny (Purdue University) (8, 15, 16, 20). 

Phrase: "Konieczny"

Phrase: "(Purdue University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "(8,"

Phrase: "15,"

Phrase: "16,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.65: Fragments encoding the bHLH domains were again amplified by PCR, incorporating EcoRI and BamHI sites for MyoD or BamHI and PstI sites for myogenin, Myf-5, and MRF4/Myf-6 and cloned in-frame into pGBT9 and pGAD424. 

Phrase: "Fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the bHLH domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   929   C0206678:Helix-Loop-Helix Domain [Spatial Concept]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "were"

Phrase: "again"

Phrase: "amplified by PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "incorporating"

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "BamHI sites for MyoD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "or"

Phrase: "BamHI"

Phrase: "and"

Phrase: "PstI sites for myogenin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "Myf-5,"

Phrase: "and"

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: "and"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "in-frame into pGBT9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080089:Frame [Nucleotide Sequence]
   770   C0180979:Frame [Medical Device]
   770   C1705858:Frame [Manufactured Object]

Phrase: "and"

Phrase: "pGAD424."
Processing 00000000.tx.66: The regions amplified included codons 83-184 of MyoD, 55-155 of myogenin, 56-143 of Myf-5, and 65-168 of MRF4/Myf-6. 

Phrase: "The regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "amplified"

Phrase: "included codons 83-184 of MyoD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0009221:Codon [Nucleotide Sequence]
   753   C0332257:included [Functional Concept]
   753   C1095825:Codon [Plant]
   753   C1417574:MYOD [Gene or Genome]
   753   C2985443:MYOD [Gene or Genome]
   753   C3538986:INCLUDED [Gene or Genome]

Phrase: "55-155 of myogenin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450382:55 [Intellectual Product]
   770   C1417575:MYOGENIN [Gene or Genome]
   770   C2986638:MYOGENIN [Gene or Genome]

Phrase: "56-143 of Myf-5,"

Phrase: "and"

Phrase: "65-168 of MRF4/Myf-6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   753   C0450385:65 [Intellectual Product]
   753   C1417533:MRF4 [Gene or Genome]
Processing 00000000.tx.67: Due to the presence of an internal PstI site in the second helix of Myf-5 and MRF4/Myf-6, these were cloned as BamHI/blunt fragments. 

Phrase: "Due to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of an internal PstI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "in the second helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "of Myf-5"

Phrase: "and"

Phrase: "MRF4/Myf-6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: "these"

Phrase: "were"

Phrase: "cloned as BamHI/blunt fragments."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0009013:cloned [Cell]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726 E C1522642:Clone [Tissue]
   726 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.68: The bHLH domains from MyoD and Myf-5 were also subcloned in-frame into pNLVP16 as blunt-ended fragments. 

Phrase: "The bHLH domains from MyoD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   825   C0206678:Helix-Loop-Helix Domain [Spatial Concept]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "Myf-5"

Phrase: "were"

Phrase: "also subcloned in-frame into pNLVP16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080089:Frame [Nucleotide Sequence]
   753   C0180979:Frame [Medical Device]
   753   C1705858:Frame [Manufactured Object]

Phrase: "as blunt-ended fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.69: Full-length MyoD and MRF4/Myf-6 cDNAs were cloned into pRcCMV. 

Phrase: "Full-length MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417574:MYOD [Gene or Genome]
   827   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "MRF4/Myf-6 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "cloned into pRcCMV."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009013:cloned [Cell]
   756 E C1522642:Clone [Tissue]
Processing 00000000.tx.70: The cDNAs encoding each of the class A factors were isolated from a yeast 2-hybrid screen of a murine embryo library in the pGAD10 vector (CLONTECH, Palo Alto, CA) using an Id2 bait. 

Phrase: "The cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "each of the class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456387:Class [Intellectual Product]
   770   C1457900:Each [Quantitative Concept]
   770   C1705943:Class [Classification]

Phrase: "A factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "isolated from a yeast 2-hybrid screen of a murine embryo library"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   736   C0013935:Embryo [Embryonic Structure]
   736   C0020205:Hybrid [Organism]
   736   C0023621:Library [Manufactured Object,Organization]
   736   C0026809:Murine [Mammal]
   736   C0036025:yeast [Fungus]
   736   C0043392:Yeast [Food]
   736   C0043393:Yeast [Fungus]
   736   C0205409:Isolated [Functional Concept]
   736   C0220908:screen [Health Care Activity]
   736   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   736   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   736   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C1305370:Embryo [Embryonic Structure]
   736   C1305399:screen [Functional Concept]
   736   C1548221:Isolated [Idea or Concept]
   736   C1705053:Screen [Medical Device]
   703 E C0370215:Isolate [Substance]
   703 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in the pGAD10 vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(CLONTECH,"

Phrase: "Palo Alto,"

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Id2 bait."
Processing 00000000.tx.71: These contained residues 118-264 of murine E47 (A1), residues 379-666 of murine E2-2 (ME-2), and residues 574-729 of murine HEB (Alf-1) (47-49). 

Phrase: "These contained residues 118-264 of murine E47"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0026809:Murine [Mammal]
   744   C0039828:these [Intellectual Product]
   744   C0332256:contained [Functional Concept]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C1336596:E47 [Gene or Genome]
   744   C2700400:Contained [Activity]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(A1"

Phrase: ")"

Phrase: ","

Phrase: "residues 379-666 of murine E2-2 (ME-2),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1420639:E2-2 [Gene or Genome]
   748   C0026809:Murine [Mammal]
   748   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   748   C3539520:E2 [Gene or Genome]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "residues 574-729 of murine HEB (Alf-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0026809:Murine [Mammal]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C1420632:HEB [Gene or Genome]
   744   C3273649:HEB [Gene or Genome]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")"

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.72: The E47 fragment was also cloned into both pNLVP16 and pGBT9. 

Phrase: "The E47 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "cloned into both pNLVP16"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:cloned [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "pGBT9."
Processing 00000000.tx.73: A carboxyl-terminal bHLH containing fragment of human E12 (residues 508-654) in the pAS1 vector, a gift from Dr. 

Phrase: "A carboxyl-terminal bHLH containing fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "of human E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422634:E12 [Gene or Genome]

Phrase: "(residues 508-654"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: ")"

Phrase: "in the pAS1 vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "a gift from Dr."
Processing 00000000.tx.74: E.Olsen (University of Texas), was excised and sub-cloned into pGAD424 (44). 

Phrase: "E.Olsen"

Phrase: "(University of Texas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0039711:Texas [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "excised"

Phrase: "and"

Phrase: "sub-cloned into pGAD424"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0542339:Sub- [Spatial Concept]
   770   C1264637:SUB [Quantitative Concept]
   737 E C1522642:Clone [Tissue]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.75: None of the class A clones contained the putative leucine zipper regions that are associated with transcriptional activation domains (50). 

Phrase: "None of the class"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0456148:None [Quantitative Concept]
   770   C0456387:Class [Intellectual Product]
   770   C0549184:None [Quantitative Concept]
   770   C1705943:Class [Classification]

Phrase: "A clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the putative leucine zipper regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "associated with transcriptional activation domains"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   828   C1519594:Transcriptional Activation Domain [Amino Acid Sequence]
   806   C0162493:Transcriptional Activation [Genetic Function]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0040649:Transcriptional [Genetic Function]
   760   C1879547:Activation [Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   726   C1880389:Domain [Functional Concept]
   726   C1883221:Domain [Conceptual Entity]
   726   C3541951:Domain [Intellectual Product]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.76: An almost full-length E12 clone in bluescript (E12R, a gift from Dr. H.Weintraub), including the putative leucine zipper domain, was used for in vitro translation (6). 

Phrase: "An almost full-length E12 clone in bluescript"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0009013:Clone [Cell]
   744   C1522642:Clone [Tissue]

Phrase: "(E12R,"

Phrase: "a gift from Dr. H.Weintraub"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the putative leucine zipper domain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   812   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0453984:Zipper [Manufactured Object]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "used for in vitro translation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0040712:Translation [Intellectual Product]
   760   C0597295:translation [Molecular Function]
   760   C1273517:used [Finding]
   760   C1519614:Translation [Genetic Function]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.77: Full-length E12 and E47 in the mammalian expression vector pGK were a gift from Dr. 

Phrase: "Full-length E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "E47 in the mammalian expression vector pGK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1336596:E47 [Gene or Genome]

Phrase: "were"

Phrase: "a gift from Dr."
Processing 00000000.tx.78: G.Kato (Johns Hopkins University School of Medicine). 

Phrase: "G.Kato"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
   861   C1551914:Kato [Language]

Phrase: "(Johns Hopkins University School of Medicine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: ")."
Processing 00000000.tx.79: The cDNAs for human hematopoietic factors Scl/Tal-1, Tal-2, and Lyl-1 were provided by Drs. 

Phrase: "The cDNAs for human hematopoietic factors Scl/Tal-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Tal-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1447263:TAL-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1428449:TAL [Gene or Genome]

Phrase: "and"

Phrase: "Lyl-1"

Phrase: "were"

Phrase: "provided by Drs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.80: I.Kirsch (National Cancer Institute), R.Baer (University of Texas), and M.Cleary (Stanford University), respectively (14, 19, 21). 

Phrase: "I.Kirsch"

Phrase: "(National Cancer Institute"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "R.Baer (University of Texas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0039711:Texas [Geographic Area]
   804   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "M."

Phrase: "Cleary"

Phrase: "(Stanford University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "respectively"

Phrase: "(14,"

Phrase: "19,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.81: bHLH domains were again amplified by PCR with primers containing EcoRI and BamHI sites and were cloned in-frame into both pGAD424 and PGBT9. 

Phrase: "bHLH domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   929   C0206678:Helix-Loop-Helix Domain [Spatial Concept]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]
   717   C0282642:helix loop helix [Spatial Concept]

Phrase: "were"

Phrase: "again"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "with primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "EcoRI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "BamHI sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "were"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "in-frame into both pGAD424"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080089:Frame [Nucleotide Sequence]
   760   C0180979:Frame [Medical Device]
   760   C1705858:Frame [Manufactured Object]

Phrase: "and"

Phrase: "PGBT9."
Processing 00000000.tx.82: The amplified fragments encoded amino acids residues 66-138 of Scl/Tal-1, 2-69 of Tal-2, and 127-200 of Lyl-1. 

Phrase: "The amplified fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "encoded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679058:encoded [Mental Process]
  1000   C2700640:Encoded [Activity]

Phrase: "amino acids residues 66-138 of Scl/Tal-1,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0001128:Acids [Chemical]
   742   C1428449:TAL [Gene or Genome]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "2-69 of Tal-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C1447263:TAL-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0450388:69 [Intellectual Product]
   760   C0740116:+2 [Quantitative Concept]
   760   C1428449:TAL [Gene or Genome]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "127-200 of Lyl-1."
Processing 00000000.tx.83: Full-length Scl/Tal-1 was subcloned into pBluescript SK+ (Stratagene, La Jolla, CA). 

Phrase: "Full-length Scl/Tal-1"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0443225:Full [Qualitative Concept]
   804   C1428449:TAL [Gene or Genome]
   804   C1444754:Length [Quantitative Concept]
   804   C1706316:LENGTH [Research Activity]
   733 E C0205166:Long [Qualitative Concept]
   733 E C1522425:Longest [Qualitative Concept]
   733 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "subcloned into pBluescript SK+ (Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)."
Processing 00000000.tx.84: The multimerized gal4:CAT reporter construct pGal5E472CAT was supplied by Dr. 

Phrase: "The multimerized gal4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ":"

Phrase: "CAT reporter construct pGal5E472CAT"

Phrase: "was"

Phrase: "supplied by Dr."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Supplied [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C0243163:supply [Idea or Concept]
   756 E C0699914:supply [Quantitative Concept]
   756 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   756 E C1561604:supply [Functional Concept]
   756 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.85: M.

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.86: Green (51). 

Phrase: "Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.87: The muscle creatinine kinase (MCK) CAT construct was obtained from Dr. 

Phrase: "The muscle creatinine kinase (MCK) CAT construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.88: S.

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.89: Hauschka (University of Washington). 

Phrase: "Hauschka"

Phrase: "(University of Washington"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: ")."
Processing 00000000.tx.90: Yeast 2-Hybrid System This was performed according to the protocol developed in the laboratory of Dr. 

Phrase: "Yeast 2-Hybrid System"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
  1000   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0449913:System [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "This"

Phrase: "was"

Phrase: "performed according to the protocol"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0442711:Protocol [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "developed in the laboratory of Dr."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0022877:Laboratory [Manufactured Object,Organization]
   753   C0031831:DR [Professional or Occupational Group]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3244292:laboratory [Functional Concept]
   753   C3540849:DR [Idea or Concept]
Processing 00000000.tx.91: S.

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.92: Elledge, who also supplied the Saccharomyces cerevisiae strain Y153 (MATa, leu2-3, trp1-901, his3-200, ura5-32, ade2-101, gal4, gal80GGAL-HIS3, LYS2::GAL-HIS3). 

Phrase: "Elledge,"

Phrase: "who also"

Phrase: "supplied"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1999230:Supplied [Activity]
   966 E C0243163:supply [Idea or Concept]
   966 E C0699914:supply [Quantitative Concept]
   966 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966 E C1561604:supply [Functional Concept]
   966 E C1875802:SUPPLY [Medical Device]

Phrase: "the Saccharomyces cerevisiae strain Y153"

Phrase: "(MATa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0327149:mata [Reptile]

Phrase: "leu2-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1333223:LEU2 [Gene or Genome]
   861   C1705129:LEU2 [Gene or Genome]
   861   C1861281:LEU2 [Gene or Genome]
   861   C3540595:Leu2 [Gene or Genome]

Phrase: "trp1-901,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0700256:trp 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1421165:TRP1 [Gene or Genome]
   861   C1421168:TRP1 [Gene or Genome]

Phrase: "his3-200,"

Phrase: "ura5-32,"

Phrase: "ade2-101,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1150840:ADE2 [Molecular Function]

Phrase: "gal4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416832:GAL4 [Gene or Genome]

Phrase: "gal80GGAL-HIS3,"

Phrase: "LYS2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2240229:LYS2 [Gene or Genome]

Phrase: ":"

Phrase: ":"

Phrase: "GAL-HIS3"

Phrase: ")."
Processing 00000000.tx.93: Potential partner genes in either pGAD424 or pGBT9 were co-transformed into yeast by a lithium chloride/polyethylene glycol precipitation method (52). 

Phrase: "Potential partner genes in either pGAD424"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "or"

Phrase: "pGBT9"

Phrase: "were"

Phrase: "co-transformed into yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C1510411:Transformed [Pathologic Function]

Phrase: "by a lithium chloride/polyethylene glycol precipitation method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025663:Method [Intellectual Product]
   799   C0449851:Method [Functional Concept]
   799   C0871511:METHOD [Intellectual Product]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.94: Semi-quantitative determination of interaction strengths was performed by in situ assessment of -galactosidase activity. 

Phrase: "Semi-quantitative determination of interaction strengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "was"

Phrase: "performed by in situ assessment of -galactosidase activity."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0444498:In situ [Spatial Concept]
   770   C1150051:galactosidase activity [Molecular Function]
   770   C1550369:Performed By [Qualitative Concept]
   744   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0884358:Performed [Functional Concept]
   744   C1261322:Assessment [Health Care Activity]
   744   C1516048:Assessment [Activity]
   744   C1561536:*Activity [Idea or Concept]
   711 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.95: Quantitative -Galactosidase Assay Yeast transformants were grown to stationary phase in complete EGG medium containing 2% ethanol, 2% galactose, and 3% glycerol and lacking tryptophan and leucine. 

Phrase: "Quantitative -Galactosidase Assay Yeast transformants"

Phrase: "were"

Phrase: "grown to stationary phase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2348532:Stationary Phase [Research Device]
   833   C2611014:stationary phase [Cell Function]
   770   C0205390:Phase [Temporal Concept]
   770   C0439835:Stationary [Qualitative Concept]

Phrase: "in complete EGG medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2% ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "2% galactose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016945:Galactose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "3% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "lacking tryptophan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041249:Tryptophan [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "leucine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.96: 107 cells were pelleted and resuspended in 50l of Z buffer (60 mM Na2HPO4, 40mM NaH2PO4, 10mM MgCl2, 50mM -mercaptoethanol) containing 0.01% SDS. 

Phrase: "107 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "resuspended in 50l of Z buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(60 mM Na2HPO4,"

Phrase: "40mM NaH2PO4,"

Phrase: "10mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "50mM -mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.01% SDS."
Processing 00000000.tx.97: Two microliters of CHCl2 were added followed by two cycles of freeze-thawing in liquid nitrogen. 

Phrase: "Two microliters of CHCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439243:microliter [Quantitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "followed by two cycles of freeze-thawing"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0016701:Freeze [Natural Phenomenon or Process]
   748   C0205448:Two [Quantitative Concept]
   714   C1511572:Cycle [Temporal Concept]
   714   C1710378:Thaw [Laboratory Procedure]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "in liquid nitrogen."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
  1000   C1550121:Liquid nitrogen [Intellectual Product]
   861   C0028158:Nitrogen [Element, Ion, or Isotope]
   861   C0302908:Liquid [Substance]
   861   C1304698:Liquid [Finding]
   861   C1546699:Liquid NOS [Intellectual Product]
   861   C1550581:nitrogen [Human-caused Phenomenon or Process]
   861   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.98: Lysates were transferred to 96-well plates, and 50l of a fluorogenic substrate (8mM 3-carboxyumbelliferyl--D-galactopyranoside, Molecular Probes Inc., Eugene, OR) was added. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "transferred to 96-well"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C0348011:transferred [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "50l of a fluorogenic substrate"

Phrase: "(8mM 3-carboxyumbelliferyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactopyranoside [Biologically Active Substance,Carbohydrate]

Phrase: "Molecular Probes Inc.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Eugene,"

Phrase: "OR)"

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.99: After 30min, 100l of stop buffer (300mM glycine, 15mM EDTA, pH 11.5) was added, and the reactions were allowed to stabilize for 1h. 

Phrase: "After 30min,"

Phrase: "100l of stop buffer"

Phrase: "(300mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "15mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "pH 11.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize for 1h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0184512:stabilize [Qualitative Concept]
   790   C1442450:1H [Temporal Concept]
Processing 00000000.tx.100: Fluorescence was determined in a Perkin-Elmer microtiter plate reader (Foster City, CA; excitation 390nm, emission 460nm), and the amount of -galactosidase synthesized was calculated relative to a dilution series of -galactosidase enzyme standards (Sigma) assayed simultaneously with the yeast lysates. 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "determined in a Perkin-Elmer microtiter plate reader"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1709027:Microtiter Plate [Research Device]
   744   C0005971:Plate [Medical Device]
   744   C1139930:plate [Medical Device]
   744   C1514743:Reader [Professional or Occupational Group]
   744   C1706461:Reader [Manufactured Object]
   744   C3537155:Plate [Manufactured Object]

Phrase: "(Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA"

Phrase: "; excitation 390nm,"

Phrase: "emission 460nm"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the amount of -galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "relative to a dilution series of -galactosidase enzyme standards"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "simultaneously with the yeast lysates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0036025:yeast [Fungus]
   760   C0043392:Yeast [Food]
   760   C0043393:Yeast [Fungus]
   760   C0521115:simultaneously [Temporal Concept]
   760   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   726   C1881488:Lysate [Physical Object]
Processing 00000000.tx.101: All assays were performed in triplicate with standard errors of less than 10% in each case. 

Phrase: "All assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed in triplicate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with standard errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:errors [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1608199:Error [Functional Concept]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 10%"

Phrase: "in each case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.102: None of the individual vectors used in this series displayed a background higher than 10pg of -galactosidase enzyme/107 cells which represents the lower limit of detection with this assay. 

Phrase: "None of the individual vectors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0027361:Individual [Population Group]
   760   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0237401:Individual [Human]
   760   C0442335:Vectors [Spatial Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726 E C1705099:Vector [Idea or Concept]

Phrase: "used in this series"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205549:Series [Quantitative Concept]
   770   C1273517:used [Finding]
   770   C2348044:Series [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "higher than 10pg of -galactosidase enzyme/107 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "which"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the lower limit of detection"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C2718050:Limit of Detection [Quantitative Concept]
           Detection Limit
   760   C0439801:limit [Functional Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C1549649:Limit [Idea or Concept]
   760   C2003888:Lower [Activity]
   760   C2349209:Limit [Conceptual Entity]
   726 E C0205251:low [Qualitative Concept]
   726 E C1299352:Low [Qualitative Concept]
   726 E C1550472:low [Idea or Concept]

Phrase: "with this assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.103: Western Blot Analysis Yeast were grown in EGG medium until they reached stationary phase. 

Phrase: "Western Blot Analysis Yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   756   C0949466:Western blot analysis [Laboratory Procedure]

Phrase: "were"

Phrase: "grown in EGG medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0013710:EGG [Food]
   770   C0029974:Egg [Cell]
   770   C0439536:Medium [Quantitative Concept]
   770   C1508746:Egg [Organic Chemical,Pharmacologic Substance]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "until"

Phrase: "they"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "stationary phase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348532:Stationary Phase [Research Device]
  1000   C2611014:stationary phase [Cell Function]
   861   C0205390:Phase [Temporal Concept]
   861   C0439835:Stationary [Qualitative Concept]
Processing 00000000.tx.104: They were then pelleted and subject to two cycles of freeze-thawing followed by boiling in standard SDS-polyacrylamide gel electrophoresis (PAGE) lysis buffer for 10min to ensure complete lysis (53). 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and subject to two cycles of freeze-thawing"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0016701:Freeze [Natural Phenomenon or Process]
   744   C0205448:Two [Quantitative Concept]
   744   C0681850:Subject [Group]
   744   C1515981:And [Idea or Concept]
   744   C1550501:{Subject} [Idea or Concept]
   744   C1706203:Subject [Idea or Concept]
   744   C2349001:Subject [Human]
   744   C2697811:Subject [Functional Concept]
   711   C1511572:Cycle [Temporal Concept]
   711   C1710378:Thaw [Laboratory Procedure]

Phrase: "followed by boiling"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756   C0242301:Boil [Disease or Syndrome]
   756   C1546559:Boil [Intellectual Product]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in standard SDS-polyacrylamide gel electrophoresis (PAGE) lysis buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   710   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]

Phrase: "for 10min to"

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "complete lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0024348:Lysis [Pathologic Function]
   861   C1536403:lysis [Cell Function]
   789 E C0439680:Lytic [Qualitative Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.105: 100g of protein was resolved by 12% PAGE and transferred to Immobilon-P membranes (Sigma) by semi-dry electroblotting. 

Phrase: "100g of protein"

Phrase: "was"

Phrase: "resolved by 12% PAGE"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   790   C0596607:Gel Electrophoresis [Laboratory Procedure]
   783 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C1382104:Gel [Substance]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to Immobilon-P membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0123400:Immobilon P [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0063412:Immobilon [Organic Chemical,Pharmacologic Substance]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "by semi-dry electroblotting."
Processing 00000000.tx.106: Membranes were preincubated in wash solution (1phosphate-buffered saline +0.1% Tween 20). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "preincubated in wash solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037633:Solution [Substance]
   770   C0441648:Wash [Activity]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(1phosphate-buffered saline +0.1% Tween 20"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   818   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   795   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0036082:Saline [Substance]
   795   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   790 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   740 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.107: This was followed by a 1-h incubation in block solution (5% non-fat dry milk powder, phosphate-buffered saline +0.1% Tween 20) containing either an anti-yeast gal4 DNA binding domain or activation domain antibody (at 1:500 and 1:2000 dilutions, respectively) (Upstate Biotechnology Inc., Lake Placid, NY). 

Phrase: "This"

Phrase: "was"

Phrase: "followed by a 1-h incubation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "in block solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(5% non-fat dry milk powder,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   839   C0991850:fat milk [Lipid,Pharmacologic Substance]
   827   C1440965:Milk powder [Immunologic Factor]
   799   C0026131:Milk [Body Substance]
   799   C0032861:Powder [Biomedical or Dental Material]
   799   C0349374:Milk [Food]
   799   C0444318:Milk [Substance]
   799   C1382110:Powder [Substance]
   799   C2825079:Milk [Food]
   743 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   743 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   727 E C0443260:Milky [Finding]

Phrase: "phosphate-buffered saline +0.1% Tween 20"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   818   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   801   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   795   C0031701:phosphate [Organophosphorus Compound]
   795   C0036082:Saline [Substance]
   795   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   795   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   790 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   740 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either"

Phrase: "an anti-yeast gal4 DNA binding domain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C1511662:DNA Binding Domain [Amino Acid Sequence]
   858   C0282056:Anti-DNA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1148673:DNA Binding [Genetic Function]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "or"

Phrase: "activation domain antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "500"

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000 dilutions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: "(Upstate Biotechnology Inc.,"

Phrase: "Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Membranes were washed four times before the addition of a horseradish peroxidase-linked goat anti-mouse antibody (1:1000 dilution; 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times before the addition"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1279919:time before [Temporal Concept]
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "of a horseradish peroxidase-linked goat anti-mouse antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   829   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.109: Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in blocking solution and incubated for a further 1h at room temperature. 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc.,"

Phrase: "Santa Cruz,"

Phrase: "CA) in blocking solution"

Phrase: "and"

Phrase: "incubated for a further 1h"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1442450:1H [Temporal Concept]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.110: After a further four washes, proteins were visualized using an enhanced chemiluminescence detection kit according to the manufacturer's instructions (Amersham International, Buckinghamshire, UK). 

Phrase: "After a further four washes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0441648:Wash [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescence detection kit according to the manufacturer's instructions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   739   C0812225:KIT [Medical Device]
   739   C1150635:KIT [Molecular Function]
   739   C1705212:Kit [Medical Device]
   739   C1705213:KIT [Medical Device]
   739   C3273202:Kit [Manufactured Object]

Phrase: "(Amersham International, Buckinghamshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454842:Buckinghamshire [Geographic Area]

Phrase: "UK"

Phrase: ")."
Processing 00000000.tx.111: In Vitro Transcription/Translation and Co-immunoprecipitation Full-length E12, Id1, Id2, Id3, Scl/Tal-1, MyoD, and MRF4/Myf-6 cDNAs in either pBluescript SK+ or pRcCMV were transcribed and translated in vitro using a coupled reticulocyte lysate kit (TNT, Promega, Madison, WI) in the presence of [35S]methionine (1mCi/mmol). 

Phrase: "In Vitro Transcription/Translation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0040712:Translation [Intellectual Product]
   812   C0597295:translation [Molecular Function]
   812   C1519614:Translation [Genetic Function]

Phrase: "and"

Phrase: "Co-immunoprecipitation Full-length E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1422634:E12 [Gene or Genome]

Phrase: "Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "Id3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "Scl/Tal-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "MRF4/Myf-6 cDNAs in either pBluescript SK+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "pRcCMV"

Phrase: "were"

Phrase: "transcribed"

Phrase: "and"

Phrase: "translated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:translated [Occupational Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a coupled reticulocyte lysate kit (TNT,"

Phrase: "Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI) in the presence of [35S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043193:WI [Geographic Area]

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(1mCi/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.112: Labeled proteins were mixed and incubated at 37C for 20min before the addition of 100l of IP buffer (250mM NaCl, 0.25% Nonidet P-40, 20mM Tris-HCl, pH 7.5,1mM EDTA, 1mM dithiothreitol). 

Phrase: "Labeled proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "and"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20min"

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 100l"

Phrase: "of IP buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(250mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.25% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "20mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.113: Anti-Id, E12, or MyoD polyclonal antibodies were added and reactions incubated on ice for 30min prior to the addition of 30l of a 1:1 mix of protein A-Sepharose (Bio-Rad) in IP buffer. 

Phrase: "Anti-Id, E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1422634:E12 [Gene or Genome]

Phrase: "or"

Phrase: "MyoD polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30min"

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 30l"

Phrase: "of a 1"

Phrase: ":"

Phrase: "1 mix of protein A-Sepharose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205430:Mix [Functional Concept]
   753   C1421951:MIX [Gene or Genome]
   753   C1720722:Mix [Qualitative Concept]

Phrase: "(Bio-Rad) in IP buffer."
Processing 00000000.tx.114: After a further 60min incubation, samples were washed four times in IP buffer before resolution by 12% SDS-PAGE. 

Phrase: "After a further 60min incubation,"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times in IP buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "before resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514893:Resolution [Idea or Concept]
  1000   C1706463:Resolution [Quantitative Concept]
  1000   C2699488:Resolution [Conceptual Entity]

Phrase: "by 12% SDS-PAGE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   884   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   840   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   840   C0596607:Gel Electrophoresis [Laboratory Procedure]
   804   C0013855:Electrophoresis [Laboratory Procedure]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   804   C1382104:Gel [Substance]
Processing 00000000.tx.115: The intensity of each partner was quantified by PhosphorImage analysis (Molecular Dynamics) using Image-Quant software and normalized relative to methionine content of each protein. 

Phrase: "The intensity of each partner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "quantified by PhosphorImage analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "(Molecular Dynamics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Image-Quant software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "normalized relative to methionine content of each protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.116: The value was then expressed as a ratio of the amount of input proteins. 

Phrase: "The value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "expressed as a ratio of the amount of input proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0456603:Ratio [Quantitative Concept]
   739   C1265611:Amount [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]
   739   C1708517:Input [Conceptual Entity]
Processing 00000000.tx.117: All antibodies were tested for cross-reactivity and shown to be specific for their respective protein under the conditions described here. 

Phrase: "All antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "tested for cross-reactivity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0010357:Cross Reactivity [Molecular Function]
   833   C0872139:cross reactivity [Molecular Function]
   833   C1880190:CROSS REACTIVITY [Event]
   770   C0392366:tested [Intellectual Product]
   770   C2828360:Cross [Conceptual Entity]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specific for their respective protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here."
Processing 00000000.tx.118: Mammalian 2-Hybrid Analysis/Transient Transfections 5 g of each vector DNA was introduced into HeLa cells by calcium phosphate precipitation, and the cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% calf serum (Life Technologies, Inc.) 

Phrase: "Mammalian 2-Hybrid Analysis/Transient Transfections 5 g of each vector DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "introduced into HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1292748:introduce [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by calcium phosphate precipitation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C1161320:calcium phosphate [Pharmacologic Substance]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in Dulbecco's modified Eagle medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "(DMEM"

Phrase: ")"

Phrase: "supplemented with 10% calf serum"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0229671:Serum [Body Substance]
   760   C0230445:Calf [Body Location or Region]
   760   C1305418:Calf [Body Part, Organ, or Organ Component]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]
   704 E C0626053:sural [Pharmacologic Substance]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")"
Processing 00000000.tx.119: (54). 

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.120: All transfections included a CMV -galactosidase reporter (CLONTECH) to standardize transformation efficiencies. 

Phrase: "All transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a CMV -galactosidase reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0335038:Reporter [Professional or Occupational Group]
   827   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827   C1705915:Reporter [Conceptual Entity]
   827   C1709908:Reporter [Group]

Phrase: "(CLONTECH"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "standardize"

Phrase: "transformation efficiencies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013682:efficiencies [Quantitative Concept]
   777 E C0442799:Efficient [Qualitative Concept]
Processing 00000000.tx.121: CAT assays were performed on cell lysates harvested after 48h and relative conversion calculated by PhosphorImage analysis. 

Phrase: "CAT assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "performed on cell lysates"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   816   C1881488:Cell Lysate [Physical Object]
           Lysate
   770   C0007634:Cell [Cell]
   770   C0884358:Performed [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "harvested after 48h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1442464:48H [Temporal Concept]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "relative conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439836:Conversion [Functional Concept]

Phrase: "calculated by PhosphorImage analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0444686:Calculated [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.122: A determination of the ability of Ids to repress E protein-MyoD interactions was performed in C3H myoblasts. 

Phrase: "A determination of the ability of Ids to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "repress"

Phrase: "E protein-MyoD interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0872079:protein interaction [Molecular Function]
   779   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "performed in C3H myoblasts."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025920:C3H [Mammal]
   770   C0596995:Myoblasts [Cell]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.123: The amounts of MyoD and E protein vector DNAs used were determined empirically so as to generate the maximum amount of transcriptional activation in combination over either factor alone, prior to determining the influence of co-transfected Id. 

Phrase: "The amounts of MyoD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "and"

Phrase: "E protein vector DNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   779   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "determined"

Phrase: "empirically so as to"

Phrase: "generate"

Phrase: "the maximum amount of transcriptional activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "over either factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "prior to determining"

Phrase: "the influence of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "co-transfected"

Phrase: "Id."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]
Processing 00000000.tx.124: This ensured that CAT activity was a reflection of a specific MyoD-E2A interaction, minimizing the influence of additional endogenous factors. 

Phrase: "This ensured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "that CAT activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1151952:chloramphenicol acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "a reflection of a specific MyoD-E2A interaction,"

Phrase: "minimizing"

Phrase: "the influence of additional endogenous factors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0814287:factors influence [Clinical Attribute]
Processing 00000000.tx.125: 2days post-transfection, DMEM+10% calf serum was replaced with DMEM+2% horse serum, and incubation was continued for a further 2days. 

Phrase: "2days post-transfection,"

Phrase: "DMEM+10% calf serum"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "was"

Phrase: "replaced with DMEM+2% horse serum,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1518416:Serum, Horse [Immunologic Factor]
   753   C0019944:Horse [Mammal]
   753   C0229671:Serum [Body Substance]
   753   C0242616:Horse [Mammal]
   753   C0559956:Replaced [Functional Concept]
   753   C1265527:Horse [Mammal]
   753   C1299987:replaced [Functional Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "incubation"

Phrase: "was"

Phrase: "continued for a further 2days."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0549178:Continued [Idea or Concept]
   760   C1517331:Further [Spatial Concept]
   726 E C0205108:far [Spatial Concept]
Processing 00000000.tx.126: Under these conditions, endogenous Id levels are repressed, allowing for myogenic differentiation to proceed (55). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "endogenous Id levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "repressed"

Phrase: ","

Phrase: "allowing for myogenic differentiation to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007589:Differentiation [Cell Function]
   760   C0683607:allowing [Social Behavior]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "proceed"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: All transfections were adjusted to give uniform DNA concentrations with the empty pRcCMV vector. 

Phrase: "All transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "uniform DNA concentrations with the empty pRcCMV vector."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.128: Id Protein Helix Swaps and Site-directed Mutagenesis Helix swaps between Id1 and Id3 were generated by PCR amplification of individual helices followed by a "cut and paste" cloning strategy. 

Phrase: "Id Protein Helix Swaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1416521:SWAP [Gene or Genome]
   779   C1419999:SWAP [Gene or Genome]

Phrase: "and"

Phrase: "Site-directed Mutagenesis Helix swaps between Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1416521:SWAP [Gene or Genome]
   714   C1419999:SWAP [Gene or Genome]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "were"

Phrase: "generated by PCR amplification of individual helices"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0018882:Helix [Eukaryote]
   748   C0027361:Individual [Population Group]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0229304:Helix [Body Part, Organ, or Organ Component]
   748   C0237401:Individual [Human]
   748   C0677874:pCR [Finding]
   748   C1017315:helices [Eukaryote]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1704821:Helix [Spatial Concept]
   748   C1705682:Helix [Anatomical Structure]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   748   C3146294:Generated [Activity]

Phrase: "followed by a ""cut and paste"" cloning strategy."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0000925:Cut [Injury or Poisoning]
   744   C0009015:Cloning [Research Activity]
   744   C0030634:paste [Substance]
   744   C0679199:strategy [Mental Process]
   744   C1321899:Paste [Biomedical or Dental Material]
   744   C1883724:CUT [Phenomenon or Process]
   711 E C0009013:Clone [Cell]
   711 E C1522642:Clone [Tissue]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.129: Sixteen residues upstream of the amino terminus and 14residues downstream of the carboxyl terminus of each HLH domain were maintained to promote correct folding. 

Phrase: "Sixteen residues upstream of the amino terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "14residues downstream of the carboxyl terminus of each HLH domain"

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "correct folding."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.130: A fragment of Id1 encompassing helix 1was amplified with a forward primer containing an EcoRI site. 

Phrase: "A fragment of Id1 encompassing helix 1was"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "amplified with a forward primer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1953382:Forward primer [Cell]
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0439780:Forward [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "an EcoRI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.131: The reverse primer mapped to the helix 1/loop junction and contained a BamHI site. 

Phrase: "The reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mapped to the helix 1/loop junction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C1424473:MAP-1 [Gene or Genome]
   748   C0018882:Helix [Eukaryote]
   748   C0205144:Junction [Spatial Concept]
   748   C0229304:Helix [Body Part, Organ, or Organ Component]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
   748   C1704821:Helix [Spatial Concept]
   748   C1705682:Helix [Anatomical Structure]
   748   C1706311:Junction [Medical Device]
   714   C0024779:Map [Manufactured Object]
   714   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a BamHI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.132: A SmaI site was introduced at the helix 1/loop boundary (residues 102and 103of Id1) where the codons CCC ACC were altered to CCC GGG. 

Phrase: "A SmaI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "introduced at the helix 1/loop boundary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018882:Helix [Eukaryote]
   748   C0229304:Helix [Body Part, Organ, or Organ Component]
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]
   748   C1704821:Helix [Spatial Concept]
   748   C1705682:Helix [Anatomical Structure]
   714   C1292748:introduce [Functional Concept]

Phrase: "(residues 102and 103of Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415855:ID1 [Gene or Genome]

Phrase: ")"

Phrase: "where"

Phrase: "the codons CCC ACC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175754:ACC [Congenital Abnormality,Disease or Syndrome]
   827   C0282160:ACC [Congenital Abnormality]
   827   C3541413:ACC [Gene or Genome]

Phrase: "were"

Phrase: "altered to CCC GGG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392747:Altered [Functional Concept]
Processing 00000000.tx.133: EcoRI/BamHI-digested fragments were cloned into pBluescript SK+ to create plasmid A.Helix 2 from Id3 was amplified from a 5 primer derived from the loop/helix 2region, also containing a SmaI site and a 3 primer containing a BamHI site. 

Phrase: "EcoRI/BamHI-digested fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "cloned into pBluescript SK+ to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0009013:cloned [Cell]
   726 E C1522642:Clone [Tissue]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "plasmid A.Helix 2 from Id3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018882:Helix [Eukaryote]
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0229304:Helix [Body Part, Organ, or Organ Component]
   753   C1415856:ID3 [Gene or Genome]
   753   C1704821:Helix [Spatial Concept]
   753   C1705682:Helix [Anatomical Structure]

Phrase: "was"

Phrase: "amplified from a 5 primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "derived from the loop/helix 2region,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0018882:Helix [Eukaryote]
   753   C0229304:Helix [Body Part, Organ, or Organ Component]
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1704821:Helix [Spatial Concept]
   753   C1705682:Helix [Anatomical Structure]
   753   C3245521:derived [Idea or Concept]

Phrase: "also"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a SmaI site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "a 3 primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "a BamHI site."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]
Processing 00000000.tx.134: BamHI/SmaI-digested fragments were then ligated into BamHI/SmaI-digested plasmid A, thus generating an Id1/3 chimera (plasmid B). 

Phrase: "BamHI/SmaI-digested fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "ligated into BamHI/SmaI-digested plasmid A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0868946:digested [Physiologic Function]

Phrase: "thus"

Phrase: "generating"

Phrase: "an Id1/3 chimera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]

Phrase: "(plasmid B"

Phrase: ")."
Processing 00000000.tx.135: A complementary approach was taken to constructing the Id3/1 chimera. 

Phrase: "A complementary approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "taken to constructing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
   756   C2827421:Construct [Classification]

Phrase: "the Id3/1 chimera."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0008109:Chimera [Organism]
   827   C1262946:Chimaera [Fish]
   827   C1318484:Chimera [Disease or Syndrome]
Processing 00000000.tx.136: Finally, EcoRI/BamHI fragments were excised from plasmid B and cloned into the yeast vector pGBT9 or into an m13 vector for further point mutagenesis. 

Phrase: "Finally,"

Phrase: "EcoRI/BamHI fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "excised from plasmid B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cloned into the yeast vector pGBT9"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009013:cloned [Cell]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1705099:Vector [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "or into an m13 vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1549810:M13 [Intellectual Product]
   760   C1705099:Vector [Idea or Concept]

Phrase: "for further point mutagenesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   717   C1720532:Far point [Clinical Attribute]
Processing 00000000.tx.137: Oligonucleotide-mediated site-directed mutagenesis was performed with the Muta-gene kit (Bio-Rad) according to the manufacturer's recommendations using the chimeric Id1/3 or Id3/1 single-stranded phage DNAs. 

Phrase: "Oligonucleotide-mediated site-directed mutagenesis"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   911   C0079869:Oligonucleotide-Directed Mutagenesis [Molecular Biology Research Technique]
   884   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   804   C0079866:Mutagenesis [Molecular Function]
   804   C0205145:Site [Spatial Concept]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
   804   C3146302:Mutagenesis [Laboratory Procedure]
   771   C0439851:Direct [Qualitative Concept]
   771   C1947931:Direct [Qualitative Concept]
   733 E C0439755:Directions [Spatial Concept]
   733 E C0449738:Direction [Spatial Concept]

Phrase: "was"

Phrase: "performed with the Muta-gene kit (Bio-Rad)"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   767   C0920288:KIT Gene [Gene or Genome]
   767   C1416655:KIT gene [Gene or Genome]
   767   C1705625:RAD Gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]
   744   C0812225:KIT [Medical Device]
   744   C0884358:Performed [Functional Concept]
   744   C1150635:KIT [Molecular Function]
   744   C1705212:Kit [Medical Device]
   744   C1705213:KIT [Medical Device]
   744   C3273202:Kit [Manufactured Object]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "according to the manufacturer's recommendations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:recommendations [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the chimeric Id1/3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0008109:chimeric [Organism]
   827   C1415855:ID1 [Gene or Genome]
   755 E C0333678:Chimerism [Organism Attribute]

Phrase: "or"

Phrase: "Id3/1 single-stranded phage DNAs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   856   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   766   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.138: All clones were completely sequenced to ensure the presence of the desired mutation prior to subcloning into pGBT9. 

Phrase: "All clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0009013:Clones [Cell]
   966 E C1522642:Clone [Tissue]
   916 E C1704387:Clonal [Qualitative Concept]
   893 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "the presence of the desired mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "prior to subcloning"

Phrase: "into pGBT9."
Processing 00000000.tx.139: Each construct was tested for interaction with pGAD E12 and shown to interact with consistent affinity. 

Phrase: "Each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "tested for interaction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392366:tested [Intellectual Product]
   790   C1704675:Interaction [Functional Concept]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with pGAD E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with consistent affinity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0332290:Consistent with [Idea or Concept]
           Consistent
   770   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.140: RESULTS Yeast 2-Hybrid Analysis A quantitative 2-hybrid approach was used to study interactions between Id proteins and a series of class A and class B targets expressed as gal4 binding domain and gal4 transactivation domain fusions, respectively (Fig. 1). 

Phrase: "RESULTS Yeast 2-Hybrid Analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]

Phrase: "A quantitative 2-hybrid approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0681919:quantitative approach [Research Activity]
   812   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "interactions between Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interactions protein [Molecular Function]
   737   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "a series of class A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "class B targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "expressed as gal4 binding domain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1416832:GAL4 [Gene or Genome]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "gal4 transactivation domain fusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332466:fusions [Functional Concept]
   812   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "respectively"

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.141: All Id-class A interactions were determined to be quite strong by this assay (Fig. 1A). 

Phrase: "All Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "A interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "quite strong by this assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442821:Strong [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.142: Interactions varied over a 5-fold range from the weakest (Id2-HEB) to the strongest (Id2-E47). 

Phrase: "Interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "varied over a 5-fold range"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332462:Fold [Spatial Concept]
   753   C1514721:Range [Quantitative Concept]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "from the weakest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0004093:Weak [Sign or Symptom]
   966   C1762617:Weak [Qualitative Concept]

Phrase: "(Id2-HEB) to the strongest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1420632:HEB [Gene or Genome]
   760   C3273649:HEB [Gene or Genome]

Phrase: "(Id2-E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.143: The consistently strong Id-class A interactions observed stand in contrast to those seen between the Ids and the class B myogenic factors (Fig. 1B). 

Phrase: "The consistently strong Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456387:Class [Intellectual Product]
   812   C1705943:Class [Classification]

Phrase: "A interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "stand in contrast to those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0596013:stand [Finding]
   760   C1704644:Stand [Medical Device]

Phrase: "seen between the Ids"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and"

Phrase: "the class B myogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.144: These latter interactions were considerably weaker than those of Id-class A interactions and showed a far greater degree of variability. 

Phrase: "These latter interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "considerably weaker than those of Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0004093:Weak [Sign or Symptom]
   714   C1762617:Weak [Qualitative Concept]

Phrase: "A interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a far greater degree of variability."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.145: Id2 displayed the strongest binding which, in the case of MyoD and Myf-5, was 3-4-fold more avid than that of the corresponding Id1 interactions. 

Phrase: "Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the strongest binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "which,"

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5,"

Phrase: "was"

Phrase: "3-4-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442757:3 4 [Finding]

Phrase: "more avid than that of the corresponding Id1 interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2986972:Avid [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.146: In turn, Id1 bound MyoD and Myf-5 with a 5-10-fold greater affinity than Id3 which demonstrated barely detectable interaction with any of the myogenic factors. 

Phrase: "In turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5 with a 5-10-fold greater affinity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   742   C0332462:Fold [Spatial Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C1510827:Affinity [Natural Phenomenon or Process]
   742   C1704243:Greater [Quantitative Concept]
   742   C1880834:FOLD [Phenomenon or Process]
   708 E C0549177:Great [Quantitative Concept]

Phrase: "than Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "barely detectable interaction with any of the myogenic factors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.147: Of note, however, was that the strength of the Id2-Myf-5 and Id2-MyoD interactions rivaled the weakest Id-class A factor interactions. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "however,"

Phrase: "was"

Phrase: "that"

Phrase: "the strength of the Id2-Myf-5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237897:Strength [Quantitative Concept]
   748   C0808080:Strength [Idea or Concept]
   748   C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "Id2-MyoD interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "rivaled"

Phrase: "the weakest Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]

Phrase: "A factor interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.148: MyoD and Myf-5 showed the strongest interactions with all three Ids tested. 

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the strongest interactions with all three Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1704675:Interaction [Functional Concept]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.149: Although Id3 bound weakly, if at all, to the myogenic factors, its binding to class A factors was comparable to that of the other Ids (Fig. 1A). 

Phrase: "Although"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "weakly,"

Phrase: "if at all,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750557:If [Qualitative Concept]

Phrase: "to the myogenic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "its binding to class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "A factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "was"

Phrase: "comparable to that of the"

Phrase: "other Ids (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.150: Hence the differences in binding seen here cannot be attributed to differential expression. 

Phrase: "Hence"

Phrase: "the differences in binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "here"

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to differential expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0443199:Differential [Qualitative Concept]
   770   C1705242:Differential [Qualitative Concept]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.151: This was also confirmed by Western blot analysis of yeast lysates showing comparable levels of expression of all proteins under study (Fig. 2). 

Phrase: "This"

Phrase: "was"

Phrase: "also"

Phrase: "confirmed by Western blot analysis of yeast lysates"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C0750484:Confirmed [Idea or Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]
   711 E C1456348:Confirm [Qualitative Concept]
   711   C1881488:Lysate [Physical Object]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "comparable levels of expression of all proteins"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C3244092:expression level [Idea or Concept]
   748   C0441889:Levels [Qualitative Concept]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "under study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.152: When tested for their ability to bind the class A factors E47 or E12, all the myogenic factors (including MRF4/Myf-6) interacted strongly (Fig. 1B), again indicating that the differences in myogenic factor-Id binding were not due to relative differences in MRF protein expression. 

Phrase: "When"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: "or"

Phrase: "E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "all"

Phrase: "the myogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: ")"

Phrase: "interacted"

Phrase: "strongly"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "again"

Phrase: "indicating"

Phrase: "that"

Phrase: "the differences in myogenic factor-Id binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "not due to relative differences"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1547039:*Relative [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "in MRF protein expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.153: None of the hematopoietic factors displayed discernible interactions with the Id proteins, whereas all were found to interact with the class A target E2-2 (Fig. 1C). 

Phrase: "None of the hematopoietic factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0312859:Haematopoietic factor [Hormone]
   760   C0018957:Haematopoietic [Body System]
   760   C0229601:Hematopoietic [Functional Concept]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "discernible interactions with the Id proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   719   C1704675:Interaction [Functional Concept]

Phrase: "whereas"

Phrase: "all"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "A target E2-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1420639:E2-2 [Gene or Genome]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   827   C3539520:E2 [Gene or Genome]

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.154: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.155: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.156: Quantitative yeast 2-hybrid analysis. 

Phrase: "Quantitative yeast 2-hybrid analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
Processing 00000000.tx.157: Id proteins expressed as gal4 DNA binding domain fusions were tested with class A and class B targets expressed as gal4 transactivation domain fusions. 

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed as gal4 DNA binding domain fusions"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0332466:fusions [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1293131:fusions [Therapeutic or Preventive Procedure]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "tested with class A"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0392366:tested [Intellectual Product]
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "class B targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "expressed as gal4 transactivation domain fusions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040624:Transactivation [Genetic Function]
   753   C0332466:fusions [Functional Concept]
   753   C1293131:fusions [Therapeutic or Preventive Procedure]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.158: A, interaction of Id proteins with class A factors. 

Phrase: "A,"

Phrase: "interaction of Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interaction protein [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.159: B, interaction of Id proteins with MRFs. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "interaction of Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interaction protein [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with MRFs."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.160: E12 and E47 (also expressed as binding domain fusions) are shown as strong positive controls. 

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "(also"

Phrase: "expressed as binding domain fusions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0243122:binding [Functional Concept]
   760   C0332466:fusions [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1293131:fusions [Therapeutic or Preventive Procedure]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "shown as strong positive controls."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   773   C1883676:Positive Control [Conceptual Entity]
   760   C0439178:% Positive [Quantitative Concept]
   760   C0442821:Strong [Qualitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.161: C, interaction of Id proteins with the hematopoietic factors. 

Phrase: "C,"

Phrase: "interaction of Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interaction protein [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with the hematopoietic factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0312859:Haematopoietic factor [Hormone]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.162: E2-2 (also expressed as a binding domain fusion) is shown as a positive control. 

Phrase: "E2-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420639:E2-2 [Gene or Genome]
   861   C3539520:E2 [Gene or Genome]

Phrase: "(also"

Phrase: "expressed as a binding domain fusion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0243122:binding [Functional Concept]
   753   C0332466:Fusion [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "shown as a positive control."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.163: The values shown represent the average of three independent determinations (with standard errors of <10% in each case). 

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average of three independent determinations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1510992:Average [Quantitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]

Phrase: "("

Phrase: "with standard errors of <10%"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C1710181:Standard Error [Quantitative Concept]
   812   C0743559:errors [Qualitative Concept]
   812   C1442989:Standard [Qualitative Concept]
   812   C2828392:Standard [Intellectual Product]
   779 E C1608199:Error [Functional Concept]

Phrase: "in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.164: Expression of each protein was independently verified by Western blotting (Fig. 2). 

Phrase: "Expression of each protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "independently"

Phrase: "verified by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   770   C1711411:Verified [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.165: [View Larger Version of this Image (29K GIF file)] Fig. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(29K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.166: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.167: Western blot analysis of yeast 2-hybrid fusion proteins. 

Phrase: "Western blot analysis of yeast 2-hybrid fusion proteins."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   745   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]
   742   C1705493:Western [Spatial Concept]
Processing 00000000.tx.168: A, Id proteins expressed in pGBT9 were detected with an anti-gal4 DNA binding domain antibody. 

Phrase: "A,"

Phrase: "Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed in pGBT9"

Phrase: "were"

Phrase: "detected with an anti-gal4 DNA binding domain antibody."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C1511662:DNA Binding Domain [Amino Acid Sequence]
   781   C0282056:Anti DNA antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti-DNA
   764   C1148673:DNA Binding [Genetic Function]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C1262035:antibody dna [Laboratory Procedure]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0243122:binding [Functional Concept]
   742   C0442726:Detected [Finding]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1416832:GAL4 [Gene or Genome]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.169: B-D, expression of the hematopoietic factors, E proteins, and MRFs, expressed in pGAD424, were detected with an anti-gal4 activation domain antibody. 

Phrase: "B-D,"

Phrase: "expression of the hematopoietic factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "E proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "MRFs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "expressed in pGAD424,"

Phrase: "were"

Phrase: "detected with an anti-gal4 activation domain antibody."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1516004:Antibody Activation [Physiologic Function]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0442726:Detected [Finding]
   744   C1416832:GAL4 [Gene or Genome]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1879547:Activation [Activity]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.170: Untransformed Y153 lysates were used as controls. 

Phrase: "Untransformed Y153 lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.171: A size marker (in kilodaltons) is shown. 

Phrase: "A size marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "("

Phrase: "in kilodaltons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532717:Kilodalton [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.172: In other experiments (not shown), we have determined that the levels of proteins shown here do not change when they are co-expressed with other bHLH member proteins. 

Phrase: "In other experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "determined"

Phrase: "that"

Phrase: "the levels of proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   786   C0428479:Protein level [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "when"

Phrase: "they"

Phrase: "are"

Phrase: "co-expressed"

Phrase: "with other bHLH member proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   934   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.173: [View Larger Version of this Image (35K GIF file)] MRFs were also investigated for homodimerization ability. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(35K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "also"

Phrase: "investigated for homodimerization ability."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0085732:Ability [Organism Attribute]
   770   C1292732:investigated [Functional Concept]
   770   C1512485:Homodimerization [Molecular Function]
Processing 00000000.tx.174: MyoD, myogenin, and Myf-5 displayed weak homodimerization (less than 50pg of -galactosidase detected), whereas MRF4/Myf-6 homodimerization was not observed. 

Phrase: "MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "myogenin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417575:MYOGENIN [Gene or Genome]
  1000   C2986638:MYOGENIN [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5 displayed weak homodimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1512485:Homodimerization [Molecular Function]

Phrase: "(less than 50pg of -galactosidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0439092:Less Than [Intellectual Product]
           less
   760   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0547044:Less [Qualitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "MRF4/Myf-6 homodimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1512485:Homodimerization [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.175: Neither the Ids nor the hematopoietic factors displayed discernible homodimerization ability in this assay (data not shown). 

Phrase: "Neither"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "nor"

Phrase: "the hematopoietic factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0312859:Haematopoietic factor [Hormone]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "discernible homodimerization ability in this assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: Co-immunoprecipitation Analysis Co-IP of selected full-length in vitro translated proteins was employed to confirm the differences in dimerization properties identified by yeast 2-hybrid analysis (Fig. 3). 

Phrase: "Co-immunoprecipitation Analysis Co-IP"

Phrase: "of selected full-length in vitro translated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the differences in dimerization properties"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "identified by yeast 2-hybrid analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   783   C2598686:Yeast identified [Laboratory or Test Result]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0020205:Hybrid [Organism]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0205396:Identified [Qualitative Concept]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.177: Increasing amounts of Id1, Id2, or Id3 proteins were incubated with E12, and resultant heterodimers were precipitated with an anti-E12 polyclonal antibody (Fig. 3A). 

Phrase: "Increasing amounts of Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "or"

Phrase: "Id3 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated with E12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1422634:E12 [Gene or Genome]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "resultant heterodimers"

Phrase: "were"

Phrase: "precipitated with an anti-E12 polyclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1422634:E12 [Gene or Genome]
   714   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.178: Consistent with the yeast 2-hybrid data (Fig. 1), all three Ids interacted strongly with E12 with any differences being on the order of less than 2-fold. 

Phrase: "Consistent with the yeast 2-hybrid data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "all three Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "interacted"

Phrase: "strongly with E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1422634:E12 [Gene or Genome]

Phrase: "with any differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "being on the order of less"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]
   753   C2987476:Being [Conceptual Entity]

Phrase: "than 2-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.179: In contrast, interactions between Id proteins and MyoD were considerably weaker and showed more pronounced differences than those observed with Id-E protein interactions. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "interactions between Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interactions protein [Molecular Function]
   737   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "were"

Phrase: "considerably weaker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004093:Weak [Sign or Symptom]
   827   C1762617:Weak [Qualitative Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "more pronounced differences than those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "observed with Id-E protein interactions."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0872079:interactions protein [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0600091:ID [Intellectual Product]
   753   C1441672:Observed [Functional Concept]
   719   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.180: For example, Id1 and Id2 showed comparable interactions with MyoD, whereas Id3-MyoD interactions were significantly weaker. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "comparable interactions with MyoD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "whereas"

Phrase: "Id3-MyoD interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "significantly weaker."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004093:Weak [Sign or Symptom]
   827   C1762617:Weak [Qualitative Concept]
Processing 00000000.tx.181: These results were in good agreement with the results obtained by the 2-hybrid system. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were in good agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]

Phrase: "with the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained by the 2-hybrid system."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0020205:Hybrid [Organism]
   753   C0449913:System [Functional Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   719 E C1706701:Obtain [Activity]
Processing 00000000.tx.182: All Ids also bound very weakly to MRF4/Myf-6 (Fig. 3C) and not at all to Scl/Tal-1 (Fig. 3D). 

Phrase: "All Ids also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "very weakly to MRF4/Myf-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   753   C0442824:Very [Qualitative Concept]
   753   C1417533:MRF4 [Gene or Genome]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "not at all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2984077:Not at all [Intellectual Product]
   790   C1518422:Not [Functional Concept]

Phrase: "to Scl/Tal-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.183: From these experiments, we conclude that the strengths of Id-E protein and Id-MRF interactions qualitatively and quantitatively reflected those observed in yeast. 

Phrase: "From these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the strengths of Id-E protein"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0808080:strengths [Idea or Concept]
   719 E C0237897:Strength [Quantitative Concept]
   719 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "Id-MRF interactions qualitatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "quantitatively"

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "those"

Phrase: "observed in yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.184: Furthermore, our results indicate that the dimerization properties of full-length proteins are not significantly different from those of the isolated HLH domains expressed in yeast. 

Phrase: "Furthermore,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the dimerization properties of full-length proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   757   C1444754:Length property [Quantitative Concept]
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]

Phrase: "are"

Phrase: "not significantly different from those of the isolated HLH domains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "expressed in yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.185: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.187: Co-immunoprecipitation of in vitro translated full-length proteins. 

Phrase: "Co-immunoprecipitation of in vitro translated full-length proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   742   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.188: E12 (A), MyoD (B), MRF4/Myf-6 (C), and Scl/Tal-1 (D) programmed reticulocyte lysates were incubated with Id1, Id2, and Id3 programmed lysates. 

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Scl/Tal-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428449:TAL [Gene or Genome]

Phrase: "1 (D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "programmed reticulocyte lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "incubated with Id1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1415855:ID1 [Gene or Genome]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3 programmed lysates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]
Processing 00000000.tx.189: Protein complexes were captured with anti-E12, MyoD, or Id polyclonal antibodies and reactions resolved by 12% SDS-PAGE. 

Phrase: "Protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1523872:protein complex [Cell Component]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "captured with anti-E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1422634:E12 [Gene or Genome]

Phrase: "MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "or"

Phrase: "Id polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "resolved by 12% SDS-PAGE."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C0600209:SDS polyacrylamide gel electrophoresis [Laboratory Procedure,Research Activity]
   814   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   778   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   778   C0596607:Gel Electrophoresis [Laboratory Procedure]
   774 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   748   C0013855:Electrophoresis [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C1382104:Gel [Substance]
   748   C1514893:Resolved [Idea or Concept]
   748   C2699488:Resolved [Conceptual Entity]
Processing 00000000.tx.190: Quantitative determination of "captured" protein relative to Id was performed by PhosphorImage analysis, and values were normalized for methionine content. 

Phrase: "Quantitative determination of """

Phrase: "captured"

Phrase: """ protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "relative to Id"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "performed by PhosphorImage analysis,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0884358:Performed [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized for methionine content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]
Processing 00000000.tx.191: Determinations were performed at least twice, and representative graphs are shown. 

Phrase: "Determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0680730:determinations [Governmental or Regulatory Activity]
   966 E C1148554:determination [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at least twice,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0884358:Performed [Functional Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "representative graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0681493:graphs [Intellectual Product]
   827 E C2698021:Graph [Conceptual Entity]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.192: [View Larger Version of this Image (26K GIF file)] Mammalian 2-Hybrid Analysis The observation that the Ids displayed the widest range of interactions with MyoD and Myf-5 led us to investigate whether such differences were maintained in mammalian cells (Fig. 4). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(26K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Mammalian 2-Hybrid Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0020205:Hybrid [Organism]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the widest range of interactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "with MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "such differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "maintained in mammalian cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C1314677:Maintained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0024501:Maintain [Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.193: Id1, Id2, and Id3 were expressed as gal4 DNA binding domain fusions, whereas MyoD and Myf-5 were expressed as VP16 transactivation domain fusions (56). 

Phrase: "Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "were"

Phrase: "expressed as gal4 DNA binding domain fusions,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0332466:fusions [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1293131:fusions [Therapeutic or Preventive Procedure]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "whereas"

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5"

Phrase: "were"

Phrase: "expressed as VP16 transactivation domain fusions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040624:Transactivation [Genetic Function]
   753   C0332466:fusions [Functional Concept]
   753   C0733688:VP-16 [Carbohydrate,Pharmacologic Substance]
   753   C1293131:fusions [Therapeutic or Preventive Procedure]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.194: Each was tested for its ability to activate a reporter vector in HeLa cells (Fig. 4A). 

Phrase: "Each"

Phrase: "was"

Phrase: "tested for its ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a reporter vector in HeLa cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.195: E47, which displays strong interactions with each Id in yeast (Fig. 1A), was also expressed as a VP16 fusion as a positive control for Id dimerization activities. 

Phrase: "E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "which"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "strong interactions with each Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "also"

Phrase: "expressed as a VP16 fusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332466:Fusion [Functional Concept]
   760   C0733688:VP-16 [Carbohydrate,Pharmacologic Substance]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "as a positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "for Id dimerization activities."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1323329:dimerization activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.196: Appreciable CAT conversion was seen when either Id1 or Id2 was co-expressed with either MyoD or Myf-5 (Fig. 4B), whereas Id3 interaction with either of the myogenic factors was only marginally above background. 

Phrase: "Appreciable CAT conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439836:Conversion [Functional Concept]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "either Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415855:ID1 [Gene or Genome]

Phrase: "or"

Phrase: "Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "was"

Phrase: "co-expressed with either MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1417574:MYOD [Gene or Genome]
   760   C2985443:MYOD [Gene or Genome]

Phrase: "or"

Phrase: "Myf-5"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "Id3 interaction with either of the myogenic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "only marginally above background."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.197: These observations were generally consistent with both the yeast 2-hybrid data and with the co-IP experiments (Figs. 1 and 3). 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "were"

Phrase: "generally consistent with both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the yeast 2-hybrid data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "and with the co-IP experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   753   C0021069:Immunoprecipitation [Laboratory Procedure]
   753   C0681814:Experiments [Research Activity]
   753   C1515981:And [Idea or Concept]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.198: As the Ids differed in their ability to dimerize with the MRFs, we investigated their ability to bind E47 (Fig. 4B). 

Phrase: "As the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "differed in their ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "dimerize with the MRFs,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220905:regulatory [Regulation or Law]
   753   C0376525:Dimerize [Natural Phenomenon or Process]
   753   C1704735:Regulatory [Conceptual Entity]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.199: Each was found to generate comparable high levels of CAT activity as might have been predicted from our yeast 2-hybrid results (Fig. 1A). 

Phrase: "Each"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "comparable high levels of CAT activity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C0683317:activity levels [Finding]
   757   C0202354:Chloramphenicol level [Laboratory Procedure]
   757   C0427988:Chloramphenicol level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "predicted from our yeast 2-hybrid results"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0020205:Hybrid [Organism]
   748   C0036025:yeast [Fungus]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0681842:Predicted [Idea or Concept]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1882327:%{Predicted} [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.200: Thus the reduced ability of Id3 to interact with MyoD or Myf-5 cannot simply be explained by its differential expression. 

Phrase: "Thus"

Phrase: "the reduced ability of Id3 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "interact with MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1417574:MYOD [Gene or Genome]
   790   C2985443:MYOD [Gene or Genome]

Phrase: "or"

Phrase: "Myf-5"

Phrase: "cannot"

Phrase: "simply"

Phrase: "be"

Phrase: "explained by its differential expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0443199:Differential [Qualitative Concept]
   760   C1705242:Differential [Qualitative Concept]
Processing 00000000.tx.201: Our results in both mammalian cells and in yeast appear to reflect the true dimerization preferences of the Id proteins under study. 

Phrase: "Our results in both mammalian cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and in yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the true dimerization preferences of the Id proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0558295:Preferences [Idea or Concept]
   711 E C1549513:Preference [Idea or Concept]

Phrase: "under study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.202: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 4. 

Phrase: "4."
Processing 00000000.tx.204: Mammalian 2-hybrid analysis. 

Phrase: "Mammalian 2-hybrid analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0020205:Hybrid [Organism]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.205: A, an interaction between an MRF (expressed in pNLVP16) and an Id protein (expressed in pSG424) will result in the activation of a CAT reported gene bearing tandemly repeated gal4 binding sites in its promoter. 

Phrase: "A,"

Phrase: "an interaction between an MRF ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "expressed in pNLVP16"

Phrase: ")"

Phrase: "and"

Phrase: "an Id protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "expressed in pSG424"

Phrase: ")"

Phrase: "will"

Phrase: "result in the activation of a CAT"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1879547:Activation [Activity]
   744   C2825142:Result [Finding]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "tandemly repeated gal4 binding sites in its promoter."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0005456:Binding Sites [Receptor]
   744   C0205145:Sites [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1416832:GAL4 [Gene or Genome]
   737 E C0682969:Binding Site [Amino Acid Sequence]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.206: B, HLH domains of Id1, Id2, and Id3, expressed as gal4 DNA binding domain (BD) fusions, were tested for their ability to interact with MyoD, Myf-5, or E47 expressed as VP16 transactivation domain (TAD) fusions. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "HLH domains of Id1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0206678:HLH Domain [Spatial Concept]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "expressed as gal4 DNA binding domain (BD) fusions,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C0332466:fusions [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1293131:fusions [Therapeutic or Preventive Procedure]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "interact with MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1417574:MYOD [Gene or Genome]
   790   C2985443:MYOD [Gene or Genome]

Phrase: "Myf-5,"

Phrase: "or"

Phrase: "E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "expressed as VP16 transactivation domain (TAD) fusions."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040624:Transactivation [Genetic Function]
   753   C0332466:fusions [Functional Concept]
   753   C0733688:VP-16 [Carbohydrate,Pharmacologic Substance]
   753   C1293131:fusions [Therapeutic or Preventive Procedure]
   753   C1880389:Domain [Functional Concept]
   753   C1883221:Domain [Conceptual Entity]
   753   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.207: CAT conversion over background was determined by PhosphorImage analysis. 

Phrase: "CAT conversion over background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "was"

Phrase: "determined by PhosphorImage analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.208: Values shown represent the average of three independent experiments with standard errors of less than 10%. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average of three independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1510992:Average [Quantitative Concept]
   753   C2825518:AVERAGE [Quantitative Concept]

Phrase: "with standard errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:errors [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1608199:Error [Functional Concept]

Phrase: "of less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "than 10%."
Processing 00000000.tx.209: [View Larger Version of this Image (29K GIF file)] Id Repression of E Protein-MyoD Heterodimer Activity By having established that the Ids interacted similarly with each E protein (Fig. 1A), we sought to determine the influence of each Id on the transcriptional activity of full-length E2AMyoD heterodimers (Fig. 5). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(29K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Id Repression of E Protein-MyoD Heterodimer Activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0035143:Repression [Mental Process]

Phrase: "By"

Phrase: "having"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "interacted"

Phrase: "similarly with each E protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the influence of each Id"

Phrase: "on the transcriptional activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of full-length E2AMyoD heterodimers"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.210: We had previously established that this combination of factors gave the highest levels of transactivation from the MCK-CAT reporter.2 The relative consistency of Id-E2A interactions in yeast suggested that each Id should disrupt E2AMyoD complexes with comparable ability. 

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "this combination of factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "the highest levels of transactivation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "from the MCK-CAT reporter.2"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   795   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
   795   C0026845:Muscle [Tissue]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0335038:Reporter [Professional or Occupational Group]
   795   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   795   C1561535:Creatinine [Finding]
   795   C1705915:Reporter [Conceptual Entity]
   795   C1709908:Reporter [Group]
   740 E C0591251:Chloromycetin [Organic Chemical,Pharmacologic Substance]
   740 E C0699303:Ophthochlor [Organic Chemical,Pharmacologic Substance]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "The relative consistency of Id-E2A interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332529:Consistency [Qualitative Concept]
   748   C1547017:Consistency [Quantitative Concept]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "each Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "should"

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "E2AMyoD complexes with comparable ability."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.211: Low levels of transactivation were observed when either 5g of MyoD or 1g of E47 or E12 was transfected alone. 

Phrase: "Low levels of transactivation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "either 5g of MyoD"

Phrase: "or"

Phrase: "1g of E47"

Phrase: "or"

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "was"

Phrase: "transfected"

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.212: Co-transfection of these factors, however, generated significant CAT conversion, indicating that transactivation was mediated by an E2AMyoD heterodimer and not by endogenous factors. 

Phrase: "Co-transfection of these factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "however,"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "significant CAT conversion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439836:Conversion [Functional Concept]

Phrase: "indicating"

Phrase: "that transactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040624:Transactivation [Genetic Function]

Phrase: "was"

Phrase: "mediated by an E2AMyoD heterodimer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "not by endogenous factors."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1516853:Endogenous Factors [Functional Concept]
   770   C0205227:Endogenous [Functional Concept]
   770   C1518422:Not [Functional Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.213: The enhanced ability of MyoD to form heterodimers with E47 compared with E12 in yeast (Fig. 1B) was reflected in an increased ability of MyoDE47 heterodimers to activate the MCK-CAT reporter. 

Phrase: "The enhanced ability of MyoD to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "heterodimers with E47"

Phrase: "compared with E12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1422634:E12 [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "reflected in an increased ability of MyoDE47 heterodimers to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0085732:Ability [Organism Attribute]
   742   C0205217:Increased [Quantitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C0558058:reflected [Mental Process]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the MCK-CAT reporter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0335038:Reporter [Professional or Occupational Group]
   799   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   799   C1705915:Reporter [Conceptual Entity]
   799   C1709908:Reporter [Group]
Processing 00000000.tx.214: The introduction of increasing amounts of each Id led to the suppression of CAT activity in a dose-dependent fashion, with a maximal 2-3-fold reduction in transactivation observed at the highest input Id concentration. 

Phrase: "The introduction of increasing amounts of each Id"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1293116:Introduction [Health Care Activity]
   744   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "led to the suppression of CAT activity"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   800   C1151952:chloramphenicol acetyltransferase activity [Molecular Function]
   770   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1151922:acetyltransferase activity [Molecular Function]
   744   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   744   C0205177:Activity [Functional Concept]
   744   C0221103:Suppression [Pathologic Function]
   744   C0301625:Suppression [Organism Function]
   744   C0439167:% activity [Quantitative Concept]
   744   C0439181:% suppression [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0728721:suppression [Mental Process]
   744   C1561536:*Activity [Idea or Concept]
   744   C1708698:LED [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in a dose-dependent fashion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "with a maximal 2-3-fold reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0301630:Reduction [Natural Phenomenon or Process]
   804   C0392756:Reduction [Qualitative Concept]
   804   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in transactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040624:Transactivation [Genetic Function]

Phrase: "observed at the highest input Id concentration."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0086045:Concentration [Mental Process]
   748   C0600091:ID [Intellectual Product]
   748   C1441672:Observed [Functional Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1522410:Highest [Qualitative Concept]
   748   C1708517:Input [Conceptual Entity]
   714 E C0205250:High [Qualitative Concept]
   714 E C1299351:High [Qualitative Concept]
   714 E C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.215: In metabolic labeling experiments, the expression of each Id was determined to be comparable (data not shown). 

Phrase: "In metabolic labeling experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "the expression of each Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "comparable"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.217: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.218: Disruption of E2AMyoD complexes by Ids. 

Phrase: "Disruption of E2AMyoD complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]

Phrase: "by Ids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]
Processing 00000000.tx.219: Ids were tested in their ability to disrupt E47MyoD complexes (dark shading) or E12MyoD complexes (light shading). 

Phrase: "Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "tested in their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "E47MyoD complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "(dark shading"

Phrase: ")"

Phrase: "or"

Phrase: "E12MyoD complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "(light shading"

Phrase: ")."
Processing 00000000.tx.220: Values are normalized relative to MyoDE47 conversion. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "relative to MyoDE47 conversion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.221: The average of at least three experiments is shown. 

Phrase: "The average of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1510992:Average [Quantitative Concept]
   790   C2825518:AVERAGE [Quantitative Concept]

Phrase: "at least three experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.222: [View Larger Version of this Image (33K GIF file)] Id Protein Helix Swaps and Site-directed Mutagenesis To map the amino acid residues responsible for the differential binding capabilities of Id proteins with respect to the MRFs, helix swaps were generated, and site-directed mutagenesis was performed (Fig. 6). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(33K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Id Protein Helix Swaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1416521:SWAP [Gene or Genome]
   779   C1419999:SWAP [Gene or Genome]

Phrase: "and"

Phrase: "Site-directed Mutagenesis To"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   812   C0079866:Mutagenesis [Molecular Function]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
   812   C3146302:Mutagenesis [Laboratory Procedure]
   779   C0439851:Direct [Qualitative Concept]
   779   C1947931:Direct [Qualitative Concept]
   741 E C0439755:Directions [Spatial Concept]
   741 E C0449738:Direction [Spatial Concept]

Phrase: "map"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024779:Map [Manufactured Object]
  1000   C1706473:Map [Conceptual Entity]

Phrase: "the amino acid residues"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "responsible for the differential binding capabilities of Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "with respect to the MRFs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "helix swaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416521:SWAP [Gene or Genome]
   827   C1419999:SWAP [Gene or Genome]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "and"

Phrase: "site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.223: All mutants were tested in yeast for their ability to bind E12, and all were found to bind with similar avidity, varying over an approximate 2-fold range (Fig. 6, last column). 

Phrase: "All mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "tested in yeast"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0392366:tested [Intellectual Product]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "for their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "and"

Phrase: "all"

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind with similar avidity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1510996:Avidity [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]

Phrase: "varying over an approximate 2-fold range"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332232:Approximate [Qualitative Concept]
   748   C0332462:Fold [Spatial Concept]
   748   C1514721:Range [Quantitative Concept]
   748   C1880834:FOLD [Phenomenon or Process]
   748   C2348147:Range [Quantitative Concept]
   748   C3542016:Range [Intellectual Product]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "last column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.224: These results were anticipated based on our observations that wild-type Id1 and Id3 interacted to a comparable extent with E12 (Fig. 1A). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "anticipated"

Phrase: "based on our observations"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3244290:observations [Functional Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "that wild-type Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1415855:ID1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "interacted to a comparable extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "with E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.225: Initially, chimeras containing the first helix of Id1 and the loop-helix 2region of Id3 or the first helix of Id3 and the loop-helix 2region of Id1 were constructed and tested for interaction with all four MRFs (Fig. 6, lines 3and 4). 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "chimeras"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008109:Chimeras [Organism]
   966 E C1318484:Chimera [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the first helix of Id1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018882:Helix [Eukaryote]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "the loop-helix 2region of Id3"

Phrase: "or"

Phrase: "the first helix of Id3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018882:Helix [Eukaryote]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "the loop-helix 2region of Id1"

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "tested for interaction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0392366:tested [Intellectual Product]
   790   C1704675:Interaction [Functional Concept]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]

Phrase: "with all four MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 3and 4"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.226: These experiments clearly demonstrated that the region determining the specificity of interactions resided in the first helix and/or in the amino-terminal region immediately adjacent to this. 

Phrase: "These experiments clearly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "determining"

Phrase: "the specificity of interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "resided in the first helix"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0018882:Helix [Eukaryote]
   760   C0205435:First [Quantitative Concept]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1279901:First [Qualitative Concept]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]
   726   C2982691:Reside [Activity]

Phrase: "and/or in the amino-terminal region"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1706528:And/Or [Conceptual Entity]
   748   C0017446:Region [Geographic Area]
   748   C0205088:Terminal [Temporal Concept]
   748   C0205147:Region [Spatial Concept]
   748   C1515981:And [Idea or Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]

Phrase: "immediately adjacent to this."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205117:Adjacent to [Spatial Concept]
           Adjacent
Processing 00000000.tx.227: Based on this observation, the three amino acid residues that distinguish the first helices of Id1 and Id3 were altered sequentially to convert Id1 to Id3 and vice versa. 

Phrase: "Based on this observation,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the three amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "distinguish"

Phrase: "the first helices of Id1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018882:Helix [Eukaryote]
   760   C0229304:Helix [Body Part, Organ, or Organ Component]
   760   C1017315:helices [Eukaryote]
   760   C1704821:Helix [Spatial Concept]
   760   C1705682:Helix [Anatomical Structure]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "were"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "sequentially to"

Phrase: "convert"

Phrase: "Id1 to Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.228: Altering individual tyrosine, glycine, and lysine residues of Id1 to the corresponding aspartic acid, histidine, and arginine residues of Id3, respectively, reduced binding in each case (Fig. 6, lines 5,7, and 9). 

Phrase: "Altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "individual tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: "and"

Phrase: "lysine residues of Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "to the corresponding aspartic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "histidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine residues of Id3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "respectively,"

Phrase: "reduced binding in each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 5,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "7,"

Phrase: "and"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.229: However, the relative importance of each residue for dimerization was dependent upon the MRF under study. 

Phrase: "However,"

Phrase: "the relative importance of each residue"

Phrase: "for dimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "dependent upon the MRF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "under study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.230: For example Id1/3 (G92H) showed a 3-fold reduction in the ability to bind MyoD but a 14-fold reduction in the ability to bind Myf-5 (compare Fig. 6, lines 3and 7). 

Phrase: "For example Id1/3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1415855:ID1 [Gene or Genome]
   827   C1707959:Example [Conceptual Entity]

Phrase: "(G92H"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 3-fold reduction in the ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "but"

Phrase: "a 14-fold reduction in the ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Myf-5"

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 3and 7"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.231: In contrast Id1/3 (K98R) showed a 12-fold reduction in MyoD binding but only a 4-fold reduction in myogenin binding (compare Fig. 6, lines 3and 9). 

Phrase: "In contrast Id1/3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1415855:ID1 [Gene or Genome]
   827   C1979874:Contrast [Qualitative Concept]

Phrase: "(K98R"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 12-fold reduction in MyoD binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a 4-fold reduction in myogenin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 3and 9"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.232: Similarly, no single Id3 to Id1 mutation restored maximal binding (Fig. 6, lines 6,8, and 10). 

Phrase: "Similarly,"

Phrase: "no single Id3 to Id1 mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1415856:ID3 [Gene or Genome]

Phrase: "restored"

Phrase: "maximal binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 6,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "8,"

Phrase: "and"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.233: This demonstrates that each residue, even the conserved lysine of Id1 and arginine of Id3, contributes to binding specificity although the relative importance of each residue is dependent upon the MRF target. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "each residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709915:Residue [Conceptual Entity]
  1000   C1882936:RESIDUE [Phenomenon or Process]
   928 E C1609982:Residual [Qualitative Concept]

Phrase: "even"

Phrase: "the conserved lysine of Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "arginine of Id3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "contributes to binding specificity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0037791:Specificity [Quantitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1511884:Specificity [Quantitative Concept]
   770   C1880177:Contribute [Activity]

Phrase: "although"

Phrase: "the relative importance of each residue"

Phrase: "is"

Phrase: "dependent upon the MRF target."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.234: To investigate possible additive effects, two further sets of Id3 mutations were investigated for their ability to restore Id1-like binding. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "possible additive effects,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0442796:Additive [Qualitative Concept]
   827   C1280500:effects [Qualitative Concept]
   827   C1550602:Additive [Substance]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "two further sets of Id3 mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036849:Set [Mental Process]
   753   C1442518:Set [Functional Concept]
   753   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "investigated for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1292732:investigated [Functional Concept]

Phrase: "restore"

Phrase: "Id1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "like binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]
Processing 00000000.tx.235: A double mutant (Fig. 6, line 11), created by altering the aspartic acid and histidine residues of Id3/1 to the complementary tyrosine and glycine residues of Id1, resulted in almost full binding to MyoD, increased binding to Myf-5, and weak binding to MRF4/Myf-6. 

Phrase: "A double mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "line 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "created by altering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "the aspartic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "histidine residues of Id3/1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "to the complementary tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "glycine residues of Id1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "resulted in almost full binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243122:binding [Functional Concept]
   760   C0443225:Full [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "to MyoD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "increased binding to Myf-5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "weak binding to MRF4/Myf-6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1657124:Mrf4 binding [Genetic Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
Processing 00000000.tx.236: This double mutant did not, however, restore myogenin binding. 

Phrase: "This double mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "did"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "however,"

Phrase: "restore"

Phrase: "myogenin binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1658152:myogenin binding [Genetic Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.237: Even when all three residues were altered to those of Id1 (Fig. 6, line 12), no increase was seen in Myf-5 binding when compared with the double mutant. 

Phrase: "Even"

Phrase: "when"

Phrase: "all three residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "were"

Phrase: "altered to those of Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Altered [Functional Concept]
   760   C1415855:ID1 [Gene or Genome]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "line 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "no increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "seen in Myf-5 binding"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205397:Seen [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "when"

Phrase: "compared with the double mutant."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205173:Double [Functional Concept]
   760   C0596988:Mutant [Cell or Molecular Dysfunction]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.238: Some binding was seen to myogenin, whereas MRF4/Myf-6 binding was undetectable. 

Phrase: "Some"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "seen to myogenin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205397:Seen [Qualitative Concept]
   790   C1417575:MYOGENIN [Gene or Genome]
   790   C2986638:MYOGENIN [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "whereas"

Phrase: "MRF4/Myf-6 binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1657124:Mrf4 binding [Genetic Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "undetectable."
Processing 00000000.tx.239: These data suggested that helix 1residues are sufficient for MyoD recognition but that additional residues upstream of helix 1appear to be required for full dimerization with the other three myogenic factors. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that helix 1residues"

Phrase: "are"

Phrase: "sufficient for MyoD recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "but"

Phrase: "that additional residues upstream of helix 1appear to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "be"

Phrase: "required for full dimerization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0376525:Dimerization [Natural Phenomenon or Process]
   770   C0443225:Full [Qualitative Concept]
   770   C1514873:Required [Functional Concept]

Phrase: "with the"

Phrase: "other three myogenic factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.240: To investigate the upstream requirement further, a series of deletions were made in the Id1/3 swap background. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the upstream requirement further,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514873:Requirement [Functional Concept]

Phrase: "a series of deletions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205549:Series [Quantitative Concept]
   770   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "made in the Id1/3 swap background."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C1415855:ID1 [Gene or Genome]
   748   C1416521:SWAP [Gene or Genome]
   748   C1419999:SWAP [Gene or Genome]
   748   C1706907:Background [Conceptual Entity]
   714   C1881534:Make [Functional Concept]
Processing 00000000.tx.241: The initial deletion of six amino acids at the extreme NH2 terminus of the Id1/3 sequence (Fig. 6, line 13) had a minimal effect on binding (<2-fold) with the exception of Myf-5 whose binding was reduced approximately 3-fold (Fig. 6, lines 3and 13). 

Phrase: "The initial deletion of six amino acids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "at the extreme NH2 terminus"

Phrase: "of the Id1/3 sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "line 13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "had"

Phrase: "a minimal effect on binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: "<2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of Myf-5"

Phrase: "whose binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "approximately 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 3and 13"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.242: The deletion of a further six residues (Fig. 6, line 14) resulted in the abrogation of myogenin and MRF4/Myf-6 binding although little additional effect was seen with respect to Myf-5 and MyoD. 

Phrase: "The deletion of a further six residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "line 14"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "resulted in the abrogation of myogenin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1417575:MYOGENIN [Gene or Genome]
   753   C2986638:MYOGENIN [Gene or Genome]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "MRF4/Myf-6 binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1657124:Mrf4 binding [Genetic Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "although"

Phrase: "little additional effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "seen with respect to Myf-5"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0205397:Seen [Qualitative Concept]
   753   C0679133:respect [Social Behavior]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "MyoD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]
Processing 00000000.tx.243: Finally, an internal deletion of the six residues immediately adjacent to the amino terminus of the first helix (Fig. 6, line 15) severely inhibited dimerization with all MRFs, although this was least obvious with MyoD. 

Phrase: "Finally,"

Phrase: "an internal deletion of the six residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "immediately adjacent to the amino terminus of the first helix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "line 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "dimerization with all MRFs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "although"

Phrase: "this"

Phrase: "was"

Phrase: "least obvious with MyoD."
Processing 00000000.tx.244: Interestingly, all of the individual deletion mutants (Fig. 6, lines 13-15) bound E12 as well as either of the wild-type Ids (with <2-fold differences). 

Phrase: "Interestingly,"

Phrase: "all of the individual deletion mutants"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0027361:Individual [Population Group]
   753   C0237401:Individual [Human]
   753   C0444868:All [Quantitative Concept]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]
   753   C3539085:All [Idea or Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 13-15"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "bound E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1422634:E12 [Gene or Genome]

Phrase: "as well as"

Phrase: "either of the wild-type Ids ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "with"

Phrase: "<2-fold differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.245: From these studies, it appears that complete MyoD and Myf-5 interactions with Id1 require similar amino acid residues. 

Phrase: "From these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that complete MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417574:MYOD [Gene or Genome]
   861   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5 interactions with Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "require"

Phrase: "similar amino acid residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.246: The residues facilitating MyoD and Myf-5 binding are not sufficient for myogenin and MRF4/Myf-6 binding, and these latter factors require additional, upstream amino acids. 

Phrase: "The residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "facilitating"

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5 binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "not sufficient for myogenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "and"

Phrase: "MRF4/Myf-6 binding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1657124:Mrf4 binding [Genetic Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "these latter factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "require"

Phrase: "additional, upstream amino acids."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.247: Binding by E12 would appear not to require any of these upstream residues. 

Phrase: "Binding by E12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "any of these upstream residues."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0522505:Upstream [Spatial Concept]
   760   C1552551:Any [Qualitative Concept]
   760   C3272371:ANY [Intellectual Product]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.248: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.249: 6. 

Phrase: "6."
Processing 00000000.tx.250: Id protein helix swaps and site-directed mutagenesis. 

Phrase: "Id protein helix swaps"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1416521:SWAP [Gene or Genome]
   779   C1419999:SWAP [Gene or Genome]

Phrase: "and"

Phrase: "site-directed mutagenesis."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]
Processing 00000000.tx.251: A series of Id hybrid molecules were tested in their ability to bind all four MRFs and E12 using a quantitative yeast 2-hybrid assay, performed in triplicate. 

Phrase: "A series of Id hybrid molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "were"

Phrase: "tested in their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "all four MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a quantitative yeast 2-hybrid assay,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0243073:assay [Qualitative Concept]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.252: The amount of -galactosidase enzyme generated per 107 cells (ng) for each set of interactions is shown in the right hand columns. 

Phrase: "The amount of -galactosidase enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "generated per 107 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3146294:Generated [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(ng) for each"

Phrase: "set of interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "shown in the right hand columns."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0230370:Right hand [Body Part, Organ, or Organ Component]
   790   C1288948:Right hand [Body Part, Organ, or Organ Component]
   753   C0018563:Hand [Body Part, Organ, or Organ Component]
   753   C0205090:Right [Spatial Concept]
   753   C1281583:Hand [Body Part, Organ, or Organ Component]
   753   C1552914:hand [Quantitative Concept]
   719   C1185738:Column [Body Part, Organ, or Organ Component]
   719   C1547282:Show [Intellectual Product]
   719   C1706132:Column [Idea or Concept]
   718 E C0344333:Right handed [Organism Attribute]
Processing 00000000.tx.253: Standard errors were less than 5% in each case. 

Phrase: "Standard errors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:errors [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1608199:Error [Functional Concept]

Phrase: "were"

Phrase: "less than 5%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: "in each case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.254: [View Larger Version of this Image (35K GIF file)] A select number of the Id "helix swap" proteins depicted in Fig. 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(35K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "]"

Phrase: "A"

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "number of the Id ""helix swap"" proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "depicted in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.255: 4 were examined using the mammalian two-hybrid system. 

Phrase: "4"

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mammalian two-hybrid system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.256: In these experiments, the HLH domains of Id1/3, Id3/1, and Id1/3 D80-85 were cloned into the pSG424 vector and transfected into HeLa cells together with either pNLVPMyoD or pNLVPMyf5. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the HLH domains of Id1/3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0206678:HLH Domain [Spatial Concept]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "Id3/1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415856:ID3 [Gene or Genome]

Phrase: "and"

Phrase: "Id1/3 D80-85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415855:ID1 [Gene or Genome]

Phrase: "were"

Phrase: "cloned into the pSG424 vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "transfected into HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "together with either pNLVPMyoD"

Phrase: "or"

Phrase: "pNLVPMyf5."
Processing 00000000.tx.257: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.258: 7, these results recapitulated those observed in yeast. 

Phrase: "7,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "recapitulated"

Phrase: "those"

Phrase: "observed in yeast."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.259: Neither Id3, Id3/1, nor Id1/3 D80-85 gave a detectable interaction with either MyoD or Myf5. 

Phrase: "Neither Id3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "Id3/1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415856:ID3 [Gene or Genome]

Phrase: "nor"

Phrase: "Id1/3 D80-85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1415855:ID1 [Gene or Genome]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a detectable interaction with either MyoD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "Myf5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417532:MYF5 [Gene or Genome]
Processing 00000000.tx.260: In contrast, Id1 interacted strongly. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "interacted"

Phrase: "strongly."
Processing 00000000.tx.261: That each of the Id proteins was expressed was confirmed in control experiments showing that all five Id fusion proteins depicted in Fig. 

Phrase: "That"

Phrase: "each of the Id proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0600091:ID [Intellectual Product]
   760   C1457900:Each [Quantitative Concept]

Phrase: "was"

Phrase: "expressed"

Phrase: "was"

Phrase: "confirmed in control experiments"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "all five Id fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "depicted in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.262: 7 interacted strongly with a pNLVP16 fusion of the E12 bHLH domain (not shown). 

Phrase: "7"

Phrase: "interacted"

Phrase: "strongly with a pNLVP16 fusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332466:Fusion [Functional Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "of the E12 bHLH domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0206678:Helix-Loop-Helix Domain [Spatial Concept]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.263: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.264: 7. 

Phrase: "7."
Processing 00000000.tx.265: Mammalian 2-hybrid interactions of MyoD and Myf5 with select Id1 and Id3 mutants. 

Phrase: "Mammalian 2-hybrid interactions of MyoD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Myf5 with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1417532:MYF5 [Gene or Genome]

Phrase: "select"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Select [Activity]

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "Id3 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.266: The pNLVP vectors used were the same as those described in Fig. 

Phrase: "The pNLVP vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "the same as those"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.267: 6. 

Phrase: "6."
Processing 00000000.tx.268: The Id1/3, Id3/1, and Id1D80-85 mutant HLH domains shown in Fig. 

Phrase: "The Id1/3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415855:ID1 [Gene or Genome]

Phrase: "Id3/1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415856:ID3 [Gene or Genome]

Phrase: "and"

Phrase: "Id1D80-85 mutant HLH domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   823   C0206678:HLH Domain [Spatial Concept]
   771   C1880389:Domain [Functional Concept]
   771   C1883221:Domain [Conceptual Entity]
   771   C3541951:Domain [Intellectual Product]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.269: 6 were amplified by PCR and cloned into the pSG424 vector. 

Phrase: "6"

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "cloned into the pSG424 vector."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]
Processing 00000000.tx.270: The indicated amounts of each plasmid along with pGal5E472CAT (5g/plate) and a CMV-gal (2g/plate) were transfected into HeLa cells using a calcium phosphate precipitation procedure and assayed for -galactosidase and CAT 2days later. 

Phrase: "The indicated amounts of each plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "along with pGal5E472CAT"

Phrase: "(5g/plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005971:Plate [Medical Device]
   861   C1139930:plate [Medical Device]
   861   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "a CMV-gal (2g/plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005971:Plate [Medical Device]
   812   C1139930:plate [Medical Device]
   812   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "transfected into HeLa cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a calcium phosphate precipitation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C1948041:Procedure [Therapeutic or Preventive Procedure]
   812   C2700391:Procedure [Activity]
   812   C3274430:PROCEDURE [Health Care Activity]
   812   C3538935:Procedure [Idea or Concept]
   812   C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "assayed for -galactosidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "CAT 2days later."
Processing 00000000.tx.271: [View Larger Version of this Image (16K GIF file)] DISCUSSION bHLH proteins are involved in diverse aspects of cellular physiology, from establishing the topography of the early embryo (e.g. Twist) to promoting cellular transformation, proliferation, and apoptosis (e.g. c-Myc) and ultimately to the regulation of terminal differentiation programs such as myogenesis (the MRFs) (25, 57, 58). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(16K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] DISCUSSION bHLH proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   940   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "involved in diverse aspects of cellular physiology,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   804   C0010820:Cellular aspects of [Qualitative Concept]
           cellular aspects
   778   C0007613:Cellular Physiology [Cell Function]
   748   C0007634:Cellular [Cell]
   748   C0031842:Physiology [Biomedical Occupation or Discipline]
   748   C0031843:physiology [Physiologic Function]
           physiological aspects
   748   C0178539:Cellular [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1880371:Diverse [Qualitative Concept]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "from establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "the topography of the early embryo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205627:Topography, NOS [Spatial Concept]
   753   C0392918:TOPOGRAPHY [Classification]
   753   C0870781:topography [Spatial Concept]
   753   C1522605:Topography [Qualitative Concept]

Phrase: "("

Phrase: "e.g. Twist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040480:twist [Physiologic Function]

Phrase: ")"

Phrase: "to promoting cellular transformation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1510411:Cellular Transformation [Pathologic Function]
           Transformation
   827   C0040682:Transformation [Cell Function]
   827   C1705163:Transformation [Research Activity]

Phrase: "proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "("

Phrase: "e.g. c-Myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "ultimately to the regulation of terminal differentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C2752630:terminal differentiation [Cell Function]
   748   C0007589:Differentiation [Cell Function]
   748   C0205088:Terminal [Temporal Concept]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C2945687:Differentiation [Functional Concept]

Phrase: "programs such as myogenesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376691:Programs [Intellectual Product]
   770   C0596997:Myogenesis [Organ or Tissue Function]
   770   C1709697:Program [Conceptual Entity]
   770   C2728259:Program [Pharmacologic Substance]
   770   C3484370:Program [Functional Concept]

Phrase: "("

Phrase: "the MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220905:regulatory [Regulation or Law]
   827   C1704735:Regulatory [Conceptual Entity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "(25,"

Phrase: "57,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.272: As an increasing number of such proteins are characterized, it is apparent that spatial and temporal expression patterns combine with a hierarchical network of specific protein-protein interactions to provide precise control of many cellular processes. 

Phrase: "As an increasing number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of such proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "apparent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]

Phrase: "that spatial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428114:spatial [Gene or Genome]

Phrase: "and"

Phrase: "temporal expression patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "combine with a hierarchical network of specific protein-protein interactions to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   759   C3178902:Protein Interaction Network [Functional Concept]
   754   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   754   C0872079:interactions protein [Molecular Function]
           Protein-Protein Interaction
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0205369:Specific [Qualitative Concept]
   738   C0336789:Combine [Manufactured Object]
   738   C1513822:Network [Professional or Occupational Group]
   738   C1552740:specific [Intellectual Product]
   738   C1705739:Network [Manufactured Object]
   738   C1882071:Network [Conceptual Entity]
   704   C1704675:Interaction [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "precise control of many cellular processes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.273: A variety of biochemical, genetic, and in vivo approaches have been taken in the investigation of dimerization potential, sequence-specific DNA binding, and transcriptional activity of bHLH factors (35, 41, 43, 56, 59-62). 

Phrase: "A variety of biochemical, genetic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "in vivo approaches"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "taken in the investigation of dimerization potential,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0376525:Dimerization [Natural Phenomenon or Process]
   748   C1261322:Investigation [Health Care Activity]
   748   C1552578:investigation [Idea or Concept]
   748   C1883727:Taken [Conceptual Entity]
   748   C3245505:Potential [Qualitative Concept]
   714 E C1515187:Take [Health Care Activity]

Phrase: "sequence-specific DNA binding,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C1624609:sequence-specific DNA binding [Genetic Function]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0205369:Specific [Qualitative Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1519249:Sequence [Functional Concept]
   812   C1552740:specific [Intellectual Product]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "transcriptional activity of bHLH factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   755   C1148759:transcription factor activity [Genetic Function]
   755   C3537021:Transcription Factor Activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(35,"

Phrase: "41,"

Phrase: "43,"

Phrase: "56,"

Phrase: "59-62"

Phrase: ")."
Processing 00000000.tx.274: Although our investigation generally considers only one aspect of these activities, dimerization, we feel that a comprehensive understanding of the relative affinities displayed by a group of key factors may provide insight into mechanisms of transcriptional activation. 

Phrase: "Although"

Phrase: "our investigation generally"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "considers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:consider [Idea or Concept]

Phrase: "only one aspect of these activities,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1547011:Aspect [Quantitative Concept]
   753   C1879746:Aspect [Qualitative Concept]

Phrase: "dimerization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "feel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013987:feel [Mental Process]
   916 E C1527305:Feeling, NOS [Mental Process]

Phrase: "that"

Phrase: "a comprehensive understanding of the relative affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162340:Understanding [Mental Process]

Phrase: "displayed by a group of key factors"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   774   C0441835:Group A [Classification]
   757   C0960756:factor A [Organic Chemical]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C0870432:displayed [Functional Concept]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   714   C1521761:Factor [Functional Concept]
   714 E C1705417:Display [Manufactured Object]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into mechanisms of transcriptional activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:Insight [Mental Process]
Processing 00000000.tx.275: As the function of the myogenic factors both in establishing the myoblast lineage and initiating terminal differentiation is reasonably well described, myogenesis may provide a useful model for other tissue-specific differentiation pathways (reviewed in Ref. 58). 

Phrase: "As the function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of the myogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "both in establishing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0238767:Both [Spatial Concept]
   790   C0443211:establishing [Qualitative Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "the myoblast lineage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881379:Lineage [Conceptual Entity]

Phrase: "and"

Phrase: "initiating terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2752630:terminal differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "reasonably well described, myogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596997:Myogenesis [Organ or Tissue Function]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a useful model for other tissue-specific differentiation pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1519523:Tissue Model [Experimental Model of Disease]
   742   C3161035:Model [Intellectual Product]

Phrase: "("

Phrase: "reviewed in Ref. 58"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.276: Numerous groups have reported the ability of class A, class B, and Id proteins to homo- and heterodimerize. 

Phrase: "Numerous groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the ability of class A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "class B,"

Phrase: "and"

Phrase: "Id proteins to homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "heterodimerize."
Processing 00000000.tx.277: Sun and Baltimore (60) reported the dissociation constants (Kd) for MyoD homodimers, E47 homodimers, and E47MyoD heterodimers to be 6.8 104, 1.5105, and 1.9106 M, respectively (60). 

Phrase: "Sun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "and"

Phrase: "Baltimore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "(60"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the dissociation constants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "(Kd) for MyoD homodimers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026691:KD [Disease or Syndrome]
   770   C1705240:KD [Gene or Genome]
   770   C1839259:KD [Disease or Syndrome]

Phrase: "E47 homodimers,"

Phrase: "and"

Phrase: "E47MyoD heterodimers to"

Phrase: "be"

Phrase: "6.8 104,"

Phrase: "1.5105,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1.9106 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "respectively"

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.278: These differences are remarkably consistent with the values of 0.05,1.5,and 24ng of -galactosidase obtained for these interactions in our study. 

Phrase: "These differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "are"

Phrase: "remarkably consistent with the values of 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "1.5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "24ng of -galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "obtained for these interactions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1301820:Obtained [Functional Concept]
   737   C1704675:Interaction [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "in our study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.279: Similarly, Estojak et al. 

Phrase: "Similarly,"

Phrase: "Estojak et al."
Processing 00000000.tx.280: (63) reported that high, intermediate, and low level interactions, determined in a semi-quantitative yeast 2-hybrid system, accurately reflected calculated Kd values (63). 

Phrase: "(63"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that high, intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205103:Intermediate [Spatial Concept]
   861   C1550465:intermediate [Idea or Concept]
   861   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "low level interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "determined in a semi-quantitative yeast 2-hybrid system,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   818   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
   818   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   764   C0522525:Semi-quantitative [Quantitative Concept]
   742   C0020205:Hybrid [Organism]
   742   C0036025:yeast [Fungus]
   742   C0043392:Yeast [Food]
   742   C0043393:Yeast [Fungus]
   742   C0392762:Quantitative [Quantitative Concept]
   742   C0449913:System [Functional Concept]
   742   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   742   C1553451:System [Manufactured Object]
   742   C1704459:System [Medical Device]

Phrase: "accurately"

Phrase: "reflected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflected [Mental Process]

Phrase: "calculated Kd values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0026691:KD [Disease or Syndrome]
   827   C0042295:Values [Qualitative Concept]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.281: Other yeast 2-hybrid analyses have shown that Id1 and the class B factors MyoD and Scl/Tal-1 bind to the class A factors E2-2 and E12 (43, 44). 

Phrase: "Other yeast 2-hybrid analyses"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   779   C0002778:Analysis [Laboratory Procedure]
   779   C0936012:Analysis [Research Activity]
   779   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "the class B factors MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1417574:MYOD [Gene or Genome]
   812   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Scl/Tal-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "bind to the class"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0456387:Class [Intellectual Product]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1705943:Class [Classification]

Phrase: "A factors E2-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1420639:E2-2 [Gene or Genome]
   827   C3539520:E2 [Gene or Genome]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "(43,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.282: Loveys et al. 

Phrase: "Loveys et al."
Processing 00000000.tx.283: (35) demonstrated the ability of Id3 to interact with E12, E47, HEB, and MyoD both in yeast and in vitro, observing that Id3 interacted strongly with each E protein but with reduced ability to MyoD (35). 

Phrase: "(35"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "the ability of Id3 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "interact with E12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1422634:E12 [Gene or Genome]

Phrase: "E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "HEB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420632:HEB [Gene or Genome]
  1000   C3273649:HEB [Gene or Genome]

Phrase: "and"

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "both in yeast"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0238767:Both [Spatial Concept]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "observing"

Phrase: "that Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "interacted"

Phrase: "strongly with each E protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but with reduced ability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0085732:Ability [Organism Attribute]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "to MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.284: They were also able to show that Id3 could repress E protein-mediated transcription from a multimerized immunoglobulin E box reporter. 

Phrase: "They"

Phrase: "were"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "could"

Phrase: "repress"

Phrase: "E protein-mediated transcription from a multimerized immunoglobulin E box reporter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.285: Id1 and Id2 bind at low levels to MyoD and very weakly, if at all, to Scl/Tal-1 as demonstrated by co-IP and glutathione S-transferase-pull down analysis (28, 34, 41). 

Phrase: "Id1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "and"

Phrase: "Id2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "bind at low levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205251:low [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "to MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "very weakly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442824:Very [Qualitative Concept]

Phrase: "if at all,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750557:If [Qualitative Concept]

Phrase: "to Scl/Tal-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "as"

Phrase: "demonstrated by co-IP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "glutathione S-transferase-pull down analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]

Phrase: "(28,"

Phrase: "34,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.286: Mammalian 2-hybrid approaches have also demonstrated the ability of Id1 to interact with both MyoD and E12 and of Scl/Tal-1 to interact with E47 (56, 64). 

Phrase: "Mammalian 2-hybrid approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449445:Approaches [Spatial Concept]
   812   C1292724:Approaches [Functional Concept]

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "the ability of Id1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "interact with both MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1417574:MYOD [Gene or Genome]
   770   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: "and of Scl/Tal-1 to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1428449:TAL [Gene or Genome]
   753   C1515981:And [Idea or Concept]

Phrase: "interact with E47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1336596:E47 [Gene or Genome]

Phrase: "(56,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.287: These reports concur with the general observation that class A-class B and Id-class A complexes are more stable than Id-class B complexes. 

Phrase: "These reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0684224:Reports [Intellectual Product]
  1000   C0700287:reports [Health Care Activity]
   966 E C3273238:Report [Intellectual Product]

Phrase: "concur with the general observation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0588388:General observation [Health Care Activity]
   760   C0205246:General [Spatial Concept]
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1553889:General [Idea or Concept]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "that class A-class B"

Phrase: "and"

Phrase: "Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "A complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "more stable than Id-class B complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.288: Our study not only confirms and extends previous reports of HLH protein dimerization potentials but attempts to provide a consistent comparison of a broad range of interactions. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "previous reports of HLH protein dimerization potentials"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0684224:Reports [Intellectual Product]
   748   C0700287:reports [Health Care Activity]
   714 E C3273238:Report [Intellectual Product]

Phrase: "but"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a consistent comparison of a broad range of interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]
Processing 00000000.tx.289: All three Id proteins tested here interacted strongly with all class A factors, consistent with their role in the sequestration of these ubiquitous proteins. 

Phrase: "All three Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "here"

Phrase: "interacted"

Phrase: "strongly with all class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "A factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "consistent with their role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in the sequestration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443301:Sequestration [Functional Concept]

Phrase: "of these ubiquitous proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.290: Although Id-class A interactions displayed the strongest and most consistent interactions among the series of factors tested, each Id nevertheless displayed a discrete "fingerprint" of preferred class A partner. 

Phrase: "Although"

Phrase: "Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "A interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "the strongest"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   966   C0442821:Strong [Qualitative Concept]
   916 E C0237897:Strength [Quantitative Concept]
   916 E C0808080:Strength [Idea or Concept]
   916 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "most consistent interactions among the series of factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1704675:Interaction [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "each Id nevertheless"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a discrete ""fingerprint"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016126:Fingerprint [Manufactured Object]

Phrase: "of preferred class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "A partner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0682323:Partner [Family Group]
Processing 00000000.tx.291: Specific patterns of Id-MRF interactions were also observed, although these interactions were considerably weaker and showed greater variability than those of Id-class A interactions. 

Phrase: "Specific patterns of Id-MRF interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "although"

Phrase: "these interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "considerably weaker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004093:Weak [Sign or Symptom]
   827   C1762617:Weak [Qualitative Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "greater variability than those of Id-class"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2827666:Variability [Conceptual Entity]

Phrase: "A interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.292: The finding that Id-MRF interactions were conserved, in contrast to Id-hematopoietic factor interactions, suggests that the Ids may have a role in myogenesis that is distinct from that in hematopoiesis. 

Phrase: "The finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that Id-MRF interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "conserved"

Phrase: ","

Phrase: "in contrast to Id-hematopoietic factor interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1704675:Interaction [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "have"

Phrase: "a role in myogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "distinct from that"

Phrase: "in hematopoiesis."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.293: Finally, the overlap in Id-class B and Id-class A interaction strengths provides additional reason to believe that the former may be physiologically relevant. 

Phrase: "Finally,"

Phrase: "the overlap in Id-class B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185027:overlap [Therapeutic or Preventive Procedure]
   753   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "Id-class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "A interaction strengths"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0808080:strengths [Idea or Concept]
   827 E C0237897:Strength [Quantitative Concept]
   827 E C1705922:Strength [Qualitative Concept]
   777 E C0442821:Strong [Qualitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "additional reason to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0392360:Reason [Idea or Concept]

Phrase: "believe"

Phrase: "that"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "physiologically relevant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.294: When the Ids were expressed as full-length proteins in vitro, or as HLH domains in human cells, the differences in relative affinities observed in yeast persisted (Figs. 3 and 4), indicating that the discrete range of interactions accurately reflects the in vivo situation and was not merely a consequence of the expression of mammalian genes in yeast. 

Phrase: "When"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "expressed as full-length proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443225:Full [Qualitative Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "or as HLH domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C0206678:HLH Domain [Spatial Concept]
   770   C0024291:HLH [Disease or Syndrome]
   737   C1880389:Domain [Functional Concept]
   737   C1883221:Domain [Conceptual Entity]
   737   C3541951:Domain [Intellectual Product]

Phrase: "in human cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0427861:Human cells [Laboratory or Test Result]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the differences in relative affinities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "observed in yeast"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0036025:yeast [Fungus]
   790   C0043392:Yeast [Food]
   790   C0043393:Yeast [Fungus]
   790   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "persisted"

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the discrete range of interactions accurately"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1514721:Range [Quantitative Concept]
   753   C2348147:Range [Quantitative Concept]
   753   C3542016:Range [Intellectual Product]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the in vivo situation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "was"

Phrase: "not merely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "a consequence of the expression of mammalian genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in yeast."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.295: Homodimerization of bHLH proteins seems to be important in certain contexts. 

Phrase: "Homodimerization of bHLH proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1512485:Homodimerization [Molecular Function]
   724   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important in certain contexts."
Processing 00000000.tx.296: For example, E47 homodimers are sufficient to activate immunoglobulin gene expression (65). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "E47 homodimers"

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "immunoglobulin gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0017350:Immunoglobulin gene [Gene or Genome]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.297: MyoD is also capable of binding DNA as a homodimer, although it has not been established if this is biologically significant as the concentrations required for homodimerization in vitro may not be achievable in vivo (8). 

Phrase: "MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "is"

Phrase: "also capable of binding DNA"

Phrase: "as a homodimer,"

Phrase: "although"

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "if"

Phrase: "this"

Phrase: "is"

Phrase: "biologically significant as the concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "required for homodimerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1512485:Homodimerization [Molecular Function]
   790   C1514873:Required [Functional Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "achievable in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.298: On the other hand, it is conceivable that apparently weak interactions are stabilized by accessory factors or that low concentrations of MyoD homodimers are sufficient to initiate the myogenic cascade, and this may be sensitive to direct Id-mediated suppression. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that apparently weak interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "stabilized by accessory factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0184512:Stabilized [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "or"

Phrase: "that low concentrations of MyoD homodimers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "are"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "the myogenic cascade,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707310:Cascade [Manufactured Object]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "be"

Phrase: "sensitive to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332324:Sensitive to [Functional Concept]
           Sensitive
   861   C1550474:sensitive [Idea or Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "Id-mediated suppression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0221103:Suppression [Pathologic Function]
   827   C0301625:Suppression [Organism Function]
   827   C0439181:% suppression [Quantitative Concept]
   827   C0728721:suppression [Mental Process]
Processing 00000000.tx.299: Therefore, cell fate determination may in part depend on the relative level of distinct Id proteins to create a permissive environment. 

Phrase: "Therefore,"

Phrase: "cell fate determination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1160037:cell fate determination [Cell Function]
   827   C1148554:determination [Laboratory Procedure]
   734   C1540661:cell fate [Cell Function]

Phrase: "may in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "depend on the relative level of distinct Id proteins to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0080103:Relative [Family Group]
   739   C0205345:Relative [Qualitative Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C0600091:ID [Intellectual Product]
   739   C0725813:depend [Medical Device]
   739   C1547039:*Relative [Quantitative Concept]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a permissive environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.300: Interestingly, our observations indicate that the Ids bind with the highest affinity those myogenic factors involved in myoblast lineage determination (MyoD and Myf-5), whereas those MRFs active post-mitotically (myogenin and MRF4/Myf-6), a time when Id levels are generally low or undetectable, bind Ids considerably less well. 

Phrase: "Interestingly,"

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "bind with the highest affinity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "those myogenic factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in myoblast lineage determination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0596995:Myoblast [Cell]
   760   C1148554:determination [Laboratory Procedure]
   760   C1314939:Involved [Functional Concept]
   760   C1881379:Lineage [Conceptual Entity]

Phrase: "(MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: "and"

Phrase: "Myf-5"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "those MRFs active post-mitotically"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0220905:regulatory [Regulation or Law]
   799   C1704735:Regulatory [Conceptual Entity]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]

Phrase: "(myogenin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1417575:MYOGENIN [Gene or Genome]
  1000   C2986638:MYOGENIN [Gene or Genome]

Phrase: "and"

Phrase: "MRF4/Myf-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "a time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "when"

Phrase: "Id levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "generally low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "undetectable,"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Ids considerably less well."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205170:Well [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]
   729   C1517604:idic [Cell or Molecular Dysfunction]
Processing 00000000.tx.301: The differential affinities of the Id proteins for both the class A and class B MRFs could be explained if these latter proteins homodimerized. 

Phrase: "The differential affinities of the Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for both"

Phrase: "the class A"

Phrase: "and"

Phrase: "class B MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "could"

Phrase: "be"

Phrase: "explained"

Phrase: "if"

Phrase: "these latter proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homodimerized."
Processing 00000000.tx.302: Under such conditions, there might exist a differential availability of E proteins or MRFs for Ids due to their sequestration in homodimeric form. 

Phrase: "Under such conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "there"

Phrase: "might"

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "a differential availability of E proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "or"

Phrase: "MRFs for Ids"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0220905:regulatory [Regulation or Law]
   760   C1704735:Regulatory [Conceptual Entity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "due to their sequestration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443301:Sequestration [Functional Concept]

Phrase: "in homodimeric form."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]
Processing 00000000.tx.303: In other experiments, we have examined the ability of the Ids, the E proteins, and the class B MRFs and hematopoietic factors to homodimerize using the same two-hybrid system shown in Fig. 

Phrase: "In other experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of the Ids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "the E proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the class B MRFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0206474:Myogenic Regulatory Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0220905:regulatory [Regulation or Law]
   804   C1704735:Regulatory [Conceptual Entity]
   771   C1521761:Factor [Functional Concept]
   771   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "hematopoietic factors to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0312859:Haematopoietic factor [Hormone]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "homodimerize"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same two-hybrid system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.304: 1.3 We detected homodimerization only with E47, although at levels that were 10-30-fold lower than its interaction with any of the three Ids. 

Phrase: "1.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "We"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "homodimerization only with E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512485:Homodimerization [Molecular Function]

Phrase: "although at levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "10-30-fold lower than its interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "with any"

Phrase: "of the three Ids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]
Processing 00000000.tx.305: Thus, limitation of E protein accessibility to the Ids due to homodimeric sequestration appears unable to explain our results. 

Phrase: "Thus,"

Phrase: "limitation of E protein accessibility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449295:Limitation [Functional Concept]

Phrase: "to the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "due to homodimeric sequestration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443301:Sequestration [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "explain"

Phrase: "our results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.306: Having demonstrated that Id proteins bind each class A molecule and a subset of class B molecules, we tested the ability of each Id to suppress transactivation from a muscle-specific E box by an E2AMyoD complex in vivo (Fig. 5). 

Phrase: "Having"

Phrase: "demonstrated"

Phrase: "that Id proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2945730:id proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "each class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "a subset of class B molecules,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of each Id to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "transactivation from a muscle-specific E box"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040624:Transactivation [Genetic Function]

Phrase: "by an E2AMyoD complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.307: Id1, Id2, and Id3 were found to disrupt E2AMyoD complexes with comparable ability, consistent with the yeast data. 

Phrase: "Id1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "Id2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0123156:ID2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334077:ID2 [Gene or Genome]

Phrase: "and"

Phrase: "Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "E2AMyoD complexes with comparable ability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "consistent with the yeast data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.308: Interestingly, an apparent excess of Id was unable to completely abrogate binding. 

Phrase: "Interestingly,"

Phrase: "an apparent excess of Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1979886:Excess [Qualitative Concept]

Phrase: "was"

Phrase: "unable to completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205197:Completely [Qualitative Concept]
   827   C1299582:Unable [Finding]

Phrase: "abrogate"

Phrase: "binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]
Processing 00000000.tx.309: Other studies on the effect of Id1 or Id3 on the transactivation potential of MyoD or E proteins have also reported a less than complete suppression of activity, with even greater excesses of Id than we have utilized (28, 35). 

Phrase: "Other studies on the effect of Id1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "or"

Phrase: "Id3 on the transactivation potential of MyoD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1415856:ID3 [Gene or Genome]

Phrase: "or"

Phrase: "E proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a less than complete suppression of activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0205177:Activity [Functional Concept]
   748   C0205197:Complete [Qualitative Concept]
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439167:% activity [Quantitative Concept]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0725685:COMPLEAT [Food]
   748   C0728721:suppression [Mental Process]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "with even greater excesses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1979886:Excess [Qualitative Concept]

Phrase: "of Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600091:ID [Intellectual Product]

Phrase: "than we"

Phrase: "have"

Phrase: "utilized"

Phrase: "(28,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.310: Investigation of the activity of any transcription factor in isolation is complicated by the influence of endogenous factors. 

Phrase: "Investigation of the activity of any transcription factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1261322:Investigation [Health Care Activity]
   744   C1552578:investigation [Idea or Concept]

Phrase: "in isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "is"

Phrase: "complicated by the influence of endogenous factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1516853:Endogenous Factors [Functional Concept]
   774   C0814287:factors influence [Clinical Attribute]
   748   C0205227:Endogenous [Functional Concept]
   748   C0231242:Complicated [Functional Concept]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.311: Having established conditions in which each factor alone results in minimal transactivation, we can be certain that the repressive effect of the Ids is exerted only on the factors under study. 

Phrase: "Having"

Phrase: "established conditions in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "each factor alone results in minimal transactivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "we"

Phrase: "can"

Phrase: "be"

Phrase: "certain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205423:Certain [Qualitative Concept]
  1000   C1704787:Certain [Qualitative Concept]
   928 E C0439543:Certainties [Qualitative Concept]

Phrase: "that"

Phrase: "the repressive effect of the Ids"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "exerted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Exerted [Organism Function]

Phrase: "only on the factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "under study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.312: The observation that the Ids differed in their ability to recognize myogenic partners led us to investigate the precise residues responsible for this specificity (Fig. 6). 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the Ids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C1517604:idic [Cell or Molecular Dysfunction]

Phrase: "differed in their ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "recognize"

Phrase: "myogenic partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:partners [Family Group]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the precise residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "responsible for this specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.313: Dimeric bHLH complexes bound to DNA are predicted to form a parallel 4-helix bundle stabilized by a hydrophobic core as well as by electrostatic interactions (2, 8, 62). 

Phrase: "Dimeric bHLH complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C1704241:Complexes [Chemical Viewed Structurally]
   766 E C0439855:Complex [Qualitative Concept]

Phrase: "bound to DNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a parallel 4-helix bundle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0018882:Helix [Eukaryote]
   812   C0229304:Helix [Body Part, Organ, or Organ Component]
   812   C1704821:Helix [Spatial Concept]
   812   C1705682:Helix [Anatomical Structure]

Phrase: "stabilized by a hydrophobic core"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0184512:Stabilized [Qualitative Concept]
   760   C0444669:Core [Spatial Concept]
   760   C0598629:Hydrophobic [Qualitative Concept]
   760   C1167518:core [Cell Component]
   760   C1706352:Core [Medical Device]
   760   C1882467:Core [Manufactured Object]
   760   C3274653:Core [Body Substance]

Phrase: "as well as by electrostatic interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C0376534:electrostatic [Natural Phenomenon or Process]
   753   C3146287:Well [Manufactured Object]
   719   C1704675:Interaction [Functional Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "8,"

Phrase: "62"

Phrase: ")."
Processing 00000000.tx.314: Shirakata et al. 

Phrase: "Shirakata et al."
Processing 00000000.tx.315: (62) reported that the alteration of five non-hydrophobic residues distinguishing chicken MyoD from the Drosophila MyoD homologue nautilus (which does not bind E12) led to a progressive reduction in MyoDE12 dimer formation, suggesting that these residues confer an additive effect on binding (62). 

Phrase: "(62"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the alteration of five non-hydrophobic residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]

Phrase: "distinguishing"

Phrase: "chicken MyoD from the Drosophila MyoD homologue nautilus"

Phrase: "("

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "E12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422634:E12 [Gene or Genome]

Phrase: ")"

Phrase: "led to a progressive reduction"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0205329:Progressive [Functional Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in MyoDE12 dimer formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "confer"

Phrase: "an additive effect on binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442796:Additive [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1550602:Additive [Substance]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.316: Likewise, in our study, no single residue was able to confer Id1-like characteristics. 

Phrase: "Likewise,"

Phrase: "in our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "no single residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "confer"

Phrase: "Id1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415855:ID1 [Gene or Genome]

Phrase: "like characteristics."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.317: Rather a combination of non-conserved residues was involved in MRF binding. 

Phrase: "Rather"

Phrase: "a combination of non-conserved residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "was"

Phrase: "involved in MRF binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1623505:MRF binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C0312443:MRF [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1314939:Involved [Functional Concept]
   770   C1412879:MRF [Gene or Genome]
Processing 00000000.tx.318: However, these residues did not appear to be important for Id-class A interaction (Fig. 6). 

Phrase: "However,"

Phrase: "these residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important for Id-class"

Phrase: "A interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.319: Two non-conserved residues in the first helix were sufficient for almost complete MyoD binding. 

Phrase: "Two non-conserved residues in the first helix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "sufficient for almost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "MyoD binding."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1660007:MyoD binding [Genetic Function]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.320: These residues, Tyr-88 and Gly-92 of Id1, are uncharged, whereas the corresponding residues of Id3 (Asp-42 and His-46) confer a negative and positive charge, respectively. 

Phrase: "These residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "Tyr-88"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: "and"

Phrase: "Gly-92 of Id1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017890:Gly [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1415855:ID1 [Gene or Genome]

Phrase: "are"

Phrase: "uncharged,"

Phrase: "whereas"

Phrase: "the corresponding residues of Id3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Asp-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0206293:Asp [Reptile]
   861   C3541260:ASP [Gene or Genome]

Phrase: "and"

Phrase: "His-46"

Phrase: ")"

Phrase: "confer"

Phrase: "a negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "positive charge,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2825490:Positive Charge [Qualitative Concept]
   861   C0007961:Charge [Quantitative Concept]
   861   C1706211:Charge [Organism Attribute]

Phrase: "respectively."
Processing 00000000.tx.321: Thus, the differences in Id binding (with respect to MyoD) may be consistent with the "charged pair" model which suggests that attractive or repulsive forces between contacting residues in the helices of aligned molecules act to stabilize or destabilize dimer formation (62). 

Phrase: "Thus,"

Phrase: "the differences in Id binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "("

Phrase: "with respect to MyoD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417574:MYOD [Gene or Genome]
  1000   C2985443:MYOD [Gene or Genome]

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "consistent with the """
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "pair"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: """ model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that attractive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346874:Attractive [Qualitative Concept]

Phrase: "or"

Phrase: "repulsive forces between contacting residues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441722:forces [Phenomenon or Process]
   726 E C0563538:Force [Phenomenon or Process]

Phrase: "in the helices"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1017315:helices [Eukaryote]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "of aligned molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "or"

Phrase: "destabilize"

Phrase: "dimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.322: The residue at the third position also influences heterodimerization even though this represents a conservative change (Lys-98 in Id1 to Arg-52 in Id3). 

Phrase: "The residue at the third position also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "influences"

Phrase: "heterodimerization even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512424:Heterodimerization [Molecular Function]

Phrase: "though"

Phrase: "this"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a conservative change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "(Lys-98 in Id1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1415855:ID1 [Gene or Genome]

Phrase: "to Arg-52"

Phrase: "in Id3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415856:ID3 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.323: In this case, the larger arginine side chain may act to destabilize Id3MRF complexes. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the larger arginine side chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:Chain [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chain [Idea or Concept]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "destabilize"

Phrase: "Id3MRF complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.324: Despite the obvious importance of these residues, the complete conversion of Id3 helix 1to that of Id1 helix 1restored only 50% Myf-5 binding and only minimal interaction with myogenin and MRF4/Myf-6, suggesting that additional residues exert an effect. 

Phrase: "Despite the obvious importance"

Phrase: "of these residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "the complete conversion of Id3 helix 1to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439836:Conversion [Functional Concept]

Phrase: "that of Id1 helix 1restored only 50% Myf-5 binding"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0018882:Helix [Eukaryote]
   739   C0205171:Only [Quantitative Concept]
   739   C0229304:Helix [Body Part, Organ, or Organ Component]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1415855:ID1 [Gene or Genome]
   739   C1704821:Helix [Spatial Concept]
   739   C1705682:Helix [Anatomical Structure]
   739   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "only minimal interaction with myogenin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "MRF4/Myf-6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that additional residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "an effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.325: Indeed, a series of amino-terminal deletions (Fig. 6, lines 13 and 14) demonstrated that a region outside the HLH domain was important for Id1-MRF interactions, particularly with respect to myogenin and MRF4/Myf-6. 

Phrase: "Indeed,"

Phrase: "a series of amino-terminal deletions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lines 13"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "14"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the HLH domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206678:HLH Domain [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "important for Id1-MRF interactions,"

Phrase: "particularly with respect to myogenin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0679133:respect [Social Behavior]
   760   C1417575:MYOGENIN [Gene or Genome]
   760   C2986638:MYOGENIN [Gene or Genome]

Phrase: "and"

Phrase: "MRF4/Myf-6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0083504:Myf-6 [Amino Acid, Peptide, or Protein]
           MRF4
   827   C1417533:MRF4 [Gene or Genome]
Processing 00000000.tx.326: Interestingly, these deletions did not appear to influence E12 binding. 

Phrase: "Interestingly,"

Phrase: "these deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "E12 binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
Processing 00000000.tx.327: Upstream sequences may not be involved in establishing dimeric complexes as such, but rather in stabilizing pre-formed interactions determined by residues in the HLH region. 

Phrase: "Upstream sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "involved in establishing dimeric complexes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0443211:establishing [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "as such,"

Phrase: "but"

Phrase: "rather in stabilizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0184512:stabilizing [Qualitative Concept]

Phrase: "pre-formed"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0205431:Formed [Functional Concept]
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]
   827 E C0348078:Form [Qualitative Concept]
   827 E C0376315:Form [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "determined by residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1709915:Residue [Conceptual Entity]
   756   C1882936:RESIDUE [Phenomenon or Process]
   706 E C1609982:Residual [Qualitative Concept]

Phrase: "in the HLH region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.328: Such subtle cooperative effects might be expected to contribute more to weak Id-myogenin or Id-MRF4/Myf-6 interactions than to stronger associations. 

Phrase: "Such subtle cooperative effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "more to weak Id-myogenin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0004093:Weak [Sign or Symptom]
   760   C0067053:Myogenin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205172:More [Functional Concept]
   760   C0600091:ID [Intellectual Product]
   760   C1417575:MYOGENIN [Gene or Genome]
   760   C1762617:Weak [Qualitative Concept]
   760   C2986638:MYOGENIN [Gene or Genome]

Phrase: "or"

Phrase: "Id-MRF4/Myf-6 interactions than to stronger associations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.329: Goldfarb et al. 

Phrase: "Goldfarb et al."
Processing 00000000.tx.330: (43) used random mutagenesis in conjunction with a yeast 2-hybrid system to generate both hydrophobic and hydrophilic substitutions which enhanced the ability of Scl/Tal-1 to recognize E2-2 (43). 

Phrase: "(43"

Phrase: ")"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "random mutagenesis in conjunction with a yeast 2-hybrid system to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079866:Mutagenesis [Molecular Function]
   738   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "generate"

Phrase: "both hydrophobic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598629:Hydrophobic [Qualitative Concept]

Phrase: "and"

Phrase: "hydrophilic substitutions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "which"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the ability of Scl/Tal-1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "recognize"

Phrase: "E2-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420639:E2-2 [Gene or Genome]
   861   C3539520:E2 [Gene or Genome]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.331: Such alterations were again found to have a synergistic effect on dimer stability. 

Phrase: "Such alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "again"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a synergistic effect on dimer stability."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   753   C2986495:Synergistic [Qualitative Concept]
Processing 00000000.tx.332: More extensive mutagenesis is required to fully understand the diversity of dimer preferences displayed by HLH factors. 

Phrase: "More extensive mutagenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079866:Mutagenesis [Molecular Function]
   827   C3146302:Mutagenesis [Laboratory Procedure]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the diversity of dimer preferences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880371:Diversity [Qualitative Concept]

Phrase: "displayed by HLH factors."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0024291:HLH [Disease or Syndrome]
   770   C0870432:displayed [Functional Concept]
   737   C1521761:Factor [Functional Concept]
   737 E C1705417:Display [Manufactured Object]
   737   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.333: The quantitative yeast 2-hybrid system described in this report provides a useful tool for this purpose. 

Phrase: "The quantitative yeast 2-hybrid system"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   937   C0599647:Yeast Two Hybrid System [Molecular Biology Research Technique]
   937   C1961118:Yeast Two-Hybrid System [Molecular Biology Research Technique]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0449913:System [Functional Concept]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "described in this report"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1552738:described [Idea or Concept]
   770   C3273238:Report [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a useful tool for this purpose."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0336791:Tool [Manufactured Object]
   753   C2827396:Tool [Manufactured Object]
   748   C0871532:tool use [Finding]
Processing 00000000.tx.334: Regions other than the HLH domain, such as the putative leucine zipper present in the class A proteins, have the potential to modulate interactions (1, 11, 12). 

Phrase: "Regions other than the HLH domain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "such as the putative leucine zipper present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0150312:Present [Quantitative Concept]
   812   C0449450:Present [Idea or Concept]

Phrase: "in the class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.335: Because our co-IP findings with full-length proteins are consistent with both our yeast and mammalian 2-hybrid results, we infer that other potential dimerization domains do not contribute significantly to the interactions observed here. 

Phrase: "Because"

Phrase: "our co-IP findings with full-length proteins"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C2607943:findings [Functional Concept]
   744   C2926606:Findings [Clinical Attribute]
   744   C3539655:Findings [Intellectual Product]
   711 E C0037088:Finding [Sign or Symptom]
   711 E C0243095:Finding [Finding]
   711 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with both"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "our yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "mammalian 2-hybrid results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1274040:Result [Functional Concept]
   779   C1546471:Result [Idea or Concept]
   779   C2825142:Result [Finding]

Phrase: "we"

Phrase: "infer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "that"

Phrase: "other potential dimerization domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "significantly to the interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "here."
Processing 00000000.tx.336: However, we have not evaluated the possible influence of post-translational modifications on dimerization (47, 59, 66, 67). 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the possible influence of post-translational modifications"

Phrase: "on dimerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "(47,"

Phrase: "59,"

Phrase: "66,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.337: Although HLH activity may be modulated in vivo, the key differences in binding characteristics presented in this study may play a fundamental role in the establishment of differentiation programs. 

Phrase: "Although"

Phrase: "HLH activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "modulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulated [Spatial Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "the key differences in binding characteristics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "presented in this study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0449450:Presented [Idea or Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a fundamental role in the establishment of differentiation programs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.338: There still exists, however, a great deal of redundancy. 

Phrase: "There still"

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "however,"

Phrase: "a great deal of redundancy."
Processing 00000000.tx.339: One apparent paradox is that there is little evidence, as yet, for the combinatorial variation in E box binding allowed by heterodimerization between different class B groups and any class A factor. 

Phrase: "One apparent paradox"

Phrase: "is"

Phrase: "that there"

Phrase: "is"

Phrase: "little evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "as yet,"

Phrase: "for the combinatorial variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variation [Qualitative Concept]

Phrase: "in E box binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2753969:E-box binding [Genetic Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "allowed by heterodimerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683607:allowed [Social Behavior]
   790   C1512424:Heterodimerization [Molecular Function]

Phrase: "between different class B groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "any class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "A factor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.340: For example, all class AMRF dimers so far studied efficiently bind an element in the muscle creatine kinase enhancer, and binding site selection indicates that Scl/Tal-1, Tal-2 and Lyl-1 heterodimers with E2-2 all recognize the same putative hematopoietic-specific element (68, 69). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "all class AMRF dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "so"

Phrase: "far"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "efficiently"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "an element in the muscle creatine kinase enhancer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0014290:Enhancer Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0013879:Element [Element, Ion, or Isotope]
   744   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "binding site selection"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0036576:selection [Genetic Function]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "indicates"

Phrase: "that Scl/Tal-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1428449:TAL [Gene or Genome]

Phrase: "Tal-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1447263:TAL-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1428449:TAL [Gene or Genome]

Phrase: "and"

Phrase: "Lyl-1 heterodimers with E2-2"

Phrase: "all"

Phrase: "recognize"

Phrase: "the same putative hematopoietic-specific element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C1705248:Element [Conceptual Entity]

Phrase: "(68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.341: Spatial and temporal differences in the expression of factors with apparently conserved function may also explain some of the apparent overlap. 

Phrase: "Spatial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1428114:spatial [Gene or Genome]

Phrase: "and"

Phrase: "temporal differences in the expression of factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "with apparently conserved function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "also"

Phrase: "explain"

Phrase: "some of the apparent overlap."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0185027:overlap [Therapeutic or Preventive Procedure]
   760   C0205392:Some [Quantitative Concept]
   760   C0750489:apparent [Idea or Concept]
   760   C1948020:Overlap [Conceptual Entity]
   760   C3540770:Some [Intellectual Product]
Processing 00000000.tx.342: Alternatively, redundancy may reflect the need for cooperative occupancy of proximal promoter elements by accessory factors. 

Phrase: "Alternatively,"

Phrase: "redundancy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1313915:Redundancy [Functional Concept]
   928 E C0425087:Redundant [Finding]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the need for cooperative occupancy of proximal promoter elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0027552:Need [Qualitative Concept]
   742   C0686904:need [Functional Concept]

Phrase: "by accessory factors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.343: A distinct group of tissue-restricted non-bHLH transcription factors have been identified, such as the myocyte enhancer family (MEF-2) in muscle and the zinc finger GATA factors in erythropoiesis (70, 71). 

Phrase: "A distinct group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of tissue-restricted non-bHLH transcription factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0288972:Basic Helix-Loop-Helix Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   874   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   874   C1333522:TISSUE FACTOR [Gene or Genome]
   807   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0040649:Transcription [Genetic Function]
   758   C1521761:Factor [Functional Concept]
   758   C2827422:Factor [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "such as the myocyte enhancer family (MEF-2)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "in muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the zinc finger GATA factors in erythropoiesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1564871:GATA Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "(70,"

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.344: These may act to enhance the transcriptional activity of bHLH dimers, thereby modulating lineage-specific gene expression. 

Phrase: "These"

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the transcriptional activity of bHLH dimers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "thereby"

Phrase: "modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "lineage-specific gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0017262:Gene Expression [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.345: Indeed, the apparent redundancy in function may mask the requirement for a subtle gradient of both ubiquitous and tissue-specific factors to facilitate the controlled establishment of the differentiated phenotype. 

Phrase: "Indeed,"

Phrase: "the apparent redundancy in function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1313915:Redundancy [Functional Concept]

Phrase: "may"

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "the requirement for a subtle gradient of both ubiquitous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "tissue-specific factors to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C1333522:TISSUE FACTOR [Gene or Genome]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "facilitate"

Phrase: "the controlled establishment of the differentiated phenotype."
Processing 00000000.tx.346: FOOTNOTES * This work was supported by National Institutes of Health Grant HL33741 (to E.V.P.).

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grant HL33741"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to E.V.P."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1535597:v p [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.347: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.348: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.349: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.350: To whom correspondence should be addressed: Section of Hematology/Oncology, Children's Hospital Medical Center, 3705Fifth Ave., Pittsburgh, PA 15213.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Section of Hematology/Oncology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205155:Section [Spatial Concept]
   770   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   770   C1522472:Section [Substance]
   770   C1552923:Section [Quantitative Concept]
   770   C1705191:Section [Physical Object]

Phrase: "Children's Hospital Medical Center,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0020017:Children's hospital [Health Care Related Organization]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0008059:Children [Age Group]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]
   812   C0680063:Children [Family Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "3705Fifth Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Pittsburgh,"

Phrase: "PA 15213.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.351: 412-692-6796; 

Phrase: "412-692-6796"

Phrase: ";"
Processing 00000000.tx.352: Fax: 412-692-5723. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "412-692-5723."
Processing 00000000.tx.353: 1 The abbreviations used are: bHLH, basic-helix-loop-helix; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "bHLH,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0282642:helix loop helix [Spatial Concept]
   812   C0018882:Helix [Eukaryote]
   812   C0229304:Helix [Body Part, Organ, or Organ Component]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   812   C1527178:Basic [Functional Concept]
   812   C1704821:Helix [Spatial Concept]
   812   C1705682:Helix [Anatomical Structure]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "basic-helix-loop-helix"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   923   C0282642:helix loop helix [Spatial Concept]
   812   C0018882:Helix [Eukaryote]
   812   C0229304:Helix [Body Part, Organ, or Organ Component]
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]
   812   C1527178:Basic [Functional Concept]
   812   C1704821:Helix [Spatial Concept]
   812   C1705682:Helix [Anatomical Structure]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.354: CAT, chloramphenicol acetyltransferase; 

Phrase: "CAT,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   805 E C0591251:Chloromycetin [Organic Chemical,Pharmacologic Substance]
   805 E C0699303:Ophthochlor [Organic Chemical,Pharmacologic Substance]

Phrase: "chloramphenicol acetyltransferase"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0008169:Chloramphenicol Acetyl Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008168:Chloramphenicol [Antibiotic,Organic Chemical]
   805 E C0591251:Chloromycetin [Organic Chemical,Pharmacologic Substance]
   805 E C0699303:Ophthochlor [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.355: MCK, muscle creatinine kinase; 

Phrase: "MCK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "muscle creatinine kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.356: MRF, myogenic regulatory factor; 

Phrase: "MRF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0312443:MRF [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1412879:MRF [Gene or Genome]

Phrase: "myogenic regulatory factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0220905:regulatory [Regulation or Law]
   827   C1521761:Factor [Functional Concept]
   827   C1704735:Regulatory [Conceptual Entity]
   827   C2827422:Factor [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.357: IP, immunoprecipitation; 

Phrase: "IP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.358: DMEM, Dulbecco's modified Eagle's medium; 

Phrase: "DMEM,"

Phrase: "Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagle [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1551720:Eagle [Population Group]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.359: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.360: PCR, polymerase chain reaction; 

Phrase: "PCR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.361: CMV, cytomegalovirus. 

Phrase: "CMV,"

Phrase: "cytomegalovirus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010825:Cytomegalovirus [Virus]
Processing 00000000.tx.362: 2 K. 

Phrase: "2 K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.363: Langlands, X.Yin, G.Anand, and E.V.

Phrase: "Langlands,"

Phrase: "X.Yin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2945618:yin [Idea or Concept]

Phrase: "G.Anand,"

Phrase: "and"

Phrase: "E.V."
Processing 00000000.tx.364: Prochownik, unpublished data. 

Phrase: "Prochownik,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.365: 3 K. 

Phrase: "3 K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.366: Langlands and E.V.

Phrase: "Langlands"

Phrase: "and"

Phrase: "E.V."
Processing 00000000.tx.367: Prochownik, unpublished data. 

Phrase: "Prochownik,"

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.368: ACKNOWLEDGEMENTS We thank members of our laboratory for helpful discussions and advice and Geneva Jordan for skilled secretarial assistance. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "members of our laboratory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "for helpful discussions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150600:Advice [Health Care Activity]

Phrase: "and"

Phrase: "Geneva Jordan for skilled secretarial assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0022418:Jordan [Geographic Area]
Processing 00000000.tx.369: REFERENCES Murre, C., McCaw, P. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McCaw,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.370: S., and Baltimore, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.371: (1989) Cell 56, 777-783 [Medline] [OrderarticleviaInfotrieve] Ellenberger, T., Fass, D., Arnaud, M., and Harrison, S. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 56,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "777-783"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ellenberger,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fass,"

Phrase: "D."

Phrase: ","

Phrase: "Arnaud,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Harrison,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.372: C. 

Phrase: "C."
Processing 00000000.tx.373: (1994) Genes Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.374: 8, 970-980 [Abstract] Ferr-D'Amar, A. 

Phrase: "8,"

Phrase: "970-980"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ferr-"

Phrase: "D'"

Phrase: "Amar,"

Phrase: "A."
Processing 00000000.tx.375: R., Prendergast, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Prendergast,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.376: C., Ziff, E. 

Phrase: "C., Ziff,"

Phrase: "E."
Processing 00000000.tx.377: B., and Burley, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Burley,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.378: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.379: (1993) Nature 363, 38-45 [CrossRef][Medline] [OrderarticleviaInfotrieve] Ma, P. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Nature 363,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "38-45"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ma,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.380: C.M., Rould, M. 

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Rould,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.381: A., Weintraub, H., and Pabo, C. 

Phrase: "A.,"

Phrase: "Weintraub,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Pabo,"

Phrase: "C."
Processing 00000000.tx.382: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.383: (1994) Cell 77, 451-459 [Medline] [OrderarticleviaInfotrieve] Voronova, A., and Baltimore, D. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 77,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "451-459"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Voronova,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.384: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.385: Natl. 

Phrase: "Natl."
Processing 00000000.tx.386: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.387: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.388: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.389: 87, 4722-4726 [Abstract] Murre, C., McCaw, P. 

Phrase: "87,"

Phrase: "4722-4726"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McCaw,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.390: S., Vaessin, H., Caudy, M., Jan, L. 

Phrase: "S."

Phrase: ","

Phrase: "Vaessin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Caudy,"

Phrase: "M."

Phrase: ","

Phrase: "Jan,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.391: Y., Jan, Y. 

Phrase: "Y.,"

Phrase: "Jan,"

Phrase: "Y."
Processing 00000000.tx.392: N., Cabrera, C. 

Phrase: "N., Cabrera,"

Phrase: "C."
Processing 00000000.tx.393: V., Buskin, J. 

Phrase: "V., Buskin,"

Phrase: "J."
Processing 00000000.tx.394: N., Hauschka, S. 

Phrase: "N., Hauschka,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.395: D., Lassar, A. 

Phrase: "D."

Phrase: ","

Phrase: "Lassar,"

Phrase: "A."
Processing 00000000.tx.396: B., Weintraub, H., and Baltimore, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Weintraub,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.397: (1989) Cell 58, 537-544 [Medline] [OrderarticleviaInfotrieve] Blackwell, T. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 58,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "537-544"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Blackwell,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.398: K., and Weintraub, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.399: (1990) Science 250, 1104-1110 [Medline] [OrderarticleviaInfotrieve] Davis, R. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 250,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1104-1110"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.400: L., Cheng, P.-F., Lassar, A. 

Phrase: "L., Cheng,"

Phrase: "P.-F.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Lassar,"

Phrase: "A."
Processing 00000000.tx.401: B., and Weintraub, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.402: (1990) Cell 60, 733-746 [Medline] [OrderarticleviaInfotrieve] Ephrussi, A., Church, G. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cell 60,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "733-746"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ephrussi,"

Phrase: "A.,"

Phrase: "Church,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562324:Church [Manufactured Object]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.403: H., Tonegawa, S., and Gilbert, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tonegawa,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "W."
Processing 00000000.tx.404: (1985) Science 227, 134-140 [Medline] [OrderarticleviaInfotrieve] Murre, C., and Baltimore, D. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Science 227,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "134-140"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.405: (1992) in Transcriptional Regulation (Mcknight, S. L., and Yamamoto, K. R., eds), pp. 

Phrase: "(1992"

Phrase: ")"

Phrase: "in Transcriptional Regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "(Mcknight,"

Phrase: "S. L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439394:s l [Quantitative Concept]

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K. R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.406: 861-879, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY Henthorn, P., Kiledjian, M., and Kadesch, T. 

Phrase: "861-879,"

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Henthorn,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kiledjian,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.407: (1990) Science 247, 467-470 [Medline] [OrderarticleviaInfotrieve] Hu, J.-S, Olson, E. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Science 247,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "467-470"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hu,"

Phrase: "J.-S,"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.408: N., and Kingston, R. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kingston,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.409: E. 

Phrase: "E."
Processing 00000000.tx.410: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.411: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.412: Biol. 

Phrase: "Biol."
Processing 00000000.tx.413: 12, 1031-1042 [Abstract] Lassar, A. 

Phrase: "12,"

Phrase: "1031-1042"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lassar,"

Phrase: "A."
Processing 00000000.tx.414: B., Davis, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.415: L., Wright, W. 

Phrase: "L., Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "W."
Processing 00000000.tx.416: E., Kadesch, T., Murre, C., Voronova, A., Baltimore, D., and Weintraub, H. 

Phrase: "E.,"

Phrase: "Kadesch,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Murre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1081327:Murre, NOS [Bird]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Voronova,"

Phrase: "A.,"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.417: (1991) Cell 66, 305-315 [Medline] [OrderarticleviaInfotrieve] Begley, C. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell 66,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "305-315"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Begley,"

Phrase: "C."
Processing 00000000.tx.418: G., Aplan, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aplan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.419: D., Denning, S. 

Phrase: "D."

Phrase: ","

Phrase: "Denning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178587:DEN [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: M., Haynes, B. 

Phrase: "M."

Phrase: ","

Phrase: "Haynes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.421: F., Waldmann, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Waldmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.422: A., and Kirsch, I. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kirsch,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.423: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.425: Natl. 

Phrase: "Natl."
Processing 00000000.tx.426: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.427: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.428: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.429: 86, 10128-10132 [Abstract] Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E., and Arnold, H. 

Phrase: "86,"

Phrase: "10128-10132"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Braun,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Buschhausen-Denker,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bober,"

Phrase: "E.,"

Phrase: "Tannich,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Arnold,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.430: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: (1989) EMBO J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.432: 8, 701-709 [Abstract] Braun, T., Bober, E., Winter, N., Rosenthal, N., and Arnold, H. 

Phrase: "8,"

Phrase: "701-709"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Braun,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bober,"

Phrase: "E.,"

Phrase: "Winter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241737:Winter [Temporal Concept]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rosenthal,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Arnold,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.433: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.434: (1990) EMBO J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.435: 9, 821-831 [Abstract] Davis, R. 

Phrase: "9,"

Phrase: "821-831"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.436: L., Weintraub, H., and Lassar, A. 

Phrase: "L., Weintraub,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lassar,"

Phrase: "A."
Processing 00000000.tx.437: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.438: (1987) Cell 51, 987-1000 [Medline] [OrderarticleviaInfotrieve] Edmonson, D. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Cell 51,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "987-1000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Edmonson,"

Phrase: "D."
Processing 00000000.tx.439: G., and Olson, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.440: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.441: (1989) Genes Dev. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.442: 3, 628-640 [Abstract] Mellentin, J. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "628-640"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mellentin,"

Phrase: "J."
Processing 00000000.tx.443: D., Smith, S. 

Phrase: "D."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.444: D., and Cleary, M. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Cleary,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.446: (1989) Cell 58, 77-83 [Medline] [OrderarticleviaInfotrieve] Rhodes, S. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cell 58,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "77-83"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rhodes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454812:Rhodes [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.447: J., and Konieczny, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Konieczny,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.449: (1989) Genes Dev. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.450: 3, 2050-2061 [Abstract] Xia, Y., Brown, L., Yang, C. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2050-2061"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Xia,"

Phrase: "Y.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.451: Y.-C., Tsan, J. 

Phrase: "Y.-C., Tsan,"

Phrase: "J."
Processing 00000000.tx.452: T., Siciliano, M., Espinosa, R., LeBeau, M., and Baer, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Siciliano,"

Phrase: "M."

Phrase: ","

Phrase: "Espinosa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3416079:Espinosa [Eukaryote]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "LeBeau,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.453: E. 

Phrase: "E."
Processing 00000000.tx.454: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.455: Natl. 

Phrase: "Natl."
Processing 00000000.tx.456: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.457: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.458: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.459: 88, 11416-11420 [Abstract] Johnson, J. 

Phrase: "88,"

Phrase: "11416-11420"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Johnson,"

Phrase: "J."
Processing 00000000.tx.460: E., Birren, S. 

Phrase: "E.,"

Phrase: "Birren,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.461: J., and Anderson, D. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Anderson,"

Phrase: "D."
Processing 00000000.tx.462: J. 

Phrase: "J."
Processing 00000000.tx.463: (1990) Nature 346, 858-861 [CrossRef][Medline] [OrderarticleviaInfotrieve] Lee, J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Nature 346,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "858-861"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "J."
Processing 00000000.tx.464: E., Hollenberger, S. 

Phrase: "E.,"

Phrase: "Hollenberger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.465: M., Snider, L., Turner, D. 

Phrase: "M."

Phrase: ","

Phrase: "Snider,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Turner,"

Phrase: "D."
Processing 00000000.tx.466: L., Lipnick, N., and Weintraub, H. 

Phrase: "L., Lipnick,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.467: (1995) Science 268, 836-844 [Medline] [OrderarticleviaInfotrieve] Naya, F. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 268,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "836-844"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Naya,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.468: J., Stellrecht, C. 

Phrase: "J.,"

Phrase: "Stellrecht,"

Phrase: "C."
Processing 00000000.tx.469: M., and Tsai, M.-J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Tsai,"

Phrase: "M.-"

Phrase: "J."
Processing 00000000.tx.470: (1995) Genes Dev. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.471: 9, 1009-1019 [Abstract] Spicer, D. 

Phrase: "9,"

Phrase: "1009-1019"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Spicer,"

Phrase: "D."
Processing 00000000.tx.472: B., Rhee, J., Cheung, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rhee,"

Phrase: "J.,"

Phrase: "Cheung,"

Phrase: "W."
Processing 00000000.tx.473: L., and Lassar, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Lassar,"

Phrase: "A."
Processing 00000000.tx.474: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.475: (1996) Science 272, 1476-1480 [Abstract] Cserjesi, P., Brown, D., Ligon, K. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1476-1480"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cserjesi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."

Phrase: ","

Phrase: "Ligon,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: L., Lyons, G. 

Phrase: "L., Lyons,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.477: E., Copeland, N. 

Phrase: "E.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.478: G., Gilbert, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.479: J., Jenkins, N. 

Phrase: "J.,"

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.480: A., and Olson, E. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.481: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.482: (1995) Development 121, 1099-1110 [Abstract/Free FullText] Tontonoz, P., Kim, J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Development 121,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "1099-1110"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tontonoz,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.483: B., Graves, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Graves,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: A., and Spiegelman, B. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Spiegelman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.485: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.486: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.487: Biol. 

Phrase: "Biol."
Processing 00000000.tx.488: 13, 4753-4759 [Abstract] Benezra, R., Davis, R. 

Phrase: "13,"

Phrase: "4753-4759"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Benezra,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.489: L., Lockshon, D., Turner, D. 

Phrase: "L., Lockshon,"

Phrase: "D."

Phrase: ","

Phrase: "Turner,"

Phrase: "D."
Processing 00000000.tx.490: L., and Weintraub, H. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.491: (1990) Cell 61, 49-59 [Medline] [OrderarticleviaInfotrieve] Biggs, J., Murphy, E. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Cell 61,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "49-59"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Biggs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442992:Biggs [Intellectual Product]

Phrase: "J.,"

Phrase: "Murphy,"

Phrase: "E."
Processing 00000000.tx.492: V., and Israel, M. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Israel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.493: A. 

Phrase: "A."
Processing 00000000.tx.494: (1992) Proc. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.495: Natl. 

Phrase: "Natl."
Processing 00000000.tx.496: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.497: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.498: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.499: 89, 1512-1516 [Abstract] Christy, B. 

Phrase: "89,"

Phrase: "1512-1516"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Christy,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.500: A., Sanders, L. 

Phrase: "A.,"

Phrase: "Sanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.501: K., Lau, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lau,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.502: F., Copeland, N. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.503: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.504: A., and Nathans, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Nathans,"

Phrase: "D."
Processing 00000000.tx.505: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.506: Natl. 

Phrase: "Natl."
Processing 00000000.tx.507: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.508: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.509: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.510: 88, 1815-1819 [Abstract] Deed, R. 

Phrase: "88,"

Phrase: "1815-1819"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Deed,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.511: W., Bianchi, S. 

Phrase: "W., Bianchi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.512: M., Atherton, G. 

Phrase: "M."

Phrase: ","

Phrase: "Atherton,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.513: T., Johnston, D., Santibanez-Koref, M., Murphy, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnston,"

Phrase: "D."

Phrase: ","

Phrase: "Santibanez-Koref,"

Phrase: "M."

Phrase: ","

Phrase: "Murphy,"

Phrase: "J."
Processing 00000000.tx.514: J., and Norton, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Norton,"

Phrase: "J."
Processing 00000000.tx.515: D. 

Phrase: "D."
Processing 00000000.tx.516: (1993) Oncogene 8, 599-607 [Medline] [OrderarticleviaInfotrieve] Ellmeier, W., Aguzzi, A., Kleiner, E., Kurzbauer, R., and Weith, A. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Oncogene 8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "599-607"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ellmeier,"

Phrase: "W.,"

Phrase: "Aguzzi,"

Phrase: "A.,"

Phrase: "Kleiner,"

Phrase: "E.,"

Phrase: "Kurzbauer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Weith,"

Phrase: "A."
Processing 00000000.tx.517: (1992) EMBO J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.518: 11, 2563-2571 [Abstract] Reichman, V., van Crchten, I., and Sablitzky, F. 

Phrase: "11,"

Phrase: "2563-2571"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Reichman,"

Phrase: "V.,"

Phrase: "van Crchten,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Sablitzky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.519: (1994) Nucleic Acids Res. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.520: 22, 749-755 [Abstract] Sun, X.-H., Copeland, N. 

Phrase: "22,"

Phrase: "749-755"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.521: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.522: A., and Baltimore, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.523: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.524: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.525: Biol. 

Phrase: "Biol."
Processing 00000000.tx.526: 11, 5603-5611 [Medline] [OrderarticleviaInfotrieve] Loveys, D. 

Phrase: "11,"

Phrase: "5603-5611"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Loveys,"

Phrase: "D."
Processing 00000000.tx.527: A., Streiff, M. 

Phrase: "A.,"

Phrase: "Streiff,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.528: B., and Kato, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.529: J. 

Phrase: "J."
Processing 00000000.tx.530: (1996) Nucleic Acids Res. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.531: 24, 2813-2820 [Abstract/Free FullText] Jen, Y., Weintraub, H., and Benezra, R. 

Phrase: "24,"

Phrase: "2813-2820"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706322:JEN [Gene or Genome]

Phrase: "Y.,"

Phrase: "Weintraub,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Benezra,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: (1992) Genes Dev. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.533: 6, 1466-1479 [Abstract] Kreider, B. 

Phrase: "6,"

Phrase: "1466-1479"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kreider,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.534: L., Benezra, R., Rovera, G., and Kadesch, T. 

Phrase: "L., Benezra,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rovera,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.535: (1992) Science 255, 1700-1702 [Medline] [OrderarticleviaInfotrieve] Shoji, W., Yamamoto, T., and Obinata, M. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Science 255,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1700-1702"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shoji,"

Phrase: "W.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Obinata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.536: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Biol. 

Phrase: "Biol."
Processing 00000000.tx.538: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.539: 269, 5078-5084 [Abstract/Free FullText] Sun, X.-H. 

Phrase: "269,"

Phrase: "5078-5084"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.-H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.540: (1994) Cell 79, 893-900 [Medline] [OrderarticleviaInfotrieve] Wilson, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Cell 79,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "893-900"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wilson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.541: B., Kiledjian, M., Shen, C.-P., Benezra, R., Zwollo, P., Dymecki, S., Desiderio, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kiledjian,"

Phrase: "M."

Phrase: ","

Phrase: "Shen,"

Phrase: "C.-P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Benezra,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zwollo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dymecki,"

Phrase: "S."

Phrase: ","

Phrase: "Desiderio,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.542: V., and Kadesch, T. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.543: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.544: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.545: Biol. 

Phrase: "Biol."
Processing 00000000.tx.546: 11, 6185-6191 [Medline] [OrderarticleviaInfotrieve] Hsu, H.-L., Wadman, I., and Baer, R. 

Phrase: "11,"

Phrase: "6185-6191"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hsu,"

Phrase: "H.-L., Wadman,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.547: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.548: Natl. 

Phrase: "Natl."
Processing 00000000.tx.549: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.550: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.551: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.552: 91, 3181-3185 [Abstract] Fields, S., and Song, O. 

Phrase: "91,"

Phrase: "3181-3185"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Fields,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   966   C1521738:Field [Conceptual Entity]
   966   C2346620:Field [Conceptual Entity]
   966   C2349184:Field [Conceptual Entity]
   966   C3539073:FIELD [Spatial Concept]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.553: (1989) Nature 340, 245-246 [CrossRef][Medline] [OrderarticleviaInfotrieve] Goldfarb, A. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nature 340,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "245-246"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goldfarb,"

Phrase: "A."
Processing 00000000.tx.554: N., Lewandowska, K., and Shoham, M. 

Phrase: "N., Lewandowska,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Shoham,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.558: 271, 2683-2688 [Abstract/Free FullText] Staudinger, J., Perry, M., Elledge, S. 

Phrase: "271,"

Phrase: "2683-2688"

Phrase: "[Abstract/Free FullText"

Phrase: "] Staudinger,"

Phrase: "J.,"

Phrase: "Perry,"

Phrase: "M."

Phrase: ","

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.559: J., and Olson, E. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.560: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.561: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.562: Biol. 

Phrase: "Biol."
Processing 00000000.tx.563: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.564: 268, 4608-4611 [Abstract/Free FullText] Dang, C. 

Phrase: "268,"

Phrase: "4608-4611"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dang,"

Phrase: "C."
Processing 00000000.tx.565: V., Barrett, J., Villa-Garcia, M., Resar, L. 

Phrase: "V., Barrett,"

Phrase: "J.,"

Phrase: "Villa-Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442999:Garcia [Intellectual Product]
   861   C1621797:Garcia [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Resar,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.566: M., Kato, G. 

Phrase: "M."

Phrase: ","

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.567: J., and Fearon, E. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fearon,"

Phrase: "E."
Processing 00000000.tx.568: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.569: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.570: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.571: Biol. 

Phrase: "Biol."
Processing 00000000.tx.572: 11, 954-962 [Medline] [OrderarticleviaInfotrieve] Sadowski, I., and Ptashne, M. 

Phrase: "11,"

Phrase: "954-962"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sadowski,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Ptashne,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.573: (1989) Nucleic Acids Res. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.574: 17, 7539 [Medline] [OrderarticleviaInfotrieve] Neilsen, A. 

Phrase: "17,"

Phrase: "7539"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Neilsen,"

Phrase: "A."
Processing 00000000.tx.575: L., Pallisgaard, N., Pederson, F. 

Phrase: "L., Pallisgaard,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pederson,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.576: S., and Jorgenson, P. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Jorgenson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.577: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.578: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.579: Biol. 

Phrase: "Biol."
Processing 00000000.tx.580: 12, 3449-3459 [Abstract] Soosaar, A., Chiaramello, A., Zuber, M. 

Phrase: "12,"

Phrase: "3449-3459"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Soosaar,"

Phrase: "A.,"

Phrase: "Chiaramello,"

Phrase: "A.,"

Phrase: "Zuber,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: X., and Neuman, T. 

Phrase: "X.,"

Phrase: "and"

Phrase: "Neuman,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.582: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.583: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.584: 25, 176-180 [Medline] [OrderarticleviaInfotrieve] Walker, M. 

Phrase: "25,"

Phrase: "176-180"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: D., Park, C. 

Phrase: "D."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.586: W., Rosen, A., and Aronheim, A. 

Phrase: "W., Rosen,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Aronheim,"

Phrase: "A."
Processing 00000000.tx.587: (1990) Nucleic Acids Res. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.588: 18, 1159-1166 [Abstract] Aronheim, A., Shiran, R., Rosen, A., and Walker, M. 

Phrase: "18,"

Phrase: "1159-1166"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Aronheim,"

Phrase: "A.,"

Phrase: "Shiran,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rosen,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.589: D. 

Phrase: "D."
Processing 00000000.tx.590: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.591: Natl. 

Phrase: "Natl."
Processing 00000000.tx.592: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.593: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.594: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.595: 90, 8063-8067 [Abstract/Free FullText] Lillie, J. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8063-8067"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lillie,"

Phrase: "J."
Processing 00000000.tx.596: W., and Green, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.597: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.598: (1989) Nature 338, 39-44 [CrossRef][Medline] [OrderarticleviaInfotrieve] Ausubel, F. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nature 338,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "39-44"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ausubel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.599: M., Brent, R., Kingston, R. 

Phrase: "M."

Phrase: ","

Phrase: "Brent,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kingston,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.600: E., Moore, D. 

Phrase: "E.,"

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "D."
Processing 00000000.tx.601: D., Seidman, J. 

Phrase: "D."

Phrase: ","

Phrase: "Seidman,"

Phrase: "J."
Processing 00000000.tx.602: G., Smith, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.603: A., and Struhl, K. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Struhl,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.604: (eds) (1993) Current Protocols In Molecular Biology, 2nd Ed., John Wiley &Sons, Inc., New York Sambrook, J., Fritsch, E. 

Phrase: "(eds) (1993"

Phrase: ")"

Phrase: "Current Protocols In Molecular Biology,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0442711:Protocols [Intellectual Product]
   726 E C1507394:Protocol [Intellectual Product]
   726 E C1522729:Protocol [Intellectual Product]
   726 E C2348563:Protocol [Intellectual Product]

Phrase: "2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "John Wiley &Sons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037683:Son [Family Group]

Phrase: "Inc.,"

Phrase: "New York Sambrook,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027976:New York [Geographic Area]

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E."
Processing 00000000.tx.605: F., and Maniatis, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.606: (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY Apel, I., Yu, C. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual, 2nd Ed.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3538926:ED [Idea or Concept]

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Apel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539824:APEL [Gene or Genome]

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C."
Processing 00000000.tx.607: L., Wang, T., Dobry, C., Van Antwerp, M. 

Phrase: "L., Wang,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dobry,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van Antwerp,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.608: E., Jove, R., and Prochownik, E. 

Phrase: "E.,"

Phrase: "Jove,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Prochownik,"

Phrase: "E."
Processing 00000000.tx.609: V. 

Phrase: "V."
Processing 00000000.tx.610: (1992) Mol. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.611: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.612: Biol. 

Phrase: "Biol."
Processing 00000000.tx.613: 12, 3356-3364 [Abstract] Brennan, T. 

Phrase: "12,"

Phrase: "3356-3364"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Brennan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.614: J., Edmonson, D. 

Phrase: "J.,"

Phrase: "Edmonson,"

Phrase: "D."
Processing 00000000.tx.615: G., and Olson, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.616: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.617: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.618: Natl. 

Phrase: "Natl."
Processing 00000000.tx.619: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.620: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.621: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.622: 88, 3822-3826 [Abstract] Finkel, T., Duc, J., Fearon, E. 

Phrase: "88,"

Phrase: "3822-3826"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Finkel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Duc,"

Phrase: "J.,"

Phrase: "Fearon,"

Phrase: "E."
Processing 00000000.tx.623: R., Dang, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dang,"

Phrase: "C."
Processing 00000000.tx.624: V., and Tomaselli, G. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Tomaselli,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.625: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.626: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.627: Biol. 

Phrase: "Biol."
Processing 00000000.tx.628: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.629: 268, 5-8 [Abstract/Free FullText] DePinho, R. 

Phrase: "268,"

Phrase: "5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "[Abstract/Free FullText"

Phrase: "] DePinho,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.630: A., Schreiber-Agus, N., and Alt, F. 

Phrase: "A.,"

Phrase: "Schreiber-Agus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521185:AGUS [Cell or Molecular Dysfunction]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Alt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.631: W. 

Phrase: "W."
Processing 00000000.tx.632: (1991) Adv. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.633: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.634: 57, 1-46 [Medline] [OrderarticleviaInfotrieve] Olson, E. 

Phrase: "57,"

Phrase: "1-46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Olson,"

Phrase: "E."
Processing 00000000.tx.635: N., and Klein, W. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.636: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.637: (1994) Genes Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.638: 8, 1-8 [CrossRef][Medline] [OrderarticleviaInfotrieve] Klein, E. 

Phrase: "8,"

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Klein,"

Phrase: "E."
Processing 00000000.tx.639: S., Simmons, D. 

Phrase: "S."

Phrase: ","

Phrase: "Simmons,"

Phrase: "D."
Processing 00000000.tx.640: M., Swanson, L. 

Phrase: "M."

Phrase: ","

Phrase: "Swanson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.641: W., and Rosenfeld, M. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Rosenfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.642: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.643: (1993) Genes Dev. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.644: 7, 55-71 [Abstract] Sun, X.-H., and Baltimore, D. 

Phrase: "7,"

Phrase: "55-71"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C0450389:71 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "X.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "D."
Processing 00000000.tx.645: (1991) Cell 64, 459-470 [Medline] [OrderarticleviaInfotrieve] Zhuang, Y., Cheng, P., and Weintraub, H. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell 64,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "459-470"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zhuang,"

Phrase: "Y.,"

Phrase: "Cheng,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.646: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.647: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.648: Biol. 

Phrase: "Biol."
Processing 00000000.tx.649: 16, 2898-2905 [Abstract] Shirakata, M., Friedman, F. 

Phrase: "16,"

Phrase: "2898-2905"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shirakata,"

Phrase: "M."

Phrase: ","

Phrase: "Friedman,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.650: K., Wei, Q., and Paterson, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wei,"

Phrase: "Q.,"

Phrase: "and"

Phrase: "Paterson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.651: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.652: (1993) Genes Dev. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.653: 7, 2456-2470 [Abstract] Estojak, J., Brent, R., and Golemis, E. 

Phrase: "7,"

Phrase: "2456-2470"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Estojak,"

Phrase: "J.,"

Phrase: "Brent,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Golemis,"

Phrase: "E."
Processing 00000000.tx.654: A. 

Phrase: "A."
Processing 00000000.tx.655: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.656: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.657: Biol. 

Phrase: "Biol."
Processing 00000000.tx.658: 15, 5820-5829 [Abstract] Wadman, I., Li, J., Bash, R. 

Phrase: "15,"

Phrase: "5820-5829"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wadman,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Bash,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332420:BASH [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.659: O., Forster, A., Osada, H., Rabbitts, T. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Forster,"

Phrase: "A.,"

Phrase: "Osada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.660: H., and Baer, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.661: (1994) EMBO J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.662: 13, 4831-4839 [Abstract] Shen, C. 

Phrase: "13,"

Phrase: "4831-4839"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shen,"

Phrase: "C."
Processing 00000000.tx.663: P., and Kadesch, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Kadesch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.664: (1995) Mol. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.665: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.666: Biol. 

Phrase: "Biol."
Processing 00000000.tx.667: 15, 18-24 Springhorn, J. 

Phrase: "15,"

Phrase: "18-24 Springhorn,"

Phrase: "J."
Processing 00000000.tx.668: P., Singh, K., Kelly, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Singh,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kelly,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.669: A., and Smith, T. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.670: W. 

Phrase: "W."
Processing 00000000.tx.671: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.672: Biol. 

Phrase: "Biol."
Processing 00000000.tx.673: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.674: 269, 5132-5136 [Abstract/Free FullText] Skerjanc, I. 

Phrase: "269,"

Phrase: "5132-5136"

Phrase: "[Abstract/Free FullText"

Phrase: "] Skerjanc,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.675: S., Truong, J., Filion, P., and McBurney, M. 

Phrase: "S."

Phrase: ","

Phrase: "Truong,"

Phrase: "J.,"

Phrase: "Filion,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "McBurney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.676: W. 

Phrase: "W."
Processing 00000000.tx.677: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.678: Biol. 

Phrase: "Biol."
Processing 00000000.tx.679: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.680: 271, 3555-3561 [Abstract/Free FullText] Hsu, H.-L., Huang, L., Tsan, J. 

Phrase: "271,"

Phrase: "3555-3561"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hsu,"

Phrase: "H.-L., Huang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2346686:h l [Quantitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tsan,"

Phrase: "J."
Processing 00000000.tx.681: T., Funk, W., Wright, W. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Funk,"

Phrase: "W.,"

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "W."
Processing 00000000.tx.682: E., Hu, J.-S., Kingston, R. 

Phrase: "E.,"

Phrase: "Hu,"

Phrase: "J.-S.,"

Phrase: "Kingston,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.683: E., and Baer, R. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.684: E. 

Phrase: "E."
Processing 00000000.tx.685: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.686: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.687: Biol. 

Phrase: "Biol."
Processing 00000000.tx.688: 14, 1256-1265 [Abstract] Lassar, A. 

Phrase: "14,"

Phrase: "1256-1265"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lassar,"

Phrase: "A."
Processing 00000000.tx.689: B., and Weintraub, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Weintraub,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.690: (1992) in Transcriptional Regulation (Mcknight, S. L., and Yamamoto, K. R., eds), pp. 

Phrase: "(1992"

Phrase: ")"

Phrase: "in Transcriptional Regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "(Mcknight,"

Phrase: "S. L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439394:s l [Quantitative Concept]

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K. R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.691: 1037-1061, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY Molkentin, J. 

Phrase: "1037-1061,"

Phrase: "Cold Spring Harbor Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022877:Laboratory [Manufactured Object,Organization]
   812   C3244292:laboratory [Functional Concept]

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Molkentin,"

Phrase: "J."
Processing 00000000.tx.692: D., and Olson, E. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Olson,"

Phrase: "E."
Processing 00000000.tx.693: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.694: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.695: Natl. 

Phrase: "Natl."
Processing 00000000.tx.696: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.697: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.698: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.699: 93, 9366-9373 [Abstract/Free FullText] Osada, H., Grutz, G., Axelson, H., Forster, A., and Rabbitts, T. 

Phrase: "93,"

Phrase: "9366-9373"

Phrase: "[Abstract/Free FullText"

Phrase: "] Osada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grutz,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Axelson,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Forster,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.700: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.701: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.702: Natl. 

Phrase: "Natl."
Processing 00000000.tx.703: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.704: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.705: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.706: 92, 9585-9589 [Abstract] 1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "92,"

Phrase: "9585-9589"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 1997 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

